<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-HEADER AEXT-CLASS="Y">
<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20210122">4.2</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00765851">위더스제약(주)</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">N</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">110111-3069534</EXTRACTION>
</SUMMARY>
</DOCUMENT-HEADER>

<BODY>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 정정문서 작성시 『정오표』 삽입</COMMENT>
<LIBRARYLIST>정정신고(보고)-대표이사등의확인.LCommon</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="LCommon">정정신고(보고)-대표이사등의확인</FILENAME>

<CORRECTION>
<TITLE ATOC="Y" AASSOCNOTE="CORRECTION">정 정 신 고 (보고)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">2021년 06월 08일</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
<P USERMARK="F-14">1. 정정대상 공시서류 : 사업보고서</P>
<P></P>
<P USERMARK="F-14">2. 정정대상 공시서류의 최초제출일 : 2021.03.18</P>
<P></P>
<P USERMARK="F-14">3. 정정사항</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="711" BORDER="1">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="258" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">항  목</TH>
<TH ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정정사유 </TH>
<TH ALIGN="CENTER" WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 전</TH>
<TH ALIGN="CENTER" WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">정 정 후</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="53" VALIGN="MIDDLE">I. 회사의 개요&cr;6. 배당에 관한 사항</TD>
<TD WIDTH="125" HEIGHT="219" VALIGN="MIDDLE" ROWSPAN="5" ALIGN="CENTER">내용 추가</TD>
<TD WIDTH="164" HEIGHT="219" VALIGN="MIDDLE" ROWSPAN="5" ALIGN="CENTER">주1) 정정 전</TD>
<TD WIDTH="164" HEIGHT="219" VALIGN="MIDDLE" ROWSPAN="5" ALIGN="CENTER">주2) 정정 후</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="53" VALIGN="MIDDLE">I. 회사의 개요&cr;7. 정관에 관한 사항</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="258" HEIGHT="53" VALIGN="MIDDLE">II. 사업의 내용&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN>10. 연구개발 활동</SPAN>
<SPAN></SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30" VALIGN="MIDDLE">IX. 계열회사 등에 관한 사항</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30" VALIGN="MIDDLE">XI. 그 밖에 투자자 보호를 위하여</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">주1)&cr;</SPAN>
<SPAN USERMARK=" B">I. 회사의 개요&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200 B">6. 정관에 관한 사항&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">가. 배당정책, 배당제한 관한 사항</SPAN>
<SPAN USERMARK="F-GL">&cr;당사의 정관 상 배당에 관한 사항은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="646" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="637"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="646" HEIGHT="904">
<P>제11조 (신주의 배당기산일) </P>
<P>회사가 유상증자, 무상증자 및 주식배당에 의하여 발행한 신주에 대한 이익의 배당에 </P>
<P>관하여는 신주를 발행한 때가 속하는 영업연도의 직전영업연도말에 발행된 것으로 본다. </P>
<P>&cr;</P>
<P>제53조 (이익금의 처분) </P>
<P>회사는 매사업연도의 처분전 이익잉여금을 다음과 같이 처분한다.</P>
<P>1. 이익준비금 </P>
<P>2. 기타의 법정준비금</P>
<P>3. 배당금</P>
<P>4. 임의적립금</P>
<P>5. 기타의 이익잉여금처분액</P>
<P>&cr;</P>
<P>제 54조 (이익배당) </P>
<P>① 이익배당은 금전 또는 금전 외의 재산으로 할 수 있다. </P>
<P>② 이익의 배당을 주식으로 하는 경우 회사가 종류주식을 발행한 때에는 각각 그와 같은 종류의 주식으로 할 수 있다.</P>
<P>③ 제1항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게</P>
<P>지급한다.</P>
<P>④ 이익배당은 주주총회의 결의로 정한다.&cr;&cr;</P>
<P>제 55조 (중간배당) </P>
<P>① 이 회사는 12월 31일 0시 현재의 주주에게 상법 제462조의3에 의한 중간배당을 할 수 있다.</P>
<P>② 제1항의 중간배당은 이사회의 결의로 하되, 그 결의는 제1항의 기준일 이후 45일 내에 하여야 한다.</P>
<P>③ 중간배당은 직전결산기의 대차대조표상의 순자산액에서 다음 각호의 금액을 공제한 액을 한도로 한다.</P>
<P>1. 직전 결산기의 자본금의 액</P>
<P>2. 직전 결산기까지 적립된 자본준비금과 이익준비금의 합계액</P>
<P>3. 상법시행령에서 정하는 미실현이익</P>
<P>4. 직전 결산기의 정기주주총회에서 이익배당하기로 정한 금액</P>
<P>5. 직전 결산기까지 정관의 규정 또는 주주총회의 결의에 의하여 특정목적을 위해</P>
<P>적립한 임의준비금</P>
<P>6. 중간배당에 따라 당해 결산기에 적립하여야 할 이익준비금</P>
<P>④ 사업연도 개시일이후 제1항의기준일 이전에 신주를 발행한 경우(준비금의 자본전입, 주식배당, 전환사채의 전환청구, 신주인수권부사채의 신주인수권행사의 경우를 포함한다) 에는 중간배당에 관해서는 당해 신주는 직전 사업연도 말에 발행된 것으로 본다. </P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">나. 최근 3사업년도 배당 내역</P>
<P USERMARK="F-GL">주요배당지표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="820" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="106" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="106" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기&cr;(2020.07.01~2020.12.31)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제16기&cr;(2019.07.01~2020.06.30)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제15기&cr;(2018.07.01~2019.06.30)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">주당액면가액(원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">200</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">200</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">5,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,867</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">8,039</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">8,661</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">212</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,036</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">27,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">422</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,802</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">22.6</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">22.42</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">현금배당수익률(%)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">0.23</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1.01</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주식배당수익률(%)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">48</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">205</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주당 주식배당(주)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 이익참가부 사채에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
</P>
<P></P>
<P>과거 배당 이력</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">1</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">0.37</TD>
<TD ALIGN="RIGHT" WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">0.20</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK=" B">&cr;I. 회사의 개요&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200 B">7. 정관에 관한 사항&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>
<P>정관 변경 이력</P>

<TABLE BORDER="1" WIDTH="728" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="207"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">정관변경일</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">해당주총명</TD>
<TD WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">주요변경사항</TD>
<TD WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">변경이유</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2020년 09월 25일</TD>
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제16기 정기주주총회</TD>
<TD WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1. 주주명부 폐쇄 기준일 변경&cr;2. 이사회 소집 기간 변경&cr;3. 사업연도 변경</TD>
<TD WIDTH="216" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">1. 원활한 운영에 따른 변경&cr;2. 소집 시기의 융통성 확보&cr;3. 결산기 변경으로 인한 변경</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">II. 사업의 내용&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">10. 연구개발 활동</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 연구개발 완료 실적</SPAN>
</P>

<TABLE BORDER="1" WIDTH="871" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개발완료일</P>
</TH>

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>현재 현황</P>
</TH>

<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="10" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="300">
<P>화학합성</P>
</TD>

<TD ROWSPAN="10" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="300">
<P>제네릭</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>트윈플러스정 80/5mg </P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혈압강하제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.01</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 트윈플러스정40/10</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 혈압강하제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 뮤세틸캡슐200mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 진해거담제 및 기침감기약</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017.08</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 솔리신정10mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 솔리신정5mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 로수브이정20mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 고지혈증 치료제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2018.03</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정10/160mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.06</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미르토플러스정 40/12.5mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.02</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정5/80mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.07</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정5/160mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.07</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자사생동입증품목</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1122" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="522"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구과제</P>
</TH>

<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구기관</P>
</TH>

<TH WIDTH="531" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과 및 기대효과</P>
</TH>

<TH WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과가 상품화된 경우 그 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"트윈플러스정80/5mg"&cr;(텔미사르탄 80mg, &cr;암로디핀베실레이트 &cr;6.935mg)과 대조약의 &cr;생물학적 동등성 &cr;평가시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 트윈스타정80/5mg - 한국베링거인겔하임㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 48명에게 공복 시 단회 경구투여하여 &cr;혈중 암로디핀 및 텔미사르탄을 측정하고, 비교평가항목치(AUCt, Cmax)를 &cr;로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 &cr;log0.8~log1.25 이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 트윈플러스정80/5mg</P>
<P>* 출시일자 : 2017년 1월</P>
<P>* 주성분 : Telmisartan&cr;               Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"트윈플러스정40/10, &cr;40/5mg(텔미사르탄, &cr;암로디핀베실산염)"의&cr;  비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 트윈플러스정80/5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 트윈플러스정80/5mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 &cr;시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 트윈플러스정40/10mg</P>
<P>              트윈플러스정40/5mg</P>
<P>* 출시일자 : 2017년 7월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>"뮤세틸캡슐200mg&cr;(아세틸시스테인)" 개발</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="145">
<P>* 대조약 : 뮤테란캅셀200mg (아세틸시스테인) - 한화제약㈜</P>
<P>* 진해거담제 및 기침감기약으로 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="145">
<P>* 제품명 : 뮤세틸캡슐200mg&cr;               (아세틸시스테인)</P>
<P>* 출시일자 : 2017년 8월</P>
<P>* 주성분 : Acetylcysteine</P>
<P>* 구분 : 진해거담제 & 기침감기약</P>
<P>* 제품 라인 추가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>1. "솔리신정10밀리그램&cr;(솔리페나신숙신산염)"의 생물학적 동등성시험</P>
<P> &cr;2. "솔리신정5밀리그램&cr;(솔리페나신숙신산염)"의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="283">
<P>1. * 대조약 : 베시케어정10밀리그램 (솔리페나신숙신산염) &cr;- 한국아스텔라스제약㈜</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 2X2 교차시험으로 건강한 성인 39명에게 공복 시 단회 경구투여하여 혈중 솔리페나신을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 &cr;생물학적으로 동등함을 입증 </P>
<P>&cr;2.* 대조약 : 솔리신정10mg (솔리페나신숙신산염) -  위더스제약(주)</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="283">
<P>* 제품명 :  1. 솔리신정10mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>               2. 솔리신정5mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>* 출시일자(1, 2 공통) : 2017년 7월</P>
<P>* 주성분(1, 2 공통) : Solifenacin succinate</P>
<P>* 구분(1, 2 공통) : 비뇨생식계 평활근 이완제</P>
<P>* First generic</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"로수브이정20mg&cr;(로수바스타틴칼슘)" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 로수브이정10mg (로수바스타틴칼슘) : 위더스제약㈜</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 로수브이정10mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 로수브이정20mg</P>
<P>* 출시일자 : 2018년 3월</P>
<P>* 주성분 : Rosuvastatin calcium</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 자사전환 완료 및 "로수브이정5mg"추가 허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"브이디핀정10/160mg" 의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 엑스포지정10/160mg - 한국노바티스㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 56명에게 공복 시 단회 경구투여하여 혈중 발사르탄 및 암로디핀을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 &cr;이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 브이디핀정10/160mg</P>
<P>* 출시일자 : 2018년 6월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate &cr;* 구분 : 혈압강하제</P>
<P>* Valsartan 원료 이슈 당시 해당되지 않았음</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"미르토플러스정&cr;40/12.5mg"의 &cr;비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 미르토플러스정80/12.5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 미르토플러스정80/12.5mg을 &cr;대조약으로 하여, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 미르토플러스정40/12.5mg</P>
<P>* 출시일자 : 2019년 2월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Hydrochlorothiazide</P>
<P>* 구분 : 혈압강하제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"브이디핀정5/80mg, &cr;브이디핀정5/160mg" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 브이디핀정10/160mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 브이디핀정10/160mg을 &cr;대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 브이디핀정5/80mg</P>
<P>              브이디핀정5/160mg</P>
<P>* 출시일자 : 2019년 7월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;&cr;</SPAN>
<SPAN USERMARK=" B">IX. 계열회사 등에 관한 사항</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL 0XFF1200 B">2. 타법인 출자현황</SPAN>
</P>

<TABLE WIDTH="1288" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="834"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="BOTTOM" HEIGHT="30">(기준일 : </TD>
<TD WIDTH="152" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2020년 12월 31일</TD>
<TD WIDTH="213" VALIGN="BOTTOM" HEIGHT="30">)</TD>
<TD WIDTH="843" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원, 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1288" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="68"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">법인명</TD>
<TD ROWSPAN="3" WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득일자</TD>
<TD ROWSPAN="3" WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">출자&cr;목적</TD>
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득금액</TD>
<TD COLSPAN="3" WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기초잔액</TD>
<TD COLSPAN="3" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">증가(감소)</TD>
<TD COLSPAN="3" WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기말잔액</TD>
<TD COLSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">최근사업연도&cr;재무현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">평가&cr;손익</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">총자산</TD>
<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">당기&cr;순손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수량</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(주)인벤티지랩</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년 9월 8일</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">단순투자</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="479" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,796</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</SPAN>&cr;&cr;&cr;&cr;&cr;주2)&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">I. 회사의 개요&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" 0XFF1200 B">6. 배당에 관한 사항&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN></SPAN>
<SPAN>당사는 제품 및 사업 경쟁력 강화와 함께 주주환원을 통하여 주주가치를 제고할 수 있도록 지속적으로 노력하고 있습니다. 정관에 의거 이사회 및 주주총회 결의를 통하여 배당을 실시하고 있으며, 배당가능이익 범위 내에서 회사의 지속적 성장을 위한 투자 및 경영환경 등을 고려하여 적정수준의 배당률을 결정하고 있습니다. 당사는 자사주 매입에 대한 계획 등은 현재 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">가. 배당정책, 배당제한 관한 사항</SPAN>
<SPAN USERMARK="F-GL">&cr;당사의 정관 상 배당에 관한 사항은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="646" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="637"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="646" HEIGHT="513">
<P>제11조 (신주의 배당기산일) </P>
<P>회사가 유상증자, 무상증자 및 주식배당에 의하여 발행한 신주에 대한 이익의 배당에 </P>
<P>관하여는 신주를 발행한 때가 속하는 영업연도의 직전영업연도말에 발행된 것으로 본다. </P>
<P>&cr;</P>
<P>제53조 (이익금의 처분) </P>
<P>회사는 매사업연도의 처분전 이익잉여금을 다음과 같이 처분한다.</P>
<P>1. 이익준비금 </P>
<P>2. 기타의 법정준비금</P>
<P>3. 배당금</P>
<P>4. 임의적립금</P>
<P>5. 기타의 이익잉여금처분액</P>
<P>&cr;</P>
<P>제 54조 (이익배당) </P>
<P>① 이익배당은 금전 또는 금전 외의 재산으로 할 수 있다. </P>
<P>② 이익의 배당을 주식으로 하는 경우 회사가 종류주식을 발행한 때에는 각각 그와 같은 종류의 주식으로 할 수 있다.</P>
<P>③ 제1항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게</P>
<P>지급한다.</P>
<P>④ 이익배당은 주주총회의 결의로 정한다.&cr;</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<P USERMARK="F-GL B">나. 최근 3사업년도 배당 내역</P>
<P USERMARK="F-GL">주요배당지표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="820" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="106" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="106" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기&cr;(2020.07.01~2020.12.31)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제16기&cr;(2019.07.01~2020.06.30)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제15기&cr;(2018.07.01~2019.06.30)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">주당액면가액(원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">200</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">200</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">5,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,867</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">8,039</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">8,661</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">212</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,036</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">27,940</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">422</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1,802</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">22.6</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">22.42</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">현금배당수익률(%)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">0.23</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">1.01</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주식배당수익률(%)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">48</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">205</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" ALIGN="CENTER">주당 주식배당(주)</TD>
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="30" VALIGN="MIDDLE">우선주</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="189" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">※현금배당성향 : 현금배당금총액/당기순이익 입니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 이익참가부 사채에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
</P>

<P>&cr;
<SPAN USERMARK="F-GL B">마. 과거 배당 이력</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">0</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">1</TD>
<TD ALIGN="RIGHT" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">0.37</TD>
<TD ALIGN="RIGHT" WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">0.81</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL">13기 20억규모 중간배당을 실시하였습니다. 13기 당시의 배당수익률은 비상장으로 인한 상증법으로 계산되어 3.02%입니다. &cr;※평균 배당수익률의 최근 3년간은 16기 배당수익률을 3으로 나눈 값입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL">평균 배당수익률의 최근 5년간은 13기 중간배당수익률과 16기 결산배당수익률의</SPAN>
<SPAN USERMARK="F-GL"> 합</SPAN>
<SPAN USERMARK="F-GL">을 5로 나눈 값입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL"> 16기 배당수익률 : 1.01%, 13기 중간배당수익률 : 3.02%&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>&cr;
<SPAN USERMARK=" B">I. 회사의 개요&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200 B">7. 정관에 관한 사항&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>당사의 최근 정관 개정일은 2020년 09월 25일이며, 보고서 제출일 이후 개최 예정인 제17기 정기주주총회의 안건에는 정관 변경 건이 포함되어 있지 않습니다.&cr;&cr;정관 변경 이력
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="728">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="207"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정관변경일</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">해당주총명</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="216" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주요변경사항</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="216" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">변경이유</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월 25일</TD>
<TD WIDTH="159" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">제16기 정기주주총회</TD>
<TD WIDTH="216" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">1. 주주명부 폐쇄 기준일 변경&cr;2. 이사회 소집 기간 변경&cr;3. 사업연도 변경</TD>
<TD WIDTH="216" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">1. 원활한 운영에 따른 변경&cr;2. 소집 시기의 융통성 확보&cr;3. 결산기 변경으로 인한 변경</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">II. 사업의 내용&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">10. 연구개발 활동</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 연구개발 완료 실적</SPAN>
</P>

<TABLE BORDER="1" WIDTH="871" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개발완료일</P>
</TH>

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>현재 현황</P>
</TH>

<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="15" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">
<P>화학합성</P>
</TD>

<TD ROWSPAN="15" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="450">
<P>제네릭</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>트윈플러스정 80/5mg </P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>혈압강하제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.01</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 트윈플러스정40/10</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 혈압강하제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 뮤세틸캡슐200mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 진해거담제 및 기침감기약</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017.08</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 솔리신정10mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 솔리신정5mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 로수브이정20mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 고지혈증 치료제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 2018.03</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정10/160mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2018.06</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미르토플러스정 40/12.5mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.02</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정5/80mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.07</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">브이디핀정5/160mg</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">혈압강하제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019.07</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">국내판매중</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레가바정 150mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레가바정 75mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레가바정 50mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아바젯정10/20mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>고지혈증 치료제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.05</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아바젯정 10/10mg</P>
</TD>

<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>고지혈증 치료제</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2021.05</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>비교용출 자사생산</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1122" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="522"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구과제</P>
</TH>

<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구기관</P>
</TH>

<TH WIDTH="531" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과 및 기대효과</P>
</TH>

<TH WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과가 상품화된 경우 그 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"트윈플러스정80/5mg"&cr;(텔미사르탄 80mg, &cr;암로디핀베실레이트 &cr;6.935mg)과 대조약의 &cr;생물학적 동등성 &cr;평가시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 트윈스타정80/5mg - 한국베링거인겔하임㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 48명에게 공복 시 단회 경구투여하여 &cr;혈중 암로디핀 및 텔미사르탄을 측정하고, 비교평가항목치(AUCt, Cmax)를 &cr;로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 &cr;log0.8~log1.25 이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 트윈플러스정80/5mg</P>
<P>* 출시일자 : 2017년 1월</P>
<P>* 주성분 : Telmisartan&cr;               Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"트윈플러스정40/10, &cr;40/5mg(텔미사르탄, &cr;암로디핀베실산염)"의&cr;  비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 트윈플러스정80/5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 트윈플러스정80/5mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 &cr;시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 트윈플러스정40/10mg</P>
<P>              트윈플러스정40/5mg</P>
<P>* 출시일자 : 2017년 7월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>"뮤세틸캡슐200mg&cr;(아세틸시스테인)" 개발</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="145">
<P>* 대조약 : 뮤테란캅셀200mg (아세틸시스테인) - 한화제약㈜</P>
<P>* 진해거담제 및 기침감기약으로 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="145">
<P>* 제품명 : 뮤세틸캡슐200mg&cr;               (아세틸시스테인)</P>
<P>* 출시일자 : 2017년 8월</P>
<P>* 주성분 : Acetylcysteine</P>
<P>* 구분 : 진해거담제 & 기침감기약</P>
<P>* 제품 라인 추가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>1. "솔리신정10밀리그램&cr;(솔리페나신숙신산염)"의 생물학적 동등성시험</P>
<P> &cr;2. "솔리신정5밀리그램&cr;(솔리페나신숙신산염)"의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="283">
<P>1. * 대조약 : 베시케어정10밀리그램 (솔리페나신숙신산염) &cr;- 한국아스텔라스제약㈜</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 2X2 교차시험으로 건강한 성인 39명에게 공복 시 단회 경구투여하여 혈중 솔리페나신을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 &cr;생물학적으로 동등함을 입증 </P>
<P>&cr;2.* 대조약 : 솔리신정10mg (솔리페나신숙신산염) -  위더스제약(주)</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="283">
<P>* 제품명 :  1. 솔리신정10mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>               2. 솔리신정5mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>* 출시일자(1, 2 공통) : 2017년 7월</P>
<P>* 주성분(1, 2 공통) : Solifenacin succinate</P>
<P>* 구분(1, 2 공통) : 비뇨생식계 평활근 이완제</P>
<P>* First generic</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"로수브이정20mg&cr;(로수바스타틴칼슘)" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 로수브이정10mg (로수바스타틴칼슘) : 위더스제약㈜</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 로수브이정10mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 로수브이정20mg</P>
<P>* 출시일자 : 2018년 3월</P>
<P>* 주성분 : Rosuvastatin calcium</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 자사전환 완료 및 "로수브이정5mg"추가 허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"브이디핀정10/160mg" 의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 엑스포지정10/160mg - 한국노바티스㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 56명에게 공복 시 단회 경구투여하여 혈중 발사르탄 및 암로디핀을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 &cr;이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 브이디핀정10/160mg</P>
<P>* 출시일자 : 2018년 6월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate &cr;* 구분 : 혈압강하제</P>
<P>* Valsartan 원료 이슈 당시 해당되지 않았음</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"미르토플러스정&cr;40/12.5mg"의 &cr;비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 미르토플러스정80/12.5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 미르토플러스정80/12.5mg을 &cr;대조약으로 하여, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 미르토플러스정40/12.5mg</P>
<P>* 출시일자 : 2019년 2월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Hydrochlorothiazide</P>
<P>* 구분 : 혈압강하제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>"브이디핀정5/80mg, &cr;브이디핀정5/160mg" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 브이디핀정10/160mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 브이디핀정10/160mg을 &cr;대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 브이디핀정5/80mg</P>
<P>              브이디핀정5/160mg</P>
<P>* 출시일자 : 2019년 7월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>“레가바정75mg”의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 리리카캡슐75mg ? 한국화이자제약㈜</P>
<P>* 중추신경용제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 27명에게 공복 시 단회 경구투여하여 혈중 프레가발린을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 생물학적으로 동등함을 입증 </P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 레가바정75mg</P>
<P>* 출시일자 : 2020년 11월</P>
<P>* 주성분 : Pregabalin&cr; * 구분 : 중추신경용제</P>
<P>* 캡슐제 → 정제 제형 변경하여 동등성 입증</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>“레가바정150mg, 레가바정50mg”의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 레가바정75mg ? 위더스제약㈜</P>
<P>* 중추신경용제로써 개발</P>
<P>* 생물학적 동등성을 인정받은 자사 품목인 레가바정75mg을 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성 판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 레가바정150mg, 레가바정50mg</P>
<P>* 출시일자 : 2020년 11월</P>
<P>* 주성분 : Pregabalin&cr; * 구분 : 중추신경용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>“아바젯정10/20mg”의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 아토젯정10/20mg ? 한국엠에스디(유)</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인에게 공복 시 단회 경구투여하여 혈중 아토르바스타틴 및 에제티미브를 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 아바젯정10/20mg</P>
<P>* 출시일자 : 2021년 5월</P>
<P>* 주성분 : Atorvastatin</P>
<P>           Ezetimibe</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 이중정 생산 방식</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>“아바젯정10/10mg”의 비교용출시험</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" VALIGN="MIDDLE" HEIGHT="168">
<P>* 대조약 : 아바젯정10/20mg ? 위더스제약㈜</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 생물학적 동등성을 인정받은 자사 품목인 아바젯정10/20mg을 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성 판정기준에 적합</P>
</TD>

<TD WIDTH="302" VALIGN="MIDDLE" HEIGHT="168">
<P>* 제품명 : 아바젯정10/20mg</P>
<P>* 출시일자 : 2021년 5월</P>
<P>* 주성분 : Atorvastatin</P>
<P>           Ezetimibe</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 이중정 생산 방식</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">사. 연구개발 중단 현황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">아. 판매중단 현황</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="861">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>품 목</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>적응증</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매승인일</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매중단일</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매 중단 사유</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학</P>
<P>합성</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">액사티딘정75mg</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">소화성궤양용제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2004-11-23</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020-12-24</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NDMA등 불순물 함유 우려</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK=" B">IX. 계열회사 등에 관한 사항</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL 0XFF1200 B">2. 타법인 출자현황</SPAN>
</P>

<TABLE WIDTH="1288" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="834"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="BOTTOM" HEIGHT="30">(기준일 : </TD>
<TD WIDTH="152" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2020년 12월 31일</TD>
<TD WIDTH="213" VALIGN="BOTTOM" HEIGHT="30">)</TD>
<TD WIDTH="843" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원, 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1288" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="68"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">법인명</TD>
<TD ROWSPAN="3" WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득일자</TD>
<TD ROWSPAN="3" WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">출자&cr;목적</TD>
<TD ROWSPAN="3" WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득금액</TD>
<TD COLSPAN="3" WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기초잔액</TD>
<TD COLSPAN="3" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">증가(감소)</TD>
<TD COLSPAN="3" WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기말잔액</TD>
<TD COLSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">최근사업연도&cr;재무현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">평가&cr;손익</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">총자산</TD>
<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">당기&cr;순손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수량</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)인벤티지랩&cr;(비상장)</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020년 9월 8일</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기술성 투자</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="479" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,796</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B">&cr;XI. 그 밖에 투자자 보호를 위하여 필요한 사항</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL 0XFF1200 B">1. 공시내용의 진행ㆍ변경상황 및 주주총회 현황&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-GL B">가. 공시사항의 진행 및 변경 상황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 주주총회 의사록 요약</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE BORDER="1" WIDTH="910" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="517"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주총일자</TH>
<TH WIDTH="526" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">안 건</TH>
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">결 의 내 용</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제16기 정기주주총회&cr;(2020.09.25)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 제16기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 이사보수한도 승인의 건&cr;제 4호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제16기 임시주주총회&cr;(2020.05.06)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 제 15기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제16기 임시주주총회&cr;(2019.11.28)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사외이사 이용주&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 주식매수선택권 부여의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제15기 정기주주총회&cr;(2019.09.30)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 제 15기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 이사보수한도 승인의 건&cr;제 4호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제15기 임시주주총회&cr;(2019.08.19)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="76">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 성대영&cr;제 1-2호 의안 : 사내이사 안종태</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제15기 임시주주총회&cr;(2018.12.03)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 감사 선임의 건&cr;제 1-1호 의안 : 감사 이승철</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">제14기 정기주주총회&cr;(2018.09.28)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="168">제 1호 의안 : 제 14기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 감사 선임의 건&cr;제 2-1호 의안 : 감사 이광영&cr;제 3호 의안 : 정관 일부 변경의 건&cr;제 4호 의안 : 이사보수한도 승인의 건&cr;제 5호 의안 : 감사보수한도 승인의 건&cr;제 6호 의안 : 임원 퇴직금 규정 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제14기 임시주주총회&cr;(2018.07.02)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 권광영</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제13기 정기주주총회&cr;(2017.09.29)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="76">제 1호 의안 : 제 13기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 이사보수한도 승인의 건&cr;제 3호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제13기 임시주주총회&cr;(2017.07.03)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사외이사 민경철</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제13기 임시주주총회&cr;(2016.08.19)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 성대영&cr;제 1-2호 의안 : 사내이사 김호천&cr;제 1-3호 의안 : 사내이사 안종태</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">&cr;
<SPAN></SPAN>
<SPAN USERMARK=" 0XFF1200 B">2. 우발채무 등&cr;</SPAN>
<SPAN USERMARK=" B">가. 중요한 소송사건&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음, 수표현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">다. 채무보증 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">라. 채무인수약정 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">바. 자본으로 인정되는 채무증권의 발행&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN></SPAN>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" 0XFF1200 B">3. 제재현황 등 그밖의 사항&cr;</SPAN>
<SPAN USERMARK=" B">가. 제재현황&cr;</SPAN>(1) 세무조사 등&cr;당사는 최근 5사업연도 이내 1건의 세무조사를 받은 바 있으며 납부 고지세액 전액을 납부 하였습니다. &cr;&cr;
</P>
<P USERMARK="F-GL">(가) 2017년 법인세 일반통합조사</P>

<TABLE BORDER="1" WIDTH="559" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="425"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>내용 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사기관</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>도봉세무서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사기간</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>2017.03.09. ~ 2017.05.17</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사대상기간</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>2013.07.01. ~ 2014.06.30 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사사유</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>법인세 일반통합조사(교차세무조사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>조사내용</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="53">
<P>접대성 경비의 계정분류 오류 정정</P>
<P>법정 증빙 부적격분 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>납부세액</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="53">
<P>합계 791,524,520원</P>
<P>법인세 719,567,750원, 지방세 71,956,770</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK=" B">나. 작성기준일 이후 발생한 주요사항&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">다. 중소기업 기준검토표</SPAN>
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="909">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="835" ALIGN="CENTER" HSPACE="0">위더스제약(주)_중소기업검토기준표1.jpg</IMG>
<IMG-CAPTION ATOC="N">위더스제약(주)_중소기업검토기준표1</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="30">
<P>중소기업검토기준표1</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="909">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="835" ALIGN="CENTER" HSPACE="0">위더스제약(주)_중소기업검토기준표2.jpg</IMG>
<IMG-CAPTION ATOC="N">위더스제약(주)_중소기업검토기준표2</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="30">
<P>중소기업검토기준표2</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>

<P>
<SPAN USERMARK=" B">라. 직접금융 자금의 사용&cr;</SPAN>(1) 공모자금의 사용 내역
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="924" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="624" HEIGHT="30">(단위 : 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="923" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="268" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="256" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="190" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="78" HEIGHT="53" VALIGN="MIDDLE">일반공모</TD>
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="53" VALIGN="MIDDLE">1</TD>
<TD ALIGN="CENTER" WIDTH="140" HEIGHT="53" VALIGN="MIDDLE">2020년 06월 29일</TD>
<TD ALIGN="CENTER" WIDTH="190" HEIGHT="53" VALIGN="MIDDLE">시설자금&cr;연구개발자금 및 운전자금</TD>
<TD ALIGN="RIGHT" WIDTH="78" HEIGHT="53" VALIGN="MIDDLE">10,000&cr;4,000</TD>
<TD ALIGN="CENTER" WIDTH="193" HEIGHT="53" VALIGN="MIDDLE">시설자금&cr;연구개발자금 및 운전자금</TD>
<TD ALIGN="RIGHT" WIDTH="63" HEIGHT="53" VALIGN="MIDDLE">10,000&cr;4,000</TD>
<TD ALIGN="CENTER" WIDTH="133" HEIGHT="53" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;(2) 사모자금의 사용 내역&cr;"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">마. 외국지주회사의 자회사 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">바. 법적위험 변동사항&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">사. 금융회사의 예금자 보호 등에 관한 사항&cr;</SPAN>
<SPAN>"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN USERMARK=" B">아. 기업인수목적사의 요건 충족 여부&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">자</SPAN>
<SPAN USERMARK=" B">. 기업인</SPAN>
<SPAN USERMARK=" B">수목적회사의 금융투자업의 역할 및 의부&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">차. 합병등의 사후정보&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">카. 녹색경영&cr;</SPAN>"해당사항 없음"&cr;
</P>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">타. 정부의 인증 및 그 취소에 관한 사항&cr;</SPAN>"해당사항 없음"&cr;
</P>

<P>
<SPAN USERMARK=" B">파. 조건부자본증권의 전환, 채무재조정 사유등의 변동현황&cr;</SPAN>"해당사항 없음" 
</P>
<P></P>
<P USERMARK="F-GL B">하. 보호예수 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="878" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="569"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30">(기준일 : </TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="164" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="BOTTOM" WIDTH="56" HEIGHT="30">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="578" HEIGHT="30">(단위 : 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="879" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예수주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예수일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">반환예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보호예수기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보호예수사유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총발행주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="53" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="53" VALIGN="MIDDLE">4,614,865</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE">2020년 07월 03일</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE">2023년 01월 02일</TD>
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="53" VALIGN="MIDDLE">2년 6개월</TD>
<TD ALIGN="CENTER" WIDTH="198" HEIGHT="53" VALIGN="MIDDLE">코스닥 시장 상장으로 인한&cr;최대주주보호예수</TD>
<TD ALIGN="RIGHT" WIDTH="108" HEIGHT="53" VALIGN="MIDDLE">8,792,415</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="98" HEIGHT="53" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="RIGHT" WIDTH="93" HEIGHT="53" VALIGN="MIDDLE">272,911</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE">2020년 07월 03일</TD>
<TD ALIGN="CENTER" WIDTH="137" HEIGHT="53" VALIGN="MIDDLE">2021년 07월 02일</TD>
<TD ALIGN="CENTER" WIDTH="108" HEIGHT="53" VALIGN="MIDDLE">1년</TD>
<TD ALIGN="CENTER" WIDTH="198" HEIGHT="53" VALIGN="MIDDLE">코스닥 시장 상장으로 인한&cr;우리사주보호예수</TD>
<TD ALIGN="RIGHT" WIDTH="108" HEIGHT="53" VALIGN="MIDDLE">8,792,415</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</CORRECTION>

<SECTION-1 AID="CEO-CERT-COR" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT_COR">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">대표이사등의 확인.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사등의 확인</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>
</LIBRARY>
</INSERTION>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P>&cr;&cr;&cr;</P>
<P USERMARK="F-16">                                    (제 17 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20200701">2020년 07월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2021년     03 월   18 일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">위더스제약(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">성 대 영</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">서울특별시 서초구 동산로 12길 9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-3486-7474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://withuspharm.com</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책)      전 무 이 사     (성  명)      권 광 영</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화)      02-3486-7474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TOC>
<TITLE ATOC="N">목     차</TITLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
</TOC>

<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<APPENDIX ATYPE="IMAGE">
<COMMENT>◆click◆ 대표이사 등이 서명한 『확인서』 그림파일 삽입</COMMENT>
</APPENDIX>

<IMAGE>
<IMG WIDTH="594" HEIGHT="840" ALIGN="CENTER" HSPACE="0">제17기 사업보고서_대표이사등의확인_위더스제약(주).jpg</IMG>
<IMG-CAPTION ATOC="N">제17기 사업보고서_대표이사등의확인_위더스제약(주)</IMG-CAPTION>
</IMAGE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『연결재무제표를작성하는주권상장법인』 삽입</COMMENT>
<LIBRARYLIST>11011#*연결재무제표를작성하는주권상장법인.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL B">가. 연결대상 종속기업 개황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 회사의 법적 ·상업적 명칭&cr;</SPAN>
<SPAN USERMARK="F-GL">당사의 명칭은 위더스제약 주식회사입니다. &cr;영문으로는 WITHUS PHARMACEUTICAL CO.,LTD.(약호 WITHUS)라고 표기합니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">다. 설립일자 및 존속기간</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 2004년 8월 19일 대덕약품공업주식회사로 설립되어 2005년 1월 6일 위더스메디팜 (주)가 2007년 10월 12일로 위더스제약 (주)로 상호 변경되었습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">라. 본사의 주소, 전화번호, 홈페이지 주소</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="459"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구분</TH>
<TH WIDTH="468" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">본사의 주소</TD>
<TD WIDTH="468" ALIGN="CENTER" HEIGHT="30">서울시 서초구 동산로 12길 9 (위더스빌딩)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">전화번호</TD>
<TD WIDTH="468" ALIGN="CENTER" HEIGHT="30">02-3486-7474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" ALIGN="CENTER" HEIGHT="30">홈페이지</TD>
<TD WIDTH="468" ALIGN="CENTER" HEIGHT="30">http://www.withuspharm.com</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">마. 회사사업 영위의 근거가 되는 법률 </SPAN>
</P>

<TABLE BORDER="1" WIDTH="695" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="476"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>관 련 법 규</P>
</TH>

<TH WIDTH="485" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>관 련 사 항</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>약사법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="122">
<P>약사법은 의약품의 제조, 조제, 감정, 보관, 수입, 판매에 관한 법률이며, 영업방식도 약사법에 따라야 함. 최근 사회적 문제가 되고 있는 리베이트의 금지에 관한 규정도 해당 법에 명시되어있으며, 이 법에 따라 2018년 1월부터 의료인에 대한 경제적 이익제공에 대한 지출보고서의 작성 및 제공이 의무화 되었음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>의약품 등의 안전에 관한 규칙</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>당사는 의약품 제조회사로 의약품 안전(판매허가, 임상실험 등)에 관하여 해당 규칙의 영향을 받음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>국민건강보험법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>리베이트와 관련된 약제에 대하여 요양급여적용을 정지하고, 위반횟수 및 정도에 따라 요양급여대상에서 제외하는 규정 존재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>부정청탁 및 금품등 수수의 &cr;금지에 관한법률</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="76">
<P>공직자를 비롯해 언론인, 교직원등 직무 관련성이나 대가성에 상관없이 1회 100만원(연간300만원)을 초과하는 금품을 수수하면 형사처분을 받을 수 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>산업안전보건법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="76">
<P>산업안전보건에 관한 기준을 확립하고 그 책임의 소재를 명확하게 하여 산업재해를 예방하고 쾌적한 환경을 조성함으로써 근로자의 안전과 보건을 유지, 증진하기 위한 규정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>소방기본법 및 </P>
<P>소방시설 설치 유지 및</P>
<P>안전관리에 관한 법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="76">
<P>화재, 재난재해 그 밖의 위급한 상황으로부터 국민의 생명, 신체, 재산을 보호하기 위하여 소방시설등의 설치유지 및 소방대상물의 안전관리에 관하여 필요한 규정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>위험물 안전관리법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="76">
<P>위험물의 저장ㆍ취급 및 운반과 이에 따른 안전관리에 관한 사항을 규정함으로써 위험물로 인한 위해를 방지하여 공공의 안전을 확보함을 목적으로 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>대기환경 보전법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>대기배출시설 및 방지시설 운영 및 관리에 대한 규정으로 대기환경 보전을 목적으로 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수질 및 수생태계 보전에 &cr;관한 법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>수질배출시설 및 방지시설 운영 및 관리에 대한 규정으로 수질 및 수생태계 환경 보전을 목적으로 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>폐기물 관리법</P>
</TD>

<TD WIDTH="485" VALIGN="MIDDLE" HEIGHT="53">
<P>폐기물 배출 및 처리에 대한 운영 및 관리에 대한 규정으로 폐기물의 안정적 처리를 목적으로 함</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">바. 중소기업 해당 여부&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 중소기업기본법 제2조 및 동법 시행령 제3조에 의거 중소기업에 해당합니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">사. 대한민국에 대리인이 있는 경우에는 이름(대표자), 주소 및 연락처&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">아. 주요 사업의 내용 및 향후 추진하려는 신규사업&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 2004년 8월에 설립하여 2005년 1월 영업을 개시하여 전문의약품 생산 및 판매를 주요 사업으로 영위하고 있습니다. &cr;UN 기준으로 '노인'이란 65세 이상을 말하며, 65세 이상 인구가 총인구 중 차지하는 비율이 7%이상일 경우 고령화 사회, 20% 이상은 초고령 사회로 정의 합니다. &cr;</SPAN>
</P>

<TABLE WIDTH="602" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="31">[국내 총인구 및 고령 인구 추이]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="0" ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="600" HEIGHT="363">
<P></P>

<IMAGE>
<IMG WIDTH="510" HEIGHT="289" ALIGN="CENTER" HSPACE="0">우리나라 인구고령화 추이 및 전망.jpg</IMG>
<IMG-CAPTION ATOC="N">우리나라 인구고령화 추이 및 전망</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">
<P>자료 출처 : 통계청</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">우리나라는 2000년에 7%를 넘어 이미 고령화 사회로 접어들었고 당사는 노인성 약품에 쓰이는 순환기용제 약물에 강점을 보이고 있습니다. 뿐만 아니라 항생제 대표적인 약물인 세팔로스포린계 약물 별도 전용 생산 시설을 보유하여 1세대부터 3세대까지 생산라인을 구축 하였습니다. 또한, 제조, 제제 기술력을 바탕으로 국내 최초로 생물학적 동등성 실험을 실시한 회사로 CMO(생산대행 : Contract Manufacturing Organization) 사업을 영위하고 있습니다. 당사는 경기도 수원 영통에 신약연구소와, 경기도 안성에 중앙연구소 운영 중이며, R&D 중심의 연구소를 가지고 있습니다. 사업 부분별 자세한 사항은 Ⅱ. 사업의 내용을 참조하시기 바랍니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="414"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="423" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">목 적 사 업</TH>
<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="423" HEIGHT="283">
<P>1.  의약품 및 한약품 제조 및 도소매업</P>
<P>2.  식품 및 건강보조식품 제조 및 도소매업</P>
<P>3.  시약 및 화공약품 제조 및 도소매업</P>
<P>4.  의약품 및 한약재 의약품 원료 수출입업</P>
<P>5.  농수산물 수출입업 및 도소매업</P>
<P>6.  화장품 수출입업 및 도소매업</P>
<P>7.  의료기기 및 위생용품 수출입업 및 도소매업</P>
<P>8.  의료기기 제조업</P>
<P>9.  기타 잡화 수출입업 및 도소매업</P>
<P>10. 의약품 및 한약품 수출입업</P>
<P>11. 부동산 임대업</P>
<P>12. 위 각호에 관련된 부대사업일체</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="283">당사 정관&cr;제2조 (목적)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">자. 공시서류작성기준일 현재 계열회사의 총수, 주요계열회사의 명칭 및 상장여부&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">차. 신용평가에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL B">카. 상법 제290조에 따른 변태 설립 사항</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">타. 회사의 주권상장(또는 등록·지정) 여부 및 특례상장에 관한사항</SPAN>
</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장&cr;(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등&cr;적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_CHK">여&cr;(코스닥시장 상장)</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="SPC_DATE" AUNITVALUE="20200703">2020년 07월 03일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_CHP">부</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="SPC_LAW">해당없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 회사의 본점소재지 및 그 변경</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="372"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">날 짜</TH>
<TH WIDTH="381" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주 소</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" ALIGN="CENTER" HEIGHT="30">2004.08.24</TD>
<TD WIDTH="381" HEIGHT="30">서울특별시 서초구 동산로 48</TD>
<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">최초 소재지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" ALIGN="CENTER" HEIGHT="30">2014.01.24</TD>
<TD WIDTH="381" HEIGHT="30">서울특별시 서초구 동산로 12길 9 (양재동 위더스빌딩)</TD>
<TD WIDTH="121" ALIGN="CENTER" HEIGHT="30">소재지 변경</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 경영진의 중요한 변동&cr;</SPAN>
<SPAN USERMARK="F-GL">당사의 최근 5사업연도 중 경영진의 중요한 변동 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="648" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">일 자</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">대표이사</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사내이사</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사외이사</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">감사</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2017.07.02</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영&cr;김호천&cr;안종태</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">민경철</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이광영</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">민경철 사외이사 / 선임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2018.07.02</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영&cr;권광영&cr;안종태</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">민경철</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이광영</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">김호천 이사 / 사임&cr;권광영 이사 / 선임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2018.12.03</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영&cr;권광영&cr;안종태</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">민경철</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이승철</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이광영 감사 / 사임&cr;이승철 감사 / 선임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2019.11.28</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">성대영&cr;안종태&cr;권광영</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이용주</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이승철</TD>
<TD WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">민경철 사외이사 / 사임&cr;이용주 사외이사 / 선임</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">다. 최대주주의 변경&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 최근 5개년 동안 최대주주가 동일하게 유지되고 있습니다. 상세한 내용은 동 공시서류의 'VII. 주주에 관한 사항'을 참조하시기 바랍니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 상호의 변경&cr;</SPAN>
<SPAN USERMARK="F-GL">당사의 설립 이후 상호 변경 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="413"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>일자</P>
</TH>

<TH WIDTH="422" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>상호</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2004.08.19</P>
</TD>

<TD WIDTH="422" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대덕약품공업 주식회사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2005.01.06</P>
</TD>

<TD WIDTH="422" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스메디팜 주식회사</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2007.10.12</P>
</TD>

<TD WIDTH="422" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스제약 주식회사</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">마. 회사가 화의, 회사정리절차 그 밖에 이에 준하는 절차를 밟은 적이 있거나 현재 진행중인 경우 그 내용과 결과</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">바. 합병, 기업분할, 영업양수도, 감자 등 경영활동과 관련된 중요한 사실의 발생&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">사. 회사의 업종 또는 주된 사업의 변화</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">아. 그 밖의 경영활동과 관련된 중요한 사실의 발생</SPAN>
</P>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="72"></COL>
<COL WIDTH="511"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>일자</P>
</TH>

<TH WIDTH="520" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2017.02</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>경남 영업사무소 개설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>고용노동부 강소기업 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.09</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>신약연구실 개설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.11</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>대한상공회의소 일하기좋은 중소기업 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.12</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>대한씨름협회 메인 타이틀 스폰서 채결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.04</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>고용노동부 강소기업 2년 연속 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.10</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>대한상공회의소 일하기좋은 중소기업 2년연속 선정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2019.12</P>
</TD>

<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">
<P>대한씨름협회 메인 타이틀 스폰서 체결</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.06</TD>
<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">안성공장 세파동 증축</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.07</TD>
<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">코스닥(KOSDAQ)시장 상장</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09</TD>
<TD WIDTH="520" VALIGN="MIDDLE" HEIGHT="30">인벤티지랩과 전략적 파트너쉽 체결</TD>
</TR>
</TBODY>
</TABLE>
<P>&cr;</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P USERMARK="F-GL B">가. 자본금 변동 사항</P>
<P USERMARK="F-GL">증자(감자)현황</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="788" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="482"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="491" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="785" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행&cr;(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)&cr;형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="498" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당&cr;액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행&cr;(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20190930">2019년 09월 30일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="12">주식분할</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">2,790,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ALIGN="CENTER">액면분할(1:10)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20191230">2019년 12월 30일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="12">주식분할</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">4,650,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_PAR_AMT">200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_SL_AMT">-</TE>
<TD VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ALIGN="CENTER">액면분할(1:2.5)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200629">2020년 06월 29일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="01">유상증자(일반공모)</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_CNT">1,042,415</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_PAR_AMT">200</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACODE="INC_SL_AMT">15,900</TE>
<TD VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환사채 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환사채발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 신주인수권부사채 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환신주인수권부사채등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『미상환 전환형 조건부자본증권 등 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*미상환전환형조건부자본증권등발행현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P USERMARK="F-GL B">가. 주식의 총수 </P>
<P USERMARK="F-GL">주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">우선주</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">100,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">100,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">8,792,415</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">8,792,415</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">8,792,415</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">8,792,415</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">8,792,415</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">8,792,415</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆ 『자기주식 취득 및 처분 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*자기주식취득및처분현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『종류주식(명칭) 발행현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*종류주식발행현황.dsl</LIBRARYLIST>
</INSERTION>

<P USERMARK="F-GL B">나. 자기주식&cr;
<SPAN USERMARK=" !B">"</SPAN>
<SPAN USERMARK=" !B">해당사항 없음"</SPAN>
<SPAN>&cr;&cr;다. 다양한 종류의 주식&cr;</SPAN>
<SPAN USERMARK=" !B">"해당사항 없음"</SPAN>
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 의결권 현황</TITLE>
<P></P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">8,792,415</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여&cr;의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수&cr;(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">8,792,415</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">우선주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-6-0">6. 배당에 관한 사항 등</TITLE>
<P>당사는 제품 및 사업 경쟁력 강화와 함께 주주환원을 통하여 주주가치를 제고할 수 있도록 지속적으로 노력하고 있습니다. 정관에 의거 이사회 및 주주총회 결의를 통하여 배당을 실시하고 있으며, 배당가능이익 범위 내에서 회사의 지속적 성장을 위한 투자 및 경영환경 등을 고려하여 적정수준의 배당률을 결정하고 있습니다. 당사는 자사주 매입에 대한 계획 등은 현재 없습니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">가. 배당정책, 배당제한 관한 사항</SPAN>
<SPAN USERMARK="F-GL">&cr;당사의 정관 상 배당에 관한 사항은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="646" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="637"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="646" HEIGHT="513">
<P>제11조 (신주의 배당기산일) </P>
<P>회사가 유상증자, 무상증자 및 주식배당에 의하여 발행한 신주에 대한 이익의 배당에 </P>
<P>관하여는 신주를 발행한 때가 속하는 영업연도의 직전영업연도말에 발행된 것으로 본다. </P>
<P>&cr;</P>
<P>제53조 (이익금의 처분) </P>
<P>회사는 매사업연도의 처분전 이익잉여금을 다음과 같이 처분한다.</P>
<P>1. 이익준비금 </P>
<P>2. 기타의 법정준비금</P>
<P>3. 배당금</P>
<P>4. 임의적립금</P>
<P>5. 기타의 이익잉여금처분액</P>
<P>&cr;</P>
<P>제 54조 (이익배당) </P>
<P>① 이익배당은 금전 또는 금전 외의 재산으로 할 수 있다. </P>
<P>② 이익의 배당을 주식으로 하는 경우 회사가 종류주식을 발행한 때에는 각각 그와 같은 종류의 주식으로 할 수 있다.</P>
<P>③ 제1항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게</P>
<P>지급한다.</P>
<P>④ 이익배당은 주주총회의 결의로 정한다.&cr;</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">나. 최근 3사업년도 배당 내역</P>
<P USERMARK="F-GL">주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제17기&cr;(2020.07.01~2020.12.31)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제16기&cr;(2019.07.01~2020.06.30)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제15기&cr;(2018.07.01~2019.06.30)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">200</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">200</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">5,000</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">1,867</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">8,039</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">8,661</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">212</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">1,036</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">27,940</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">422</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">1,802</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">22.6</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">22.42</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">0.23</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">1.01</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">48</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">205</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL">※현금배당성향 : 현금배당금총액/당기순이익 입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 이익참가부 사채에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
</P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『과거배당이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*과거배당이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">48_과거배당이력</FILENAME>

<P>
<SPAN USERMARK="F-GL B">마. 과거 배당 이력</SPAN>
</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">0</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">0.37</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">0.81</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL">13기 20억규모 중간배당을 실시하였습니다. 13기 당시의 배당수익률은 비상장으로 인한 상증법으로 계산되어 3.02%입니다. &cr;※평균 배당수익률의 최근 3년간은 16기 배당수익률을 3으로 나눈 값입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL">평균 배당수익률의 최근 5년간은 13기 중간배당수익률과 16기 결산배당수익률의</SPAN>
<SPAN USERMARK="F-GL"> 합</SPAN>
<SPAN USERMARK="F-GL">을 5로 나눈 값입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">※</SPAN>
<SPAN USERMARK="F-GL"> 16기 배당수익률 : 1.01%, 13기 중간배당수익률 : 3.02%&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-7-0">7. 정관에 관한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">당사의 최근 정관 개정일은 2020년 09월 25일이며, 보고서 제출일 이후 개최 예정인 제17기 정기주주총회의 안건에는 정관 변경 건이 포함되어 있지 않습니다.&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆ 『정관변경이력』 삽입</COMMENT>
<LIBRARYLIST>11011#*정관변경이력.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">49_정관변경이력</FILENAME>
<P>정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="728" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="207"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="ART_DATE" AUNITVALUE="20200925" VALIGN="MIDDLE">2020년 09월 25일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="76" ACODE="ART_NAME" VALIGN="MIDDLE">제16기 정기주주총회</TE>
<TE ALIGN="CENTER" WIDTH="216" HEIGHT="76" ACODE="ART_CHN" VALIGN="MIDDLE">1. 주주명부 폐쇄 기준일 변경&cr;2. 이사회 소집 기간 변경&cr;3. 사업연도 변경</TE>
<TE ALIGN="CENTER" WIDTH="216" HEIGHT="76" ACODE="ART_RSN" VALIGN="MIDDLE">1. 원활한 운영에 따른 변경&cr;2. 소집 시기의 융통성 확보&cr;3. 결산기 변경으로 인한 변경</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『수주상황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_수주상황.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL B">1. 사업의 개요&cr;</SPAN>
<SPAN USERMARK="F-GL">당사의 사업의 개요에 앞서, 전문용어와 약어가 많은 제약산업 특성으로 인해 관련 용어 해설 기재하였습니다.</SPAN>
</P>

<TABLE WIDTH="651" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="642"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="651" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[용어 설명]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="648" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="36"></COL>
<COL WIDTH="215"></COL>
<COL WIDTH="370"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>용어</P>
</TH>

<TH WIDTH="379" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>해설</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>1</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="145">
<P>KGMP</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="145">
<P>약사법시행규칙 제22조(의약품 등의 업종별 제조업 허가신청 등의 [별표4] (의약품 제조 및 품질관리 기준)의 규정에 따른 의약품의 제조업 및 소분업이 준수해야 할 우리나라의 기준으로 The Good Manufacturing Practice for Pharmaceutical Products in Korea(KGMP)라고 합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="375">
<P>2</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="375">
<P>cGMP</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="375">
<P>cGMP (Current Good Manufacturing Practice) 의약품 및 생물의약품 제조에 있어서는 유효성(Efficacy), 안전성(Safety), 안정성(Stability) 등을 재현성 있게 확보하는 것이 필수적입니다. 따라서 이를 확보하기 위해 미국 FDA 등 선진국 규제기관들은 cGMP 등 GMP 규정을 엄격히 적용하고 있고 선진국뿐만 아니라 다른 모든 국가에서 의약품의 수입허가 시 cGMP 또는 이에 준하는 규정(EU-GMP 등)에 따른 제조 및 관리를 필수적으로 요구하고 있어 개발된 의약품의 해외시장 진출을 위해서는 cGMP 규정을 만족시키는 기술(이하, cGMP기술)의 개발 및 확보가 필수적입니다. cGMP(현행 우수제조관리기준) 유효성, 안전성, 안정성이 보장된 의약품을 재현성 있게 제조하기 위해 제조공장의 구조·설비를 비롯하여 원료의 구입으로부터 제조, 품질관리·보증, 포장, 출하에 이르기까지의 생산공정 전반에 걸쳐 요구되는 기본규정입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="375">
<P>3</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="375">
<P>PIC/s</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="375">
<P>PIC/S는 의약품 제조 및 품질관리기준(GMP)과 GMP 실사의 국제 조화를 주도하는 유일한 국제협의체로 현재 42개국 44개 기관이 가입돼 있습니다. PIC/S 가입국은 상호 의약품 수출시 GMP실사 등 일부 절차를 면제 받을 수 있기 때문에 이번 가입 공식 승인으로 국내 제약기업의 해외 진출이 한층 수월해질 전망입니다. PIC/S는 세계화 추세 속에 국가간 GMP 기준을 조화하고 보다 효율적인 실사 시스템 구축 필요성에 대한 인식이 확산되며 지난 1995년에 설립됐습니다. GMP에 시간과 비용 등 많은 역량이 집중되지만 수출입 시 국가마다 GMP에 대한 기준이나 규정이 달라 각국 규제당국의 지도 감독에 어려움이 있어, 이를 해결하기 위해 PIC/S가 설립된 것입니다. 현재 PIC/S는 GMP 실사 기초 정보의 상호 교류, GMP 규정 조화 및 각종 가이드라인 발간, GMP 조사관 교육을 실시하고 있으며 1년에 2회 정기회의를 갖고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>4</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>Validation</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="99">
<P>제조공정, 시험, 기계설비 또는 시스템이 기준에 적합한 결과가 일관되게 얻어진다는 것을 검증하고 문서화 하는 것입니다. 공정밸리데이션, 분석방법 밸리데이션, 세척밸리데이션 등의 기준이 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>5</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>DMF</P>
<P>(Drug Master File)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="76">
<P>부정, 불량 원료 사용을 차단하여 의약품의 품질을 확보할 수 있도록 2002년 7월 「원료의약품 신고제도(Drug Master File)」를 도입하였습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>6</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">
<P>CTD</P>
<P>(Common Technical Document)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="191">
<P>국제공통기술문서(CTD, Common Technical Document)는 의약품의 국제적인 연구개발을 촉진하기 위해 국제조화회의(ICH, International Conference on Harmonization)에서 의약품 허가심사 자료 양식을 국제적으로 표준화한 문서입니다. 품질, 비임상, 임상자료 신청자료 양식과 범위를 통일해 규정화했으며, 미국과 일본, 유럽 국가들은 이미 CTD에 의해 의약품 허가신청을 하고 있습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>7</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>ICH</P>
<P>(International Conference on Harmonization)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="76">
<P>국제적으로 통일된 의약품 품질 기준을 제시하기 위해 미국, 유럽, 일본을 중심으로 설립한 국제회의입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>8</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>CMO(Contract Manufacturing Operation)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="53">
<P>계약 개발/연구/생산 대행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>9</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>First Generic</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="53">
<P>오리지널 의약품 특허가 끝난 뒤 가장 먼저 만들어진 제네릭 의약품입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>10</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>개량신약</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="53">
<P>기존 신약의 화학구조 변형, 제제개선 등을 통하여 기존 의약품을 보다 개선시킨 의약품입니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>11</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>부형제</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품 제조에 추가되는 원료로 효능과 관련이 없는 원료물질을 지칭합니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="490">
<P>12</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="490">
<P>허가특허 연계제도</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="490">
<P>허가-특허 연계제도의 골자는 특허권자가 식약처에 특허권을 등재해놓으면 특허등재된 의약품과 같거나 비슷한 의약품의 허가신청시 이를 특허권자에게 ‘통보’하고, 특허권자가 제네릭(복제약) 출시에 동의하지 않으면 특허침해여부와 상관없이 일정기간 제네릭의약품의 ‘시판을 정지’시키는 제도입니다.</P>
<P>이 제도는 국내 제약회사의 의약품 개발 및 R&D 투자를 촉진하기 위해 첫 번째로 품목허가를 신청한 제약회사가 일정기간 독점적으로 판매할 수 있는 권리를 보장해주는 것입니다. 보다 구체적으로는 후발 제약회사가 해당 등재 의약품의 안전성·유효성에 관한 자료를 근거로 품목허가를 최초로 신청한 자이어야 하며 등재된 특허에 대하여 심판 또는 소송에서 승소한 심결 또는 판결을 받은 자이어야 합니다. 이때 판매가 제한되는 의약품은 우선판매품목허가 의약과 유효성분의 종류 및 함량, 제형, 용법·용량, 효능·효과가 동일한 의약품이어야 합니다. 또한 우선판매품목 허가가 소멸한 경우, 등재된 특허권이 존속기간이 만료된 경우, 우선판매품목허가가 의약품이 판매 가능일로부터 2개월 이내에 정당한 사유없이 판매되지 않는 경우 등에 해당하는 때에는 다른 의약품에 대한 제한은 소멸됩니다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>13</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>CSO</P>
<P>(Contract Sales Organization)</P>
</TD>
<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="76">의사, 약사 등의 보건의료 전문가 및 건강보험회사 등의 고객을 대상으로 제품 정보를 전달하고, 제품 사용을 권유하여 이익을 창출하는 역할</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>14</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>전문의약품</P>
<P>(Ethical Drug, ETC)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="99">
<P>제형, 약리 작용의 특성상 의사 처방이 필요한 의약품. 의사의 처방에 의해서 사용되어야 하는 의약품으로서 의사의 감독하에 사용되지 않을 경우 의료상 장해를 일으킬 수 있는 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>15</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>일반의약품</P>
<P>(Over-The-Counter, OTC)</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="122">
<P>전문의약품외의 의약품, 처방 없이 사용 가능, 부작용의 범위가 작고 유효성과 안전성이 확보되어 있는 의약품, 환자가 직접 선택, 용법 용량의 준수, 부작용의 예방 및 처치가 가능한 의약품, 경미한 질병의 치료 및 예방에 사용되는 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>16</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>API</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="99">
<P>Active Pharmaceutical Ingredient, 의약원료물질, 약효를 나타내는 효능물질로 일반적으로는 화학의약품 원료물질을 지칭, API에 체내 체류기간 증가나 약효를 돕는 염과 부형제들을 결합하면 의약품이 됨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>17</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>요양기관</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="122">
<P>환자를 진료하거나 환자에게 투약하는 기관으로서, 상급종합병원, 종합병원, 병원, 의원, 치과병원, 치과의원, 조산원, 보건의료원, 보건소, 보건지소, 보건진료소, 한방병원, 한의원, 약국을 총칭하며, 약국을 제외한 요양기관을  '의료기관'이라 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>18</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>퇴장방지의약품</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="76">
<P>환자진료에 반드시 필요하나 채산성이 없어 제조업자·위탁제조판매업자·수입자가 생산 또는 수입을 기피하는 약제로서 생산 또는 수입 원가의 보전이 필요한 약제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>19</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>이중정</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="99">
<P>두 가지 이상의 성분이 혼합된 의약품이나, 각각의 성분이 고변동성 약물로서 서로 혼합시 효과가 잘 나타나지 않아, 한 개의 의약품에 각각의 의약품을 반씩 나누어 만든 한 알의 정제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>20</P>
</TD>

<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>고변동성</P>
</TD>

<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="30">
<P>의약품 제제가 어려워 생동 및 임상이 어려운 약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">21</TD>
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">매트릭스 디자인</TD>
<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="99">안정성시험 설계시 이용되며 주성분의 분량이 다른 두 가지 이상의 제제 또는 단위 용량 중 주성분과 첨가제의 농도가 동일하나 용기 충전량만 다른 두 가지 이상의 제제 등에 적용할 수 있다. </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="45" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">22</TD>
<TD WIDTH="224" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">PMS</TD>
<TD WIDTH="379" VALIGN="MIDDLE" HEIGHT="76">다수의 환자를 대상으로 사용 경험, 유효성, 안정성을 관찰하고 용법과 용량에 따른 부작용을 살피는 이른바 신약 시판 후 조사 단계</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">가. 산업의 개요</SPAN>
<SPAN USERMARK="F-GL">&cr;제약 산업은 기술집약적이며 고부가가치 산업이라는 특성과 건강 및 삶의 질 향상을 목적으로 하는 국민보건산업으로  21세기 고도 성장이 기대되는 산업이며 신약개발 연구에서부터 의약품의 생산과 판매 등 모든 과정을 포괄하고 있습니다. 의약품은 크게 원료의약품과 완제의약품 중 완제의약품으로 나눌 수 있으며, 완제의약품은 다시 전문의약품(Ethical drug: ETC)과 일반의약품(Over the counter drug: OTC)으로 나뉩니다. 전문의약품이란 제형, 약리 작용의 특성상 의사의 감독 하에 사용되어야 하는 의약품으로서 의사의 감독 하에 사용되지 않을 경우 의료상 장해를 일으킬 수 있는 적응증을 갖는 의약품을 말합니다. 마약, 향정신성 의약품, 독약, 극약 등도 전문의약품의 범주에 포함됩니다. 이러한 전문의약품 외의 의약품을 일반의약품이라고 합니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 산업의 특성</SPAN>
</P>
<P USERMARK="F-GL B">(1)   국내제조 생산 기반을 둔 내수완제품 중심산업</P>

<P>
<SPAN USERMARK="F-GL">기존의 제약산업은 국내제조 생산 기반을 둔 내수완제품 중심이었습니다. 한국제약바이오협회에 따르면 2019년 완제의약품 생산실적은 19.7조원, 원료의약품 생산실적은 2.3조원으로 완제의약품 비중이 83%에 달합니다.&cr;</SPAN>&cr;
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="32">
<P>[국내 의약품 생산 실적]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="638">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="564" ALIGN="CENTER" HSPACE="0">의약품생산실적.jpg</IMG>
<IMG-CAPTION ATOC="N">의약품생산실적</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="30">(출처 : 한국제약바이오협회)</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL B">(2) 엄격한 국가 규제를 따르는 산업&cr;</SPAN>
<SPAN USERMARK="F-GL">제약산업은 인간의 생명과 보건에 관련된 제품을 생산하는 국민의 건강과 직결된 산업으로서 제품의 개발에서 임상시험, 인·허가 및 제조, 유통, 판매 등 전 과정을 통제하며, 판매 이후의 제품의 안정성까지 세심한 품질관리를 하고 있어 시행규칙과 관계법령들이 엄격합니다. 글로벌 경쟁력을 갖추기 위해 의약품 생산, 품질, 시설 강화를 위한 PIC/s(의약품상호실사협력기구)와 제네릭 생물학적동등성시험 결과 보고서(CTD: 국제공통기술문서)를 작성해야만 하는 ICH (국제의약품규제조화위원회) 가입으로 제조품질관리에 대한 인적·물적 자원의 지속적 투자를 진행해야만 합니다.&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">(3) 기술집약도가 높은 산업&cr;</SPAN>
<SPAN USERMARK="F-GL">제약산업은 신약개발을 위한 연구에서부터 원료 및 완제의약품의 생산과 판매 등 모든 과정을 포괄하는 첨단 부가가치산업으로 기술집약도가 높습니다. 2019년 기준 산업별 부가가치 창출지표에 따르면 30.13% 수준의 높은 부가가치율을 보이며 1인당 113백만원의 부가가치를 생산할 수 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">(4) 사회적 공헌도가 큰 산업&cr;</SPAN>
<SPAN USERMARK="F-GL">우수 의약품 개발 및 접근성 제고를 통하여 질병으로 인한 사회적 비용 감소 등 국민건강증진과 직결된 산업으로 혁신적 활동을 통해 인구고령화 등으로 급증할 수 밖에 없는 국민의료비 절감효과를 가져다 주는 복지증진사업으로서 사회적 공헌도가 큰 분야입니다.&cr;</SPAN>&cr;
<SPAN USERMARK=" B">(5) 안정적인 성장을 하고 있는 산업&cr;</SPAN>의약품가격은 비탄력적인 특성을 갖습니다. 의약품의 경우 생명 및 건강과 직접적인 관련이 있어 가격이 높아지더라도 비용을 지불하고 구매하려는 속성을 가지고 있습니다. 일반의약품의 경우 경기변동이나 계절적인 요인의 영향을 다소 받기는 하나, 전문의약품의 경우 의약품 특성상 안정적인 성장을 하고 있습니다. 따라서 타 산업에 비해 경기변동에 큰 영향을 받지 않는다고 할 수 있습니다.&cr;  
</P>

<TABLE WIDTH="598" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="598" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[국내 의약품 생산금액 및 증감률]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="253" ALIGN="CENTER" HSPACE="0">의약품 생산금액 및 증감률.jpg</IMG>
<IMG-CAPTION ATOC="N">의약품 생산금액 및 증감률</IMG-CAPTION>
</IMAGE>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="591" BORDER="0">

<COLGROUP>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="591" HEIGHT="30">출처 : 한국제약바이오협회</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">다. 산업의 성장성&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">(1) 글로벌 제약시장</SPAN>
</P>
<P USERMARK="F-GL">인구 고령화와 건강에 대한 관심 증가로 전세계 제약시장은 2017년 약 1.1조 달러 규모에서 2022년 약 1.5조 달러 규모로 매년 3~6% 성장할 것으로 예상됩니다. 특히, 전통적 제약강국인 유럽 및 일본 의약품시장의 성장은 정체되는 반면 중국, 브라질, 러시아, 인도 등 신흥시장은 경제성장, 의료접근성 개선, 의약품 수요증가 등의 요인으로 향후 높은 성장을 지속하며 세계 의약품시장 성장을 견인할 것으로 예상되고 있습니다.  </P>

<TABLE WIDTH="602" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[지역별 - 국가별 제약시장 현황 및 향후 성장 전망]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="602" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 십억달러, %)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P> 구분</P>
</TH>

<TH WIDTH="118" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2017</P>
</TH>

<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>CAGR</P>
<P>(2013~2017)</P>
</TH>

<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>2022</P>
</TH>

<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>CAGR</P>
<P>(2018~2022)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>글로벌</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>1135.1</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>6.2%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>1,415~1,445</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>3~6%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>선진국</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>753.2</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>5.8%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>915~945</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>2~5%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>미국</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>466.6</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>7.3%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>585~615</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>4~7%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>EU 5개국</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>154.4</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>4.4%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>170~200</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>1~4%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>일본</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>84.8</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>2.0%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>85~89</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>(-3)~0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>캐나다</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>20.7</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>3.9%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>23~27</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>1~4%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>대한민국</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>13.7</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>4.5%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>15~19</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>3~6%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>호주</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>13.1</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>4.7%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>12~16</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>1~4%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">
<P>신흥국</P>
</TD>

<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">
<P>269.6</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>10.3%</P>
</TD>

<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">
<P>345~375</P>
</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>6~9%</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="599" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="590"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="599" VALIGN="MIDDLE" HEIGHT="30">
<P>(출처 : 19년도 제약산업 육성지원 시행계획(안), 보건복지부)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P> &cr;
<SPAN USERMARK="F-GL">우리나라의 제약시장은 2017년 13.7억 달러에서 2022년 15~19억 달러로 3~6%의 성장이 예상됩니다.</SPAN>
</P>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">(2) 국내 제약시장&cr;</SPAN>
<SPAN USERMARK="F-GL">국내 의약품시장은 인구 고령화와 만성질환의 증가가 진행되면서 양적, 질적으로 빠르게 성장하였습니다. 국내 의약품 생산액은 2019년 기준 약 22조원으로 전년대비 5.7% 증가하였고, 수출액은 6조원으로 전년대비 17.8%, 수입액은 8조원으로 전년대비 12.6% 증가하였습니다. 전체 시장규모는 24.3조원으로 최근 5년 연평균 성장률은 4.8%입니다.  &cr;</SPAN>
</P>

<TABLE WIDTH="609" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="600"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="609" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[국내 의약품 시장규모 현황]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="256" ALIGN="CENTER" HSPACE="0">국내의약품시장.jpg</IMG>
<IMG-CAPTION ATOC="N">국내의약품시장</IMG-CAPTION>
</IMAGE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="610">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="610" HEIGHT="30" VALIGN="MIDDLE">
<P>(출처 : 식품의약품안전처, 의약품 생산실적 및 수입실적 통계자료, 2019)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">2019년 건강보험통계연보에 따르면 2014년 이후 65세 이상 진료비 증가율은 10%를 넘어섰고, 지속적인 노령인구의 증가로 노인진료에 대한 시장규모도 매해 커지고 있습니다. 현 대한민국은 다른 연령에 비해 60세부터 요양급여 비용의 증감률이 매우 높아지고 있습니다. 연령과 의료비의 밀접한 상관성 및 개인 생애의료비 지출의 절반 이상이 65세 이후 지출되는 양상을 볼 때, 기대수명의 신장 및 고령층의 증가에 따라 의료비는 급증할 것으로 전망됩니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">이에 따라 향후 국내 의약품시장은 경제수준 향상에 따른 의료 서비스의 기대치 상승과 급속한 인구 고령화에 따라 점진적으로 성장 추세가 이어질 것으로 보여집니다. 지금까지 다양한 마케팅에 의해 제약사들의 성장이 지속되어 왔으나, 약가인하와 리베이트 규제 정책으로 인하여 장기적인 관점으로 보면 차별적인 임상데이터나 효능을 마케팅할 수 있는 업체, 신약 R&D 역량, 우수 의약품의 품목 경쟁력, 글로벌 시장경쟁력, 정확한 수요예측에 따른 제네릭 의약품의 개발 등이 시장을 확대할 수 있는 핵심역량이자 핵심경쟁요소로 예측됩니다.&cr;&cr; </P>

<TABLE WIDTH="447" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="438"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="447" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[연령별 요양급여비용]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="447" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 원, %)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="447" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="233"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="242" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P> 요양급여비용 </P>
</TH>

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비율</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>0~9세</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,911,343,797 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>10~19</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,915,707,155 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>20~29</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,947,191,707 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.54</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>30~39</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,743,619,421 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>40~49</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,506,812,357 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>50~59</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,637,429,626 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16.39</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>60~69</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,299,814,637 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>70~79</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,392,784,756 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>80세이상</P>
</TD>
<TD WIDTH="242" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,533,425,301 </TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13.15</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="447" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="438"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="447" VALIGN="MIDDLE" HEIGHT="30">
<P>(출처 : 건강보험심사평가원 진료비 심사실적표)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 경기변동의 특성&cr;</SPAN>
<SPAN USERMARK="F-GL">의약품 시장은 경기변동 및 계절적 변동에 비탄력적인 특성을 가지고 있습니다. 의약품은 가격이 높아지더라도 비용을 지불하고 구매하려는 속성을 갖고 있습니다. 따라서 제약산업은 경기변동에 큰 영향을 받지 않는 대표적인 산업입니다. 당사 제품의 주된 시장인 전문의약품 시장은 의약분업 이후 성장세를 보이고 있으며, 일반의약품에 비해 경기변동 등에 대한 영향이 적습니다. 다만, 환율 등 원료 수급에 영향을 미치는 요인과 일괄 약가 인하 등과 같은 정부의 정책변화 등에 따라 매출 및 수익구조가 변동될 수 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">마. 계절성</SPAN>
</P>
<P USERMARK="F-GL">[순환기용약]</P>
<P USERMARK="F-GL">순환계 질환의 경우 약물치료 없이 수술만으로 정상상태로의 복귀가 불가능한 경우가 많기 때문에 지속적인 관리를 위하여 장기간 약물을 복용해야 하는 경우가 많고, 약물 치료를 중단할 경우 질환 발생에 따른 사회적 비용 증가로 이어져 예방을 위한 관리를 최우선 목표로 두고 있습니다. 따라서 순환계약물은 경기변동에 둔감한 편입니다. </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">[근골격용제]</P>
<P USERMARK="F-GL">근골격 질환이란 특정 신체 부위 및 근육의 부적절하고 과도한 사용으로 인해 근육, 관절, 혈관, 신경 등에 미세한 손상이 발생하여 목, 어깨, 팔, 손목, 손가락, 허리, 다리 등에 나타나는 만성적인 건강장애로 경기변동 및 계절적 요인과는 연관성이 낮은 치료제입니다.&cr;   </P>
<P USERMARK="F-GL">[소화기용제]</P>
<P USERMARK="F-GL">소화기계용약은 만성질환의 대표적인 처방약물들로 일반의약품은 경기변동과 계절적 요인에 영향을 받지만 자극적인 음식을 선호하는 한국인의 식습관으로 인해 약물의 처방이 꾸준히 발생하고 있는 의약품으로 이들 품목은 경기변동에 둔감한 편입니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">[항생제]</P>
<P USERMARK="F-GL">항생제 계열의 주 치료 영역인 폐렴 등 호흡기 감염 및 피부감염을 포함한 모든 감염증은 일반적으로 외부 노출, 감염자의 면역력 저하 등에 의해 발생합니다. 감염 질환의 대부분이 오랜 세월을 거쳐 비교적 보편적이고 꾸준히 발병하는 질환으로 경기 변동과 계절적인 요인에 의해 수요의 변동이 발생하지만 그 변동 패턴이 일정하며, 연 단위의 수요는 일정한 경향을 보입니다.</P>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">바. 국내외 시장여건</SPAN>
</P>
<P USERMARK="F-GL">[제네릭 시장]</P>
<P USERMARK="F-GL">각국의 약제비 억제정책에 따른 제네릭 의약품 사용권장과 글로벌 신약의 잇따른 만료 등으로 제네릭 의약품의 매출 비중이 증가하는 추세이며, 오리지널과 비교시 효능과 안전성 등은 동일하고 상대적으로 가격이 저렴하기 때문에 보험정책상 선호되고 있습니다. 2016년 IMS Health의 각 국가별 제네릭 의약품 처방비중 조사에 따르면 최대 제약시장인 미국의 경우 제네릭 의약품의 처방 비중이 89%에 달하는 것으로 나타났으나, 그러나 한국은 제네릭의약품의 사용 비중이 54%로 선진국 대비 낮아 추가적인 성장의 여력이 있을 것으로 판단됩니다.&cr;</P>
<P USERMARK="F-GL">국내 제약시장의 주목할 만한 점은 중소제약사의 성장세입니다. 2018년 매출액 4천억을 기준으로 상하 2개그룹으로 나눌 경우, 상위그룹의 영업이익은 전년대비 평균 +0.92% 성장한 반면 하위그룹은 평균 +5.95% 성장했습니다. 영업이익율 역시 하위그룹이 12.9%로 상위 8개사 평균인 6.0% 대비 높은 수준을 기록했습니다. </P>

<P> &cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">사. 회사의 경쟁력&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 ETC를 중심으로 완제의약품을 생산하는 제약회사로서 주요 제품에 대해 자체 생산 설비를 완비하고 있습니다. 고령화 및 만성질환의 주요 질환을 타겟으로 하는 순환기계, 근골격계, 소화기계, 항생제, 중추신경계 의약품을 중심으로 생산하고 있으며, 전국적인 영업망을 구축하고 시장점유율을 높여가고 있습니다. 또한 이들 주요 품목에 대하여 CMO사업을 병행하고 있으며, 매출 비중 역시 지속적으로 높아지고 있습니다. 주요 질환에 대한 당사의 시장 점유율을 높이기 위해 이중정을 기반으로 한 제품 라인업 및 순환기, 근골격 의약품 파이프라인을 강화하고 있으며, 지속적으로 신제품을 출시하여 해당 분야의 핵심 제약사로 발돋움하고 있습니다. &cr;</SPAN>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-GL B">(1) 기술적 우위&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 신약 및 개량신약 개발 연구에 대한 꾸준한 투자를 이어가고 있으며, 그 중 대표적인 기술적 결과물은 이중정 의약품 제제 및 타정 기술 확보입니다. 이중정 타정기 제제기술 확보는 당사포함 소수 제약회사만이 보유한 기술입니다. 당사는 이러한 기술력을 바탕으로 이중정을 기반으로 한 2개 품목에 대한 퍼스트제네릭 제제를 완료하여 시판을 기다리고 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">(2) 생산 경쟁력</SPAN>
</P>
<P USERMARK="F-GL">당사는 높은 품질의 의약품 생산을 위해 2005년 안성 GMP공장 설립 이후 엄격한 품질관리로 우수 의약품을 생산하고 있습니다. 원료구입, 제조, 포장, 출하까지 모든 공정마다 ERP를 기반으로 하여 작업 상태를 확인하고 있어 정확한 함량과 품질균등화 등을 이루고 있습니다. 이를 위해 생산 현장 근무자들에게 정기적인 GMP교육을 실시하고 있습니다.</P>

<P>
<SPAN USERMARK="F-GL"> 당사는 세파계 항생제 생산설비 건설을 시작으로 독립된 전용생산시설을 갖추어야만 생산이 가능한 특수제형의 세파계 항생제 제품들을 생산하고 있습니다. 추가적인 세파계 항생제 설비라인 증축으로 기존 캡슐제형과 더블어 타블렛 제형의 신규 진입을 예정하고 있습니다. 이로서 당사는 세파계 항생제 경구용제 포트폴리오를 모두 갖추게 되었습니다. 당사는 이러한 제형 생산에 대한 경쟁력을 바탕으로 특수제형의 생산 경쟁력 및 시장 잠재력을 확보하고자 노력하고 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">(3) 제품 경쟁력 </SPAN>
</P>
<P USERMARK="F-GL">정부의 약가 인하 정책 방향은 약제비 절감 및 재정절감을 목표로 내세우고 있으며, 부수적으로 난립하는 제네릭 의약품의 수적 통제 효과를 가져 올 것으로 예상됩니다. 즉, 자체 생동 능력을 갖추지 못한 제약사의 의약품은 약가를 보존하기가 어려워 시장에서 퇴출 될 가능성이 높아질것으로 예상됩니다. 때문에 자체 생동 능력이 약가 우위등을 통해 제품 경쟁력의 기반 요건으로 자리잡게 될 전망입니다.</P>

<P>
<SPAN USERMARK="F-GL"> 전문의약품의 경우 일반 소비재와는 달리 수요와 공급에 따른 가격 결정이나, 제약회사가 자체적으로 가격을 결정하는 것이 아니기 때문에, 정부 정책에 따른 약가 인하로 인한 낮은 가격은 시장에서 그 어떤 이점으로도 작용될 수 없습니다. 오히려 해당 품목을 포기해야 하는 요인으로 작용 될 수 있어, 약가 보존 자체가 제품의 경쟁력 확보를 의미하게 됩니다. 당사는 제품 경쟁력 강화를 위하여 자체 R&D의 강화와 동종업계 기업들과 전략적인 협업을 통하여 지속적인 복합제의약품과 이중정의약품 제조 및 제제 기술을 확보하고 발전시키며 퍼스트제네릭 출시 및 추후 출시할 제품들에 대한 역량을 강화하여 시장의 높은 진입장벽을 구축하고자 노력하고 있습니다.</SPAN>&cr;&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-GL B">(4) CMO 경쟁력</SPAN>
</P>
<P USERMARK="F-GL">당사는 CMO사업 부문에서 경쟁력을 갖추기 위해 지속적으로 노력하고 있습니다. 당사의 CMO사업이 강점을 가지고 있는 품목을 하기에 서술하였습니다.</P>

<TABLE WIDTH="569" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="569" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[CMO 시장점유율]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="569" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : %)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="569" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>생산유형</P>
</TH>

<TH WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>(가칭)성분명</P>
</TH>

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>허가</P>
<P>업체수</P>
</TH>

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>공급&cr;  업체수</P>
</TH>

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>점유율(주1)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113">
<P>고변동성제제</P>
</TD>

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(A)   성분 40mg</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>44</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>20</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>45</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(A)   성분 80mg</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>37</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>16</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>43</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>(B) 성분 16mg,</P>
<P>(C) 성분 12.5mg</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>23</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>10</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>43</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>퍼스트제네릭</P>
</TD>

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(D) 성분 10mg</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>37</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>74</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(E) 성분 5mg</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>57</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>37</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>65</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>특수공법 생산</P>
</TD>

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(F) 성분</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>43</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>17</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>40</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세팔로스포린계</P>
</TD>

<TD WIDTH="145" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(G) 성분</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>20</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>45</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="570" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="570" VALIGN="MIDDLE" HEIGHT="53">주1) 상기 점유율은 업체 수의 점유 수준을 기재하였습니다.&cr;주2) 당사 영업 관련 정보 유출로 인하여 가칭으로 대체 표기 하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">당사는 직접판매를 위한 제품 생산 외에도 CMO사업의 매출 증대를 위해 지속적으로 노력하고 있으며, 퍼스트제네릭 출시와 특수제형 및 신규제형의 출시를 통해 위탁생산 점유율을 지속적으로 늘려나갈 것입니다. &cr;</P>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">2. 주요제품, 서비스 등</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 주요 제품 등의 현황</SPAN>
</P>

<TABLE WIDTH="968" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="959"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="968" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 백만원,%)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="967" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>효능군</P>
</TH>

<TH ROWSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>품목</P>
</TH>

<TH COLSPAN="2" WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출현황(17기)</P>
</TH>

<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출현황(16기)</P>
</TH>

<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출현황(15기)</P>
</TH>

<TH COLSPAN="2" WIDTH="176" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출현황(14기)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출액</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비율</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출액</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비율</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출액</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비율</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>매출액</P>
</TH>

<TH WIDTH="88" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비율</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P>순환기용제</P>
</TD>

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아토렌정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,709</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.52</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     3,156</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     6.02</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,252</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.29</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,275</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로더스정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">469</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.79</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,065</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     2.03</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,135</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.19</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,088</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.14</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>피도그린정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">559</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.13</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,188</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     2.27</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,103</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.13</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,014</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.99</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>브이디핀정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,027</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.92</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       969</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.85</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">930</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.80</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">729</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로우딘정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">348</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.33</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       752</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.44</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">795</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.54</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">789</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.55</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,064</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.69</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     6,812</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    13.00</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,602</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.76</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,684</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.16</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,175</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27.37</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   13,942</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    26.61</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,817</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26.71</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,579</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24.69</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P>근골격용제</P>
</TD>

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레토나제정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">384</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.47</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,031</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.97</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,842</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.56</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,623</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>손페리정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">312</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.19</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       645</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.23</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">765</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.48</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">768</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.51</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>알루나주</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">395</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.51</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       781</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.49</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">703</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.36</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">490</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스페낙정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">310</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.18</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       622</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.19</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">683</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.32</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">717</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.41</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소로펜정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.87</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       626</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.19</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">660</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.28</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">628</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,028</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.92</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,797</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     3.43</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,132</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.12</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,309</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,657</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10.14</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     5,502</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    10.50</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,785</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13.12</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,535</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16.75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P>소화기용제</P>
</TD>

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가스핀정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">408</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.56</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       844</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.61</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">822</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.59</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">733</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.44</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에스라졸정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">791</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.02</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       923</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.76</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">665</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.29</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">563</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위피드정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">287</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.10</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       545</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.04</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">485</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.94</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">460</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스파모티딘정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">501</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.91</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       746</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.42</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.82</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">394</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>오프라캡슐</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">208</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.79</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       440</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.84</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">417</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.81</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">472</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,608</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.13</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     3,142</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     6.00</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,598</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.95</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,942</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.74</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,804</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14.51</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     6,640</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    12.67</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,409</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.39</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,564</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P>항생제</P>
</TD>

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스세파클러캡슐</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">563</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.15</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,455</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     2.78</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,683</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.25</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,685</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.31</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>메로엠주</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">660</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.52</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,129</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     2.15</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">505</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.98</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">358</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.70</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스세픽심캡슐</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">142</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.54</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       362</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.69</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">462</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.89</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">385</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.76</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더네신주</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">88</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.34</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       167</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.32</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">259</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.50</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">228</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세프노주</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.32</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       201</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.38</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">220</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.43</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">172</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.34</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">462</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.76</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,076</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     2.05</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">909</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.76</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">889</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,999</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.63</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     4,390</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     8.38</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4038</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.81</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3717</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P>기타 &cr;처방의약품</P>
</TD>

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>엘카론정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">338</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.29</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       747</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.43</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,426</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.76</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,415</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.78</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더페질정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">444</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.70</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       950</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.81</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,103</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.13</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,129</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>콜리린연질캡슐</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,020</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.89</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1,756</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     3.35</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">770</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.49</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">123</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레프로진정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">135</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.52</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       570</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     1.09</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">629</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.22</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">606</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스글리메피리드정</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">183</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.70</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       370</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.71</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">425</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.82</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">458</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.90</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,196</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.19</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     7,566</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    14.44</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,598</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10.82</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,965</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11.71</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,317</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.28</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   11,959</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    22.83</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,951</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.24</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,696</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="261" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">CMO</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,256</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.05</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     9,916</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    18.93</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,672</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.63</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,787</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="261" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타(임대료수입 등)</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.03</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         43</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     0.08</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">60</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.12</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">67</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="261" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,216</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">   52,392</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  100.00</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,733</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,945</TD>
<TD WIDTH="88" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 주요 제품 등의 가격변동 추이&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">(1) 가격 변동 추이</SPAN>
</P>

<TABLE WIDTH="1000" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="991"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1000" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1005" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="187"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요품목</P>
</TH>

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>효능군</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제14기&cr;('17.07.01~'18.06.30)</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아토렌정 10mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>608</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>608</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">608</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로더스정50mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>484</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>484</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">483</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>피도그린정75mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,164</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,164</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,164</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,164</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>브이디핀정5/80mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>894</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>894</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">805</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">805</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로우딘정5mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>367</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>367</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레토나제정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>70</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>70</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">70</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>손페리정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>115</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>115</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">115</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>알루나주</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,299</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,299</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,299</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,299</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스페낙정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>188</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>188</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">188</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">188</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소로펜정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>125</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">125</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가스핀정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기관용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에스라졸정20mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기관용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>849</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>849</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">764</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">764</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위피드정100mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기관용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">103</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스파모티딘정20mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기관용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>189</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>189</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">189</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>오프라캡슐</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기관용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>789</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>789</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">788</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">788</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스세파클러캡슐250mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>438</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>438</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>메로엠주1g</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>16,371</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>16,371</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,371</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,371</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스세픽심캡슐100mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>499</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>499</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">499</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">499</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더네신주150mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,279</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,279</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,279</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세프노주1그람</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,370</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,370</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,370</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,370</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>엘카론정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>544</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>544</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">544</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">544</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더페질정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,405</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,405</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,400</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>콜리린연질캡슐</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>523</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>523</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">523</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">523</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>레프로진정</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>146</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>146</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">146</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">146</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="196" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위더스글리메피리드정2mg</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>내분비용제</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>185</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>185</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">185</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">185</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-GL B">(2) 가격 변동 원인&cr;</SPAN>
<SPAN USERMARK="F-GL">의약품은 요양급여의 기준에 관한 규칙에 의거하여 약가가 결정 됩니다. 이외에 약제의 결정 및 조정기준에 조정은 다음과 같습니다.</SPAN>
</P>
<P USERMARK="F-GL">1) 사용량-연동 협상에 따른 약제 상한금액 조정 &cr;2) 사용범위 확대에 따른 약제 상한 금액 조정 &cr;3) 실거래가 조사에 따른 약제 상한 금액 조정&cr;4) 제네릭 출시로 약가 가산 종료 등 &cr;정부의 약가 정책에 따라 연동하여 변동될 수 있습니다.</P>

<P>&cr;
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">3. 주요 원재료에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 주요 매입 현황</SPAN>
</P>

<TABLE WIDTH="1067" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1058"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1067" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1067" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="234"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매입유형</P>
</TH>

<TH WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제14기&cr;('17.07.01~'18.06.30)</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P> 제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">

<P>
<SPAN> </SPAN>
<SPAN>제17기&cr;('20.07.01~'20.12.31)</SPAN>
</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="19" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="570">
<P>원재료</P>
</TD>

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>스트렙토키나제스트렙토도르나제</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,272,150</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>925,200</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">424,050</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">231,300</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세파클러수화물</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>875,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>525,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">505,000</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">170,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>솔리페나신숙신산염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>240,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>420,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">540,000</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">180,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세픽심수화물</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>403,750</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>332,500</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">435,000</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,875</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>히프로멜로오스 22084000mPa·s</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>249,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>314,650</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">301,600</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">267,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아세틸 L-카르니틴 염산염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>560,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>490,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">338,750</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>칸데사르탄실렉세틸</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>190,900</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>271,400</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">302,400</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">64,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아토르바스타틴칼슘</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>439,890</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>269,390</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">439,890</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">170,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>오메프라졸장용성과립</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>275,484($249,000)</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>220,740($186,000)</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">230,719($188,201)</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,800($47,400)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">
<P>레보플록사신수화물</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>186,300</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>207,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">62,100</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,688($31,500)</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,808($31,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>탈니플루메이트</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>806,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>186,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">186,000</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">93,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>에페리손염산염</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>132,000</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>165,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">159,000</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">72,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>아세클로페낙</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>67,275</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>124,200</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">99,450</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">102,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>로사르탄칼륨</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">139,550</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">243,300</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">105,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>기타</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,445,281</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,843,414</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,025,492</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,103,545</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>403,517($357,505)</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>377,238($322,992)</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">590,726($496,878)</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">441,620($380,952)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>원재료합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,012,546</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,188,554</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,031,232</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,885,220</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>679,001($606,505)</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>597,978($508,992)</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">860,133($716,579)</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,228($459,852)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="5" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>포장재료</P>
</TD>

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>PE용기</P>
</TD>

<TD ROWSPAN="5" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>286,033</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>216,049</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">260,003</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">117,559</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>포장호일</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>128,023</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>161,871</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,021</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,127</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>라벨 및 설명서</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>256,289</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>294,882</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">327,123</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">160,509</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>69,480</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>67,750</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,045</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">140,177</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>부자재 합계</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>739,825</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>740,552</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">827,192</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">489,372</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>외주가공비</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,088,764</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,486,527</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,666,724</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,448,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" ROWSPAN="3" WIDTH="321" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>합계</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>14,597,218</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12,397,633</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,525,148</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,823,435</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수입</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>679,001($606,505)</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>597,978($508,992)</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">860,133($716,579)</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">535,228($459,852)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,276,219</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12,995,611</P>
</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,385,281</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,283,287</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="1066" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1057"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1066" VALIGN="MIDDLE" HEIGHT="30">
<P>주1) 외화로 적시된 금액의 환율은 물품(원료) 통관일의 관세청 고시 환율을 기준으로 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1066" VALIGN="MIDDLE" HEIGHT="30">주2) 원달러 환율 14기: 1,105.48원/$, 15기: 1,149.04원/$, 16기: 1,208.51원/$, 17기: 1,163.9원/$</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">나. 주요 원재료 등의 가격변동 추이</SPAN>
</P>

<TABLE WIDTH="1123" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1114"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 원,kg)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1124" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="145"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="195"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제14기&cr;('17.07.01~'18.06.30)</P>
</TH>

<TH WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH WIDTH="182" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>

<TH WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>SKSD</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,285,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,285,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,285,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,285,000 </TD>

<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Cefaclor</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>350,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>350,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">330,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">340,000 </TD>

<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원료 중간체 단가 변동</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Solifenacin</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,000,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,000,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000 </TD>

<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Cefixime</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>475,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>475,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">485,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">485,000 </TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPMC 2208 4000CP</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>30,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>29,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,000</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시장 가격에 따른 단가 변동</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Acetyl-L-carnitine</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>70,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>70,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">80,000 </TD>

<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Candesartan</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,300,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,300,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,400,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,170,000 </TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제조원 변경</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Atorvastatin</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,550,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,550,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,550,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,550,000 </TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>Omeprazole</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>수입</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>166,960($155)</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>180,280($157)</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">187,975 ($155)</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">187,587($158)</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">운임 상승에 따른 &cr;일시적 변동</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">
<P>Levofloxacin</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>207,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>207,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">207,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">207,000 </TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">수입으로 전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,944($105)</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">133,602 ($105)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Talniflumate</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>62,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>62,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">62,000 </TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">62,000 </TD>

<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Eperisone HCI</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>110,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>110,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">90,000</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Aceclofenac</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103,500</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>103,500</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114,000</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">114,000 </TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Losartan potassium</P>
</TD>

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>국내</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>145,000</P>
</TD>

<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>164,000</P>
</TD>
<TD WIDTH="182" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">154,000</TD>
<TD WIDTH="172" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,000</TD>
<TD WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제조원 변경</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="1124" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1124" VALIGN="MIDDLE" HEIGHT="30">
<P>주) 공급처의 수입단가 조정 및 환율변동에 의한 가격 변동 존재</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">4. 생산 및 생산설비에 관한 사항</SPAN>
</P>
<P USERMARK="F-GL B">가. 생산능력 및 생산실적</P>

<TABLE WIDTH="1067" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1058"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1067" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천개, 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1067" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품</P>
</TH>

<TH ROWSPAN="2" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제품명</P>
</TH>

<TH COLSPAN="2" WIDTH="192" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제14기&cr;('17.07.01~'18.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>정제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산 능력</P>
</TD>

<TD ROWSPAN="4" WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>아토렌정 외</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>432,077</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>482,253</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">634,176</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">317,088</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산 실적</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>354,747</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12,230,145</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>308,529</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12,223,232</P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">282,161</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,748,411</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">128,791</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,531,512</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가동율</P>
</TD>

<TD COLSPAN="2" WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>82.1%</P>
</TD>

<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>64.0%</P>
</TD>
<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">44.5%</TD>
<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40.61%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말 재고</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>64,048</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,784,699</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50,955</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,590,202</P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">42,975</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,782,714</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,369</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,475,016</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>캡슐제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산 능력</P>
</TD>

<TD ROWSPAN="4" WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>위더스&cr;세파클러캡슐 외</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>38,400</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>38,400</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,400</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,200</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>생산실적 </P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>22,817</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,925,040</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>21,971</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,875,287</P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,158</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,488,376</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,062</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">422,406</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가동율</P>
</TD>

<TD COLSPAN="2" WIDTH="192" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>59.4%</P>
</TD>

<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>57.2%</P>
</TD>
<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">63.05%</TD>
<TD COLSPAN="2" WIDTH="190" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26.36%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기말 재고</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,602</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>349,385</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,206</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>278,482</P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,469</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">637,288</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,335</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">224,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="80" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>외주&cr;가공품목</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기말 재고</P>
</TD>

<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>피도그린정&cr;75mg 외</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>24,953</P>
</TD>

<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>2,248,058</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>22,365</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>2,044,468</P>
</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">23,094</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,128,224</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">34,259</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,981,892</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL B">(1) 생산능력의 산출근거</P>
<P USERMARK="F-GL">각 제형별로 생산설비 1대당 하루 생산 가능수량에 년간 평균 근무일수(240일)와 하루 중 평균 가동시간(준비, 조립, 세척시간 감안) 비중(80%)을 곱하여 산출하였습니다.&cr;  </P>
<P USERMARK="F-GL B">(2) 연간 생산능력 산출 방법</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업소</P>
</TH>

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기동기기</P>
</TH>

<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>생산능력</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="4" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">
<P>정제</P>
</TD>

<TD ROWSPAN="5" WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">
<P>안성공장</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정기1~3호기</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>각 96,000,000T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정기 4호기</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>39,936,000T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정기 5호기</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>25,804,800T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정기 7호기</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>153,600,000T/년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>캡슐제</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>캡슐충전기 1~2호기</P>
</TD>

<TD WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>각19,200,000C/년</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 생산설비에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">(1)생산설비 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1073">

<COLGROUP>
<COL WIDTH="1064"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1073" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1074">

<COLGROUP>
<COL WIDTH="63"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="72" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구분</TH>
<TH ROWSPAN="2" WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">자산별</TH>
<TH ROWSPAN="2" WIDTH="198" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초</TH>
<TH COLSPAN="2" WIDTH="284" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기증감</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기말잔액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증가</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감소</TH>
<TH WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">상각</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="72" HEIGHT="210">유형자산</TD>
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="94" HEIGHT="60">토지</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장/경기 안성시 미양면</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    2,277,782</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                        -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                        -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">           -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    2,277,782</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약연구실/경기 수원시</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       165,840</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                        -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                        -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">           -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       165,840</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="94" HEIGHT="60">건물</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장/경기 안성시 미양면</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">    6,911,637</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">     -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  100,981</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">    6,810,656</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약연구실/경기 수원시</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">       521,172</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">     6,933</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">       514,239</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="94" HEIGHT="60">기계장치</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장/경기 안성시 미양면</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">    3,172,168</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  572,853</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  481,827</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">    3,263,194</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약연구실/경기 수원시</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">       824,684</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">           -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  127,338</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">       697,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구와기구</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공구과기구</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       346,754</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  138,994</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                        -</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">    70,106</TD>
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       415,642</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="364" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">   14,220,037</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  711,847</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">                        -</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">  787,185</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="142" HEIGHT="30">   14,144,699</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="988" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="979"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="988" VALIGN="MIDDLE" HEIGHT="30">
<P>주1) 1억원을 초과한 기계장치 중 상각이 완료되어 기말잔액이 1천원에 해당되는 품목은 기타에 통합하여 기재하였습니다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="988" VALIGN="MIDDLE" HEIGHT="30">주2) 상기 기계장치들은 위치한 소재지별로 합산하여 기재하였습니다.</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">(2) 최근 3년간 변동 사항&cr;</SPAN>
</P>

<TABLE WIDTH="726" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="717"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[2020년]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="726" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">설비자산명</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)가액</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)일</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득사유</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(제조)처</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HPLC기기①</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                66,811</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-01-16</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HPLC기기②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                66,811</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-01-16</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HPLC기기③</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                66,811</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-01-16</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자동 선별기 </TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              245,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-18</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜엔클로니</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공기압축기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                83,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-19</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">KS Air comp</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">믹서기① </TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              110,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-21</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">금성산기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">믹서기②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              110,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-21</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">금성산기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">초정밀저울</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                48,200</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-27</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대정상사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">TOC 분석기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                57,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-27</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대정상사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">에어샘플러</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                12,300</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-05-27</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대정상사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">코팅기 ①</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              175,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-15</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜세종파마텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">코팅기 ②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              175,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-15</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">㈜세종파마텍</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">롤러콤팩터①</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              195,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-22</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울하이테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">롤러콤팩터②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                43,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-22</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 실험용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울하이테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동층건조기① </TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              205,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-26</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일성기공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유동층건조기②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              205,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-26</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일성기공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">더블콘믹서 </TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                32,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-26</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일성기공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">콘밀 </TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                36,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-26</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일성기공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">마이크로웨이브</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                46,435</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-06-29</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">멀티체크기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               95,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-07-02</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대정상사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">SPECTROMETERS</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">             183,423 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-07-03</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">저울</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               37,310 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-07-21</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">청솔엔지니어링</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">정제이송기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               16,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-07-31</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">금성산기㈜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">리프터</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               60,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-08-10</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울하이테크</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">지게차</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               24,300 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-09-09</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">삼성클라크지게차총판</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">일련번호 포장라인</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               84,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-09-15</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식회사 타스코</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">UPS</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               22,000 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-09-30</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">태일엔지니어링</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">검출기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               14,420 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020-12-02</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">청솔엔지니어링</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               95,600 </TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">　-</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE WIDTH="726" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="717"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[2019년]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="726" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">설비자산명</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)가액</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)일</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득사유</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(제조)처</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HLPC기기①</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                54,678</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-07-23</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 실험용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HLPC기기②</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                54,678</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-07-23</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 실험용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">HLPC기기③</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                54,678</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-07-23</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 실험용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">수입</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">타정기</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">              175,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-12-11</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">금성산기</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보일러</TD>
<TD WIDTH="158" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                57,000</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-12-03</TD>
<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제품 생산용</TD>
<TD WIDTH="167" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">한국미우라공업㈜</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<TABLE WIDTH="726" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="717"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[2018년]</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="726" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="727" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>설비자산명</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득(처분)가액</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득(처분)일</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득사유</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>용 도</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>취득(제조)처</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신형비닐투입기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>39,500</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.01.09</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 포장용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 포장용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>카운텍</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>저울</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>30,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.10</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Shimadzu</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>47,654</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>47,654</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>47,654</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>용출기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>55,113</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항온항습기 외</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>130,491</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.05.08</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>용출기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>67,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.05.14</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>UV/VIS 분광광도계</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18,500</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.05.18</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Shimadzu</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>코팅기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>99,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.06.29</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세종파마텍</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타정기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>59,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.06.29</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세종파마텍</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>49,090</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.07.04</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>49,090</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.07.04</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>정제수제조장치</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>198,786</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.07.09</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제이오텍</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이중타정기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>897,925</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.07.30</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>페테</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>용출기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>67,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.13</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>LABINDIA</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>45,568</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.20 </P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>45,568</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.20 </P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>HPLC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>53,163</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.20 </P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>GC</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>77,605</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.31</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>Agilent</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>스피드믹서기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>49,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.08.31</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 실험용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>QC 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>금성산기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구용삼층정타정기</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>105,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.12.07</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>신약연구실 실험용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>마루이앤에스</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제습설비</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>91,000</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.12.31</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 생산용</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>ANEST IWATA</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>

<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>19,455</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>  </P>
<P USERMARK="F-GL">(3) 설비의 신설,매입계획</P>

<TABLE WIDTH="891" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="882"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="891" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="891" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>설비능력</P>
</TH>

<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>총소요</P>
<P>자금</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기지출액</P>
</TH>

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>지출</P>
<P>예정일</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>착공</P>
<P>예정일</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>준 공</P>
<P>년월일</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진척율</P>
</TH>

<TH WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비 고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>건 물</P>
</TD>

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1,057.9㎡(320평)</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>79,100</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>23,730</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년 이후</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>세파동 및 일반동 증축</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기계장치</P>
</TD>

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,980,030</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2020년 이후</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>0%</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>증축에 따른 추가기계장치 매입</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>

<TD WIDTH="134" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,059,130</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>23,730</P>
</TD>

<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">5. 매출에 관한 사항&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 매출실적</SPAN>
</P>

<TABLE WIDTH="985" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="976"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="985" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위: 천T,백만원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="988" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH COLSPAN="2" WIDTH="211" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제14기&cr;('17.07.01~'18.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>수량</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>금액</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>순환기용제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>37,418</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12,579</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>40,443</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>13,815</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39,081</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,942</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,337</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,175</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>근골격용제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>120,214</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,535</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>86,643</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,785</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,013</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,502</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,311</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,657</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소화기용제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>60,467</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,564</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>52,459</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,409</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">49,902</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,640</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">29,152</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,804</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>항생제</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,168</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,717</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,545</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,034</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,128</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,390</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,319</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,999</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타 처방 의약품</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>35,621</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,696</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>37,387</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,958</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,795</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,959</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,690</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,318</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CMO</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>182,515</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,787</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>168,661</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,672</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">161,940</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,916</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">84,407</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타(임대료수입 등)</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>67</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>60</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">43</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총계</P>
</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>445,406</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>50,945</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>395,141</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>51,732</P>
</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">359,862</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,392</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">182,216</TD>
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,216</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 판매 경로</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">(1) 판매 조직&cr;</SPAN>
<SPAN USERMARK="F-GL">전문의약품은 병원, 의원, 약국, 도매업체를 통해서 유통 및 판매되고 있으며, 일반적인 유통망을 통해서는 판매될 수 없습니다. 이러한 이유로 판매조직 또한 판매처에 맞춰 구성하는 것이 일반적입니다.</SPAN>
</P>

<TABLE WIDTH="598" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="589"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="598" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[위더스제약의 판매조직 현황]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="65"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="421"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매조직</P>
</TH>

<TH WIDTH="430" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매방식</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="159">
<P>영업</P>
<P>본부</P>
</TD>

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>도매사업부</P>
</TD>

<TD WIDTH="430" VALIGN="MIDDLE" HEIGHT="53">
<P>- 본사도매부, 지역도매부(대구, 부산, 전주)</P>
<P>- 도매상과의 거래(종합도매, 품목도매, 간납도매)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>병원1사업부</P>
</TD>

<TD WIDTH="430" VALIGN="MIDDLE" HEIGHT="53">
<P>- 서울경인본부, 영남본부, 충호남본부</P>
<P>- 로컬의원, 병원, 약국 등 거래</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>병원2사업부</P>
</TD>

<TD WIDTH="430" VALIGN="MIDDLE" HEIGHT="53">
<P>- 로컬의원, 병원, 약국 등 거래&cr;- 종합병원(서울, 경기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CSO</P>
</TD>

<TD WIDTH="430" VALIGN="MIDDLE" HEIGHT="30">
<P>CSO 업체와의 계약, 관리를 통해 로컬의원 영업</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CMO 사업부</P>
</TD>

<TD WIDTH="430" VALIGN="MIDDLE" HEIGHT="30">
<P>타제약사의 제품을 생산하는 의약품 위.수탁생산</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P> &cr;
<SPAN USERMARK="F-GL B">(2) 판매 조직도</SPAN>
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="407">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="333" ALIGN="CENTER" HSPACE="0">위더스제약_조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">위더스제약_조직도</IMG-CAPTION>
</IMAGE>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">(3) 판매 경로</SPAN>
</P>

<TABLE BORDER="1" WIDTH="753" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="64"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="265"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH COLSPAN="2" WIDTH="357" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>판매 경로</P>
</TH>

<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>매출액&cr;(16기 기준)</P>
</TH>

<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비중&cr;(%)</P>
</TH>
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액&cr;(17기 기준)</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비중&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>자사&cr;  의약품</P>
</TD>

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>도매 유통</P>
</TD>

<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회사 → 도매업체 → 약국 → 소비자</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,705 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">39.52 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,800</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>병원 유통</P>
</TD>

<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회사 → 병원/의원→ 소비자(원내처방)</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,927 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.68 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">983</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3.75</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>약국 유통</P>
</TD>

<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회사 → 약국 → 소비자(원외처방)</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,634 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37.48 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,170</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38.79</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>CMO</P>
</TD>

<TD WIDTH="274" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회사 → 제약사</P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,126 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19.33 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,256</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="430" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기    타</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.03</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="3" WIDTH="430" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합    계 </P>
</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">52,392 </TD>
<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00 </TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">26,216</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">당사는 판매 경로의 다양화가 매출의 증대로 이어질 수 있기 때문에 다양한 판매경로를 활용하고 있습니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL">① 종합병원 및 대학병원 등 규모가 큰 병원은 도매상을 통해 전문의약품을 공급받고 있습니다. 이로 인해 도매 유통 비중이 높아 보일 수는 있으나, 이러한 특수성과 유통비 등 소모비용을 고려할 때 도매상을 이용한 거래가 비용 절감 효과 측면과 안정적인 매출 구조 유지 차원에서 장점이 있습니다. </P>
<P USERMARK="F-GL">② 병원유통은 당사의 의약품이 병·의원 통해 직접 소비자에게 전달됩니다. &cr;③ 소매유통은 당사의 의약품이 약국을 통해 소비자에게 전달되는 경로로 이러한 경우, 약국과의 별도 계약을 통해 의약품을 공급하고 있습니다. </P>
<P USERMARK="F-GL">④ CMO 영업은 거래 제약사의 주문에 따라 적시 생산, 수탁납기 준수, 원가절감, 고변동성약물, 소수 제약회사만 보유한 특수제형 의약품을 수행함으로써 해당 부문 역량을 강화하고 있습니다. </P>

<P>&cr;
<SPAN USERMARK=" B">(4) 판매 전략</SPAN>
</P>
<P USERMARK="F-GL">당사는 임·직원들에게 고도화된 약품과 의료서비스에 대한 지식을 부여하기 위하여 지속적으로 교육을 하고 있으며, 외부 전문가의 강의를 실시 하여 마케팅 기법, 외부커뮤니케이션 능력 등을 향상 시키고 있습니다.</P>
<P USERMARK="F-GL">당사가 취급하는 주된 의약품은 전문의약품으로 공익 사업 후원 등을 통해 당사의 기업 인지도를 높이고 있습니다. 또한 우수거래처 확보 및 유지를 통해 영업 효율을 높이고자 브로셔 및 판촉물 제작하여 홍보활동을 실시하고 있습니다. 무엇보다 기본적으로 제품력이 뛰어난 우수 의약품 개발 및 생산에 전력을 다하고 있으며, 여러 유통 경로를 활용하는 만큼 유통 관리를 통한 판매 체계화에 심혈을 기울이고 있습니다. </P>

<P> &cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">6. 수주상황&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 국내매출의 경우 도매상 매출 및 병의원, 약국의 직접매출을 진행하고 있기 때문에 장기계약에 의한 판매가 일어나지 않고, CMO매출의 경우에도 국내제약사의 Order를 받아 통상 1~3개월내에 출고를 진행하고 있어 제출일 현재 품목별 수주금액 및 수주잔고는 의미가 없습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">7. 시장위험과 위험관리</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">당사는 여러 활동으로 인하여 시장위험, 신용위험 및 유동성위험과 같은 다양한 재무위험에 노출되어 있습니다. 회사의 전반적인 위험관리정책은 금융시장의 변동성에 초점을 맞추고 있으며 재무성과에 미치는 부정적 영향을 최소화하는데 중점을 두고 있습니다.&cr;위험관리는 이사회에서 승인한 정책에 따라 이루어지고 있습니다. 이사회는 전반적인 위험관리에 대한 문서화된 정책, 외환위험, 이자율 위험, 신용 위험, 파생금융상품과 비파생금융상품의 이용 및 유동성을 초과하는 투자와 같은 특정 분야에 관한 문서화된 정책을 검토하고 승인합니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL B">가. 주요 시장위험 내용&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 해외 영업활동 등으로 인하여 외환에 대한 환위험에 노출되어 있으며, 외환위험은 미래 예상거래, 인식된 자산과 부채와 관련하여 발생하고 있습니다. 그리고 당사의 이자율위험은 주로 미래 시장이자율 변동에 따라 변동금리부 차입금에서 발생하는 이자비용이 변동될 위험과 관련되어 있습니다. 회사의 이자율위험관리의 목표는 이자율변동으로 인한 불확실성과 순이자비용의 최소화를 추구함으로써 기업의가치를 극대화하는데 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 신용위험</SPAN>
<SPAN USERMARK="F-GL">&cr;신용위험은 금융상품의 계약자 중 일방이 의무를 이행하지 않아 상대방에게 재무손실을 입힐 위험을 의미하며, 주로 거래처에 대한 매출채권 및 기타수취채권 등에서 발생합니다.&cr;이러한 신용위험을 관리하기 위하여 회사는 주기적으로 고객과 거래상대방의 재무상태와 과거 경험 및 기타 요소들을 고려하여 재무신용도를 평가하고 있습니다. 회사는 매출채권 및 기타수취채권 등에서 발생할 것으로 예상되는 손실에 대해 충당금을 설정하고 있습니다. 회사는 고객의 재무 상태, 과거 경험 등 기타 요소들을 고려한 개별분석 및 과거의 대손경험률에 의한 추산액에 근거하여 충당금을 설정하고 있습니다.&cr;</SPAN>
</P>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">다. 유동성 위험&cr;</SPAN>
<SPAN USERMARK="F-GL">유동성위험은 만기도래 시에 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험입니다. 그 결과는 부채를 상환하거나 금융보증 및 미사용 대출약정을 이행할의무를 충족하지 못하는 것입니다. 회사의 유동성위험관리에 대한 궁극적인 책임은 단기 및 중장기 자금조달과 유동성관리규정을 적절하게 관리하기 위한 기본정책을 수립하는 이사회에 있습니다. 회사는 충분한 적립금과 차입한도를 유지하고 예측현금흐름과 실제현금흐름을 계속하여 관찰하고 금융자산과 금융부채의 만기구조를 대응시키면서 유동성위험을 관리하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 자본위험관리</SPAN>
<SPAN USERMARK="F-GL">&cr;당사의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 유지하고 자본비용을 절감하기 위해 최적의 자본구조를 유지하는 것입니다. 자본구조의 유지 또는 조정을 위하여 필요한 경우 회사는 배당을 조정하거나, 주주에 자본금을 반환하며, 부채감소를 위한 신주발행 및 자산매각 등을 실시하는 정책을 수립하고 있습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">8. 파생상품 및 풋백옵션 등 거래현황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL B">9. 경영상의 주요 계약 등&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">가. 라이센스아웃(License-out) 계약&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 라이센스인(License-in) 계약</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 기술제휴 계약&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>&cr;
<SPAN USERMARK=" B">라. 판매계약&cr;</SPAN>당사 매출액 기준 상위 5개 매출처에 대한 계약 내용 현황은 다음과 같습니다. 
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약상대방</P>
</TH>

<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약체결시기</P>
</TH>

<TH WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약기간</P>
</TH>

<TH WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약의 목적</P>
</TH>

<TH WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계약금액 &cr;또는 대금수수방법</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">A 업체</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2018.04.16</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기한</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 매출 </P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>미정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>B 업체</P>
</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2010.07.01</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기한</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 매출 </P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>미정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">C 업체</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2012.08.13</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기한</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>수탁생산</P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>현금 또는 어음결제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">D 업체</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2013.02.14</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기한</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 매출 </P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>미정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">E 업체</TD>

<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2010.07.01</P>
</TD>

<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>무기한</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품 매출 </P>
</TD>

<TD WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>미정</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">마. 기타계약</SPAN>
<SPAN USERMARK="F-GL">&cr;당사는 현재 원자재, 통화, 증권, 이자율 등에 기초하여 성립된 선물, 스왑, 선도, 옵션 기타 이와 유사한 계약을 체결하거나 매매한 사실이 없습니다.&cr;&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">10. 연구개발 활동</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">가. 연구개발활동의 개요&cr;</SPAN>
<SPAN USERMARK="F-GL">당사의 중앙연구소는 2012년 1월 설립되어 제네릭의약품 및 퍼스트제네릭의 연구개발을 담당해왔으며, 제네릭의약품의 안전성 검사 및 파이프라인 강화를 위해 노력하고있습니다. 당사는 2017년 2월부터 이중정기반 제네릭의약품 개발에 착수하였고, 개량신약 및 신약 연구 개발에 대한 필요성에 따라 2018년 6월 신약 연구소를 설립하였습니다. 현재 당사의 연구소는 이중정기반 순환기용제, 근골격용제 의약품 파이프라인 강화와 개량신약에 대한 연구개발을 진행 중에 있습니다.&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 연구개발 조직도 및 업무</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 조직도</SPAN>
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="410">

<IMAGE>
<IMG WIDTH="591" HEIGHT="294" ALIGN="CENTER" HSPACE="0">연구개발조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">연구개발조직도</IMG-CAPTION>
</IMAGE>
<P></P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">(2) 연구소 조직별 업무</SPAN>
</P>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="403"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>조직구분</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>부서</P>
</TH>

<TH WIDTH="412" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 업무</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>개발부</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>RA팀</P>
</TD>

<TD WIDTH="412" VALIGN="MIDDLE" HEIGHT="30">
<P>신제품 허가/약가 신청 및 제품 관리, 임상시험진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>학술팀</P>
</TD>

<TD WIDTH="412" VALIGN="MIDDLE" HEIGHT="30">
<P>의약품 교육 및 안전관리</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="106">
<P>신약연구실</P>
<P>(수원)</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구1팀</P>
</TD>

<TD WIDTH="412" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품(개량신약, 제너릭) 제제연구 및 공정 프로세스 확립</P>
<P>의약품 분석법 확립 및 자료작성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구 2팀</P>
</TD>

<TD WIDTH="412" VALIGN="MIDDLE" HEIGHT="53">
<P>의약품(개량신약, 제너릭) 제제연구 및 공정 프로세스 확립</P>
<P>의약품 분석법 확립 및 자료작성</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>중앙 연구소</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구 1팀</P>
</TD>

<TD WIDTH="412" VALIGN="MIDDLE" HEIGHT="30">
<P>기존 의약품 제제 개선, 생산 공정 개선, 제조원 추가</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">(3) 연구개발인력 구성&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">당사는 총 19명의 연구인력을 보유하고 있으며, 그 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="595" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" ROWSPAN="2" WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH COLSPAN="4" WIDTH="362" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>인 원 (단위:명)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>박 사</P>
</TH>

<TH WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>석 사</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>학사</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>합 계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>개발부</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>임원</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>RA팀</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>5</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>학술팀</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>신약연구실</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>실장</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제제연구 1팀</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제제연구 2팀</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>4</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">
<P>중앙연구소</P>
</TD>

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소장</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>연구1팀</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>4</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="233" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>1</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>11</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>7</P>
</TD>

<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>19</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">(4) 핵심 연구인력</SPAN>
</P>
<P USERMARK="F-GL">이 중 당사의 핵심 연구인력은 신약연구소 실장인 원용훈 실장, 수석 연구원 박준호, 책임 연구원 김민주 등으로 담당업무 및 주요경력은 하기와 같습니다.</P>

<TABLE WIDTH="1124" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1115"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">[핵심 연구인력 현황]</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1124" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="379"></COL>
<COL WIDTH="540"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담당업무</TH>
<TH WIDTH="388" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
<TH WIDTH="549" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 연구실적</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="812">
<P>실장</P>
</TD>

<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="812">
<P>원용훈</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="812">
<P>프로젝트 관리</P>
<P>프로젝트 발굴</P>
</TD>

<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="812">
<P>현 중앙대학교 약학대학 박사과정 중(2019.03~현재)</P>
<P>덕성여자대학교 약학대학원 석사 (2005. 08~2007. 08)</P>
<P>우석대학교 화학과 학사 (1990. 03~1998. 02)</P>
<P>위더스제약 신약연구소 실장 (2018. 01~현재)</P>
<P>구주제약 중앙연구소 부장 (2016. 08~2018. 01)</P>
<P>광동제약 신약연구팀 차장 (2002. 07~2016. 08)</P>
<P>서울제약 중앙연구소 대리 (1999. 09~2002. 06)</P>
</TD>

<TD WIDTH="549" VALIGN="MIDDLE" HEIGHT="812">
<P><입사 후>&cr;&cr;1. 에페리손서방정 (2018.06~2018.12)</P>
<P>- 에페리손 서방정 동등성 확보 및 안정성 문제점 개선(특허출원 완료)</P>
<P>2. 텔미사르탄/로수바스타틴 복합제연구(제품명: 듀로텔정 40/20, 80/20 시리즈)</P>
<P>- 용출액별 동등성 확보 및 안정성 확보, 기시법 개선 (동시분석법 개발)</P>
<P>- 생동약 생산 및 생동 진행 중</P>
<P>3. 록소프로펜정 연구 (제품명: 소로펜정)</P>
<P>- 기존 위탁제제 대비 안정성 개선 및 동등성 확보 완료</P>
<P>- 생동약 생산 및 생동 진행 중</P>
<P>4. 클로피도그렐정 연구 (제품명: 피도그린정)</P>
<P>- 기존 위탁제제 안정성 문제(용출률저하) 개선완료 및 동등성 확보 완료</P>
<P>- 생동약 생산 및 생동 진행 중</P>
<P>5. 레바미피드정 연구 (제품명: 위피드정)</P>
<P>- 중간 용출률의 용출액을 통한 동등성 확보 및 안정성 확보완료</P>
<P>- 생동약 생산 및 생동 진행 중</P>
<P> </P>
<P><입사 전>&cr;&cr;[연구실적]&cr;1) 종합비타민제 연구 및 제품화 완료(제품명: 엘씨비탐미, 엠씨비탐파워)&cr;2) 콜린알페세레이트 연질캡슐 제품화 완료&cr;3) 탐스로이신 서방정 제제연구&cr;4) 클레리스로마이신 정제, 티로프라미드 정제 등 재품화&cr;5) 신제형ODF 개발&cr;6) 천연물 신약 개발 참여(현삼을 이용한 치매 치료제 연구)&cr;7) 기타(전문,일반의약품 개발 연구)&cr;&cr;[주요 특허 출원 연구]&cr;1. 특허 출원번호: 1020090067817, 특허출원(2009.07), &cr;애엽에 함유되어 있는   혈액응고 억제작용을 갖는 성분의 제거방법&cr;2. 특허 출원번호: 1020090098469, 특허출원(2009.10), &cr;오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제&cr;3. 특허 출원번호: 1020190038840, 특허출원(2019.04)&cr;보관 안정성이 향상된 에페리손 약제학적 조성물 특허</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="329">
<P>수석</P>
<P>연구원</P>
</TD>

<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="329">
<P>박준호</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="329">
<P>프로젝트 진행</P>
<P>신약연구실관리</P>
</TD>

<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="329">
<P>아주대학교 화학생명공학 석사  (2006. 09~2009. 02)</P>
<P>홍익대학교 화학시스템공학 학사 (1999. 03~2006. 02)</P>
<P>위더스제약 수석연구원 (2018.06~현재)</P>
<P>광동제약 제제연구팀 과장 (2015. 12~2018. 06)</P>
<P>동광제약 중앙연구소 과장 (2005. 11~2015. 11)</P>
</TD>
<TD WIDTH="549" VALIGN="MIDDLE" HEIGHT="329"><입사 후>&cr;&cr;1. 텔미사르탄/로수바스타틴 복합제연구(제품명: 듀로텔정 40/20, 80/20 시리즈)&cr;- 용출액별 동등성 확보 및 안정성 확보, 기시법 개선 (동시분석법 개발)&cr;- 생동약 생산 및 생동 진행 중&cr;2. 록소프로펜정 연구 (제품명: 소로펜정)&cr;- 기존 위탁제제 대비 안정성 개선 및 동등성 확보 완료&cr;- 생동약 생산 및 생동 진행 중&cr;&cr;<입사 전>&cr;&cr;[연구실적]&cr;1. 출원번호: 1020110003334, 특허출원(2011.01), 등록(2013.08)&cr;안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="444">
<P>책임</P>
<P>연구원</P>
</TD>

<TD WIDTH="60" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="444">
<P>김민주</P>
</TD>

<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="444">
<P>프로젝트 진행</P>
<P>신약연구실관리</P>
</TD>

<TD WIDTH="388" VALIGN="MIDDLE" HEIGHT="444">
<P>인제대학교 식의약 생명공학 석사(2010. 03~2012. 02)</P>
<P>인제대학교 제약공학과 학사 (2006. 03~2010. 02)</P>
<P>위더스제약 책임연구원(2018. 04~현재)</P>
<P>구주제약 중앙연구소 대리 (2011. 12~2018. 03)</P>
</TD>

<TD WIDTH="549" VALIGN="MIDDLE" HEIGHT="444">
<P><입사 후>&cr;&cr;1. 에페리손서방정 (2018.06~2018.12) </P>
<P>- 에페리손 서방정 동등성 확보 및 안정성 문제점 개선</P>
<P>- 처방확보/생산성 검토완료</P>
<P>2. 클로피도그렐정 연구 (제품명: 피도그린정)</P>
<P>- 기존 위탁제제 안정성 문제(용출률저하) 개선완료 및 동등성 확보 완료</P>
<P>- 생동약 생산 및 생동 진행 중</P>
<P>3. 레바미피드정 연구 (제품명: 위피드정)</P>
<P>- 중간 용출률의 용출액을 통한 동등성 확보 및 안정성 확보완료</P>
<P>- 생동약 생산 및 생동 진행 중&cr;&cr;<입사 전>&cr;&cr;</P>
<P>[연구실적]&cr;1. 고형제제인 다수 제품 개발 및 연구&cr;2. 연질캡슐제제 생산성 향상 연구&cr;3. 액제/주사제 제제 개선등 연구</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">다. 연구개발비용</SPAN>
</P>

<TABLE WIDTH="811" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="802"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="811" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원,%)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="810" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 17기</P>
</TH>

<TH WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 16기</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 15기</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제 14기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">비용의 성격별분류</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재료비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            357,755 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     656,686</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              497,950 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              272,625 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>인건비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            274,762 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     555,368</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              516,195 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              255,274 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>감가상각비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                      - </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>위탁용역비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         1,662,307 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,395,078</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              131,160 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              269,613 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>기타</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                      - </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> - </TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                 7,427 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계액</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         2,294,824 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  2,607,132</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>           1,145,305 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              804,939 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="6" WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="180">
<P>회계처리 내역</P>
</TD>

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>판매비와 관리비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            856,348 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,512,387</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              586,908 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제조경비</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            462,246 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     662,845</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              558,397 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              804,939 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>개발비(무형자산)</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">            976,230 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">     431,900</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>회계처리금액 계</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         2,294,824 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  2,607,132</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>           1,145,305 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              804,939 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>정부보조금</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                      - </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               - </TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>                        -</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계액</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">         2,294,824 </TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  2,607,132</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>           1,145,305 </P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>              804,939 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합계(매출액대비 비율)</P>
</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.75%</TD>
<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4.98%</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2.21%</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1.58%</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="811" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="802"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="811" VALIGN="MIDDLE" HEIGHT="53">
<P>주1) 회사는 외부 연구용역기관에게 지급한 제네릭 관련 생동시험 용역 금액 중 식약처 승인받은 품목을 개발비로 계상하고 있으며, 판매승인 시점부터 5년 동안 상각할 예정입니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>

<P>
<SPAN USERMARK="F-GL B">라. 연구개발 완료 실적&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="871">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="134"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="141" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개발완료일</P>
</TH>

<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>현재 현황</P>
</TH>

<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" HEIGHT="450" ROWSPAN="15" ALIGN="CENTER" VALIGN="MIDDLE">
<P>화학합성</P>
</TD>

<TD WIDTH="63" HEIGHT="450" ROWSPAN="15" ALIGN="CENTER" VALIGN="MIDDLE">
<P>제네릭</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>트윈플러스정 80/5mg </P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>혈압강하제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 2017.01</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 트윈플러스정40/10</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 혈압강하제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 뮤세틸캡슐200mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 진해거담제 및 기침감기약</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.08</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 솔리신정10mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 솔리신정5mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 비뇨생식계 평활근 이완제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 2017.07</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 로수브이정20mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 고지혈증 치료제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 2018.03</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P> 국내판매중</P>
</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">브이디핀정10/160mg</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">혈압강하제</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.06</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 국내판매중</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미르토플러스정 40/12.5mg</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">혈압강하제</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.02</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국내판매중</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">브이디핀정5/80mg</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">혈압강하제</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.07</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국내판매중</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비교용출 자사생산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">브이디핀정5/160mg</TD>
<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">혈압강하제</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019.07</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">국내판매중</TD>
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자사생동입증품목</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>레가바정 150mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.11</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>레가바정 75mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.11</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>레가바정 50mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>중추신경용약</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.11</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>비교용출 자사생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>아바젯정10/20mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>고지혈증 치료제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2021.05</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>아바젯정 10/10mg</P>
</TD>

<TD WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>고지혈증 치료제</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2021.05</P>
</TD>

<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>국내판매중</P>
</TD>

<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>비교용출 자사생산</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1122">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="522"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="180" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구과제</P>
</TH>

<TH WIDTH="109" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구기관</P>
</TH>

<TH WIDTH="531" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과 및 기대효과</P>
</TH>

<TH WIDTH="302" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구결과가 상품화된 경우 그 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"트윈플러스정80/5mg"&cr;(텔미사르탄 80mg, &cr;암로디핀베실레이트 &cr;6.935mg)과 대조약의 &cr;생물학적 동등성 &cr;평가시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 트윈스타정80/5mg - 한국베링거인겔하임㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 48명에게 공복 시 단회 경구투여하여 &cr;혈중 암로디핀 및 텔미사르탄을 측정하고, 비교평가항목치(AUCt, Cmax)를 &cr;로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 &cr;log0.8~log1.25 이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 트윈플러스정80/5mg</P>
<P>* 출시일자 : 2017년 1월</P>
<P>* 주성분 : Telmisartan&cr;               Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"트윈플러스정40/10, &cr;40/5mg(텔미사르탄, &cr;암로디핀베실산염)"의&cr;  비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 트윈플러스정80/5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 트윈플러스정80/5mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 &cr;시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 트윈플러스정40/10mg</P>
<P>              트윈플러스정40/5mg</P>
<P>* 출시일자 : 2017년 7월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 비고 : 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"뮤세틸캡슐200mg&cr;(아세틸시스테인)" 개발</P>
</TD>

<TD WIDTH="109" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="145" VALIGN="MIDDLE">
<P>* 대조약 : 뮤테란캅셀200mg (아세틸시스테인) - 한화제약㈜</P>
<P>* 진해거담제 및 기침감기약으로 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="145" VALIGN="MIDDLE">
<P>* 제품명 : 뮤세틸캡슐200mg&cr;               (아세틸시스테인)</P>
<P>* 출시일자 : 2017년 8월</P>
<P>* 주성분 : Acetylcysteine</P>
<P>* 구분 : 진해거담제 & 기침감기약</P>
<P>* 제품 라인 추가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="283" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1. "솔리신정10밀리그램&cr;(솔리페나신숙신산염)"의 생물학적 동등성시험</P>
<P> &cr;2. "솔리신정5밀리그램&cr;(솔리페나신숙신산염)"의 비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="283" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="283" VALIGN="MIDDLE">
<P>1. * 대조약 : 베시케어정10밀리그램 (솔리페나신숙신산염) &cr;- 한국아스텔라스제약㈜</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 2X2 교차시험으로 건강한 성인 39명에게 공복 시 단회 경구투여하여 혈중 솔리페나신을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 &cr;생물학적으로 동등함을 입증 </P>
<P>&cr;2.* 대조약 : 솔리신정10mg (솔리페나신숙신산염) -  위더스제약(주)</P>
<P>* 비뇨생식계 평활근 이완제로써 개발</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="283" VALIGN="MIDDLE">
<P>* 제품명 :  1. 솔리신정10mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>               2. 솔리신정5mg</P>
<P>                 (솔리페나신숙신산염)</P>
<P>* 출시일자(1, 2 공통) : 2017년 7월</P>
<P>* 주성분(1, 2 공통) : Solifenacin succinate</P>
<P>* 구분(1, 2 공통) : 비뇨생식계 평활근 이완제</P>
<P>* First generic</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"로수브이정20mg&cr;(로수바스타틴칼슘)" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 로수브이정10mg (로수바스타틴칼슘) : 위더스제약㈜</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 생동성을 인정받은 자사품목인 로수브이정10mg을 시험의 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 로수브이정20mg</P>
<P>* 출시일자 : 2018년 3월</P>
<P>* 주성분 : Rosuvastatin calcium</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 자사전환 완료 및 "로수브이정5mg"추가 허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"브이디핀정10/160mg" 의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 엑스포지정10/160mg - 한국노바티스㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 56명에게 공복 시 단회 경구투여하여 혈중 발사르탄 및 암로디핀을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 &cr;이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 브이디핀정10/160mg</P>
<P>* 출시일자 : 2018년 6월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate &cr;* 구분 : 혈압강하제</P>
<P>* Valsartan 원료 이슈 당시 해당되지 않았음</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"미르토플러스정&cr;40/12.5mg"의 &cr;비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 미르토플러스정80/12.5mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 미르토플러스정80/12.5mg을 &cr;대조약으로 하여, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 미르토플러스정40/12.5mg</P>
<P>* 출시일자 : 2019년 2월</P>
<P>* 주성분 : Telmisartan</P>
<P>              Hydrochlorothiazide</P>
<P>* 구분 : 혈압강하제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>"브이디핀정5/80mg, &cr;브이디핀정5/160mg" 의 비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 브이디핀정10/160mg - 위더스제약㈜</P>
<P>* 혈압강하제로써 개발</P>
<P>* 생물학정 동등성을 인정받은 자사 품목인 브이디핀정10/160mg을 &cr;대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 &cr;다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 브이디핀정5/80mg</P>
<P>              브이디핀정5/160mg</P>
<P>* 출시일자 : 2019년 7월</P>
<P>* 주성분 : Valsartan</P>
<P>              Amlodipine besylate</P>
<P>* 구분 : 혈압강하제</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>“레가바정75mg”의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 리리카캡슐75mg ? 한국화이자제약㈜</P>
<P>* 중추신경용제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인 27명에게 공복 시 단회 경구투여하여 혈중 프레가발린을 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 생물학적으로 동등함을 입증 </P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 레가바정75mg</P>
<P>* 출시일자 : 2020년 11월</P>
<P>* 주성분 : Pregabalin&cr; * 구분 : 중추신경용제</P>
<P>* 캡슐제 → 정제 제형 변경하여 동등성 입증</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>“레가바정150mg, 레가바정50mg”의 비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 레가바정75mg ? 위더스제약㈜</P>
<P>* 중추신경용제로써 개발</P>
<P>* 생물학적 동등성을 인정받은 자사 품목인 레가바정75mg을 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성 판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 레가바정150mg, 레가바정50mg</P>
<P>* 출시일자 : 2020년 11월</P>
<P>* 주성분 : Pregabalin&cr; * 구분 : 중추신경용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>“아바젯정10/20mg”의 생물학적 동등성시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜ 중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 아토젯정10/20mg ? 한국엠에스디(유)</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 대조약과의 생동성 입증 및 시험대상자의 안전성 확립</P>
<P>* 2X2 교차시험으로 건강한 성인에게 공복 시 단회 경구투여하여 혈중 아토르바스타틴 및 에제티미브를 측정하고, 비교평가항목치(AUCt, Cmax)를 로그변환하여 통계처리하였을 때, 평균치 차의 90% 신뢰구간이 log0.8~log1.25 이내로서 생물학적으로 동등함을 입증</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 아바젯정10/20mg</P>
<P>* 출시일자 : 2021년 5월</P>
<P>* 주성분 : Atorvastatin</P>
<P>           Ezetimibe</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 이중정 생산 방식</P>
<P>* 자사생동입증품목</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>“아바젯정10/10mg”의 비교용출시험</P>
</TD>

<TD WIDTH="109" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>위더스제약㈜</P>
<P>중앙연구소</P>
</TD>

<TD WIDTH="531" HEIGHT="168" VALIGN="MIDDLE">
<P>* 대조약 : 아바젯정10/20mg ? 위더스제약㈜</P>
<P>* 고지혈증 치료제로써 개발</P>
<P>* 생물학적 동등성을 인정받은 자사 품목인 아바젯정10/20mg을 대조약으로 하며, 이와 제형 및 주성분의 종류는 동일하나 주성분의 함량이 다른 시험약의 함량 및 비교용출시험을 실시</P>
<P>* 비교용출시험 : 대조약과 시험약은 평균용출률과 개별용출률이 동등성 판정기준에 적합</P>
</TD>

<TD WIDTH="302" HEIGHT="168" VALIGN="MIDDLE">
<P>* 제품명 : 아바젯정10/20mg</P>
<P>* 출시일자 : 2021년 5월</P>
<P>* 주성분 : Atorvastatin</P>
<P>           Ezetimibe</P>
<P>* 구분 : 고지혈증 치료제</P>
<P>* 이중정 생산 방식</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
</P>

<P>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">마. 연구개발 계획</SPAN>
</P>
<P USERMARK="F-GL">당사는 노인성 약물에 대한 제품라인업 강화를 주 연구개발계획으로 수립하였습니다. 65세 이상의 고령 환자들은 복합적인 질병으로 많은 의약품을 복용하고 있고, 이것은 복용의 불편함과 사회적 비용의 증가를 야기시키고 있습니다. 당사는 노인성 질환과 관련한 의약품 라인업 확대를 위해 개량신약에 대한 연구개발계획을 수립하였으며, 이중정 복합제 개발을 준비하고 있습니다. 준비중인 개량신약에 대한 조성물 특허와 당사 보유 특허를 연계 예정이며, 노인성 약물에 특화되어 있는 당사의 제품라인업을 강화시킬 예정입니다.</P>
<P> </P>
<P USERMARK="F-GL B">(1) 개량신약 연구계획 </P>
<P USERMARK="F-GL"><연구개발 진행 총괄표></P>

<TABLE BORDER="1" WIDTH="799" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="226"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구</P>
<P>개시일</P>
</TH>

<TH COLSPAN="2" WIDTH="338" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진행단계</P>
</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>단계</P>
</TH>

<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>승인 및 예정</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="212">개량신약</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>WU-18001LF</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>골관절염 치료제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018.12</P>
</TD>

<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구 진행 중</P>
<P>2020. 2/4분기 임상1상 진입예정</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.06</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>단독연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>WU-21001</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">소화성궤양용제</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.04</P>
</TD>

<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사전 문헌자료 조사 및 검토 중</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2022. 07</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>단독연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>WU-21002</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">순환계용약</TD>
<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2021.07</TD>
<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사전 문헌자료 조사 및 검토 중</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.10</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>단독연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>WU-21003</P>
</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">당뇨병용제</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.09</P>
</TD>
<TD WIDTH="235" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">사전 문헌자료 조사 및 검토 중</TD>
<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2022.12</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>단독연구</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">(가) 품목 : WU-19003TM</SPAN>
</P>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="463"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>골관절염 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="472" HEIGHT="76">
<P>‘A’는 Propionic acid계 NSAIDs로서 전구약물이다.</P>
<P>‘B’는 H2 수용체에서 히스타민을 가역적으로 경쟁적으로 억제해서 위산분비를 억제한다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="472" HEIGHT="99">
<P>‘A’는 최근 5년간 30%이상 성장을 하고 있으며, ‘B’는 라니티딘 이슈로 인해 2019년 하반기 매출 증가폭이 큰 품목이다. </P>
<P>해열진통소염제와 ‘B’ 계열 약물의 병용처방건수도 2019년 하반기 이후 증가폭이 높게 나타났다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>연구방향 확정 및 연구 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="472" HEIGHT="53">
<P>2/4분기 내 임상1상 진입 목표</P>
<P>자사 특허 출원 및 등록으로 경쟁력 확보 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>국내 NSAIDs 시장 3,000억 규모 (2019년 UBIST 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>복합제 개발로 자사 이층정 타정기의 활용도 증가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="132" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩연구 개시일</P>
</TD>

<TD WIDTH="472" HEIGHT="30">
<P>2018. 12</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL">(나) 품목 : WU-21001</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="455"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>소화성궤양용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="464" HEIGHT="76">
<P>‘A’는 H2 수용체에서 히스타민을 가역적으로 경쟁적으로 억제해서 위산분비를 억제한다. ‘B’ 및 ‘C’는 궤양 부위에서 보호막을 형성하여 위산 등으로부터 위점막과 궤양부위를 보호한다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>위산분비 억제와 궤양부위 보호 2중 효과</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>사전 문헌자료 조사 및 제제검토 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>자사 특허 출원 및 등록으로 경쟁력 확보 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>국내 시장 1,600억 규모 (2019년 UBIST 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩연구 개시일</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>2021.04</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">(다) 품목 : WU-21002</SPAN>
</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="455"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>순환계용약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="464" HEIGHT="99">
<P>‘A’는 Angiotensin II 수용체 중 AT1 수용체의 길항제로서 angiotensin II의 혈관수축작용 및 aldosterone 분비작용을 억제한다.</P>
<P>‘B’는 콜레스테롤 생합성의 율속 단계를 촉매하는 효소인 HMG-CoA reductase를 경쟁적으로 저해한다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="464" HEIGHT="53">
<P>‘A’는 혈당저하 및 LDL-C 감소에 우수한 효과를 나타내며 ‘B’ 계열과 함께 투여 시 콜레스테롤 저하에 시너지 효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>사전 문헌자료 조사 및 제제검토 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>자사 특허 출원 및 등록으로 경쟁력 확보 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>국내 시장 1,400억 규모 (2019년 UBIST 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>추후 3제 복합제 개발확장 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩연구 개시일</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>2021.07</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">(라) 품목 : WU-21003</SPAN>
</P>

<TABLE BORDER="1" WIDTH="594" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="455"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="99" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="464" HEIGHT="99">
<P>‘A’는 Angiotensin II 수용체 중 AT1 수용체의 길항제로서 angiotensin II의 혈관수축작용 및 aldosterone 분비작용을 억제한다.</P>
<P>‘B’는 DPP4 저해제로써 2형 당뇨병 환자에서 내인성 incretin 호르몬을 보호하고 incretin 작용을 향상시킨다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="464" HEIGHT="53">
<P>질환의 특성상 장기 복용이 필요하며 두 질환이 동반되는 경우가 많아 복합제로 구성하여 처방 및 복용의 편의성을 높임 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>사전 문헌자료 조사 및 제제검토 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>자사 특허 출원 및 등록으로 경쟁력 확보 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>공개불가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>국내 당뇨병치료제 시장 1조 규모 (2019년 UBIST 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="464" HEIGHT="53">
<P>복합제 개발로 자사 이층정 타정기의 활용도 증가</P>
<P>추후 3제 복합제 개발확장 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑩연구 개시일</P>
</TD>

<TD WIDTH="464" HEIGHT="30">
<P>2021.09</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P> </P>
<P USERMARK="F-GL B">(2) 연구개발 진행 현황 및 향후 계획</P>
<P USERMARK="F-GL"><연구개발 진행 총괄표></P>

<TABLE BORDER="1" WIDTH="873" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>품목</P>
</TH>

<TH ROWSPAN="2" WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>적응증</P>
</TH>

<TH ROWSPAN="2" WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>연구</P>
<P>개시일</P>
</TH>

<TH COLSPAN="2" WIDTH="181" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>진행단계</P>
</TH>

<TH ROWSPAN="2" WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>단계</P>
</TH>

<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>승인 및 예정</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="26" WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="1378">
<P>제네릭</P>
</TD>

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>세악틸정</P>
<P>(세푸록심악세틸)</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>세팔로스포린계 &cr;항생제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.06</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>세프포정</P>
<P>(세프포독심프록세틸)</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>세팔로스포린계 </P>
<P>항생제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.06</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위더세프캡슐</P>
<P>(세파드록실수화물)</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>세팔로스포린계 </P>
<P>항생제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>브로아제 장용정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소염효소제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.07</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.10</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>브이디핀정 단일제</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>혈압강하제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.12</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.03</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위더스라푸티딘정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.11</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.03</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>올메핀정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>혈압강하제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.11</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.02</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>티브린타정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>항혈소판제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018.12</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>글리비아정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2015.03</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2015.04</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2023.09.01</P>
<P>특허</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>글리메트정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2015.03</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2015.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2023.09.01</P>
<P>특허</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>조아나정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>진통소염제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2009.05</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2010.03</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>WU-001</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>천식을 동반한 알레르기비염</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.09</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2023.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PMS 2023.05.16</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>아바젯정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>동맥경화용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2016.10</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.03</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PMS 2021.01.22</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>레가바정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>중추신경용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017.05</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.03</P>
</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>듀로텔정 40/20</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>순환계용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017.03</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.01</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PMS 2020.10.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>듀로텔정 80/20</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>순환계용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017.03</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.01</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>PMS 2020.10.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사포디필sr정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의 혈액 및 체액용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2017.11</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>허가완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.02</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소로펜정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>해열진통소염제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위피드정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.10</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>피도그린정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>동맥경화용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.04</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상1상</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2020.10</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>리트라젠</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.06</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.11</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>리트라젠듀오정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>당뇨병용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.06</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>임상완료</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.11</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>위탁허가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>가스핀정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의 소화기관용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.07</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>아레온정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>기타의 알레르기용약</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.07</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.08</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>에스라졸정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.10</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.12</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>레이프라정</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>소화성궤양용제</P>
</TD>

<TD WIDTH="71" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019.10</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>연구단계</P>
</TD>

<TD WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2021.12</P>
</TD>

<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>자사전환</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="879" BORDER="0">

<COLGROUP>
<COL WIDTH="870"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="879" HEIGHT="30">주1) 세악틸정, 세프포정, 위더세프캡슐 품목은 자사전환 진행중입니다.  </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL">(1) 품목 : 세악틸정(세푸록심악세틸)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="879" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="742"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>세팔로스포린계 항생제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="751" HEIGHT="53">
<P>여러 가지 penicillin-결합 단백에 결합하여 세균 세포벽의 peptidoglycan 합성의 마지막 transpeptidation 단계를 억제함으로써 세균의 세포벽 합성을 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="751" HEIGHT="53">
<P>항생제 라인 확대, 세파계 항생제 자사생산 제품 확대로 경쟁력 증가</P>
<P>2세대 세팔로스포린계 항생제로 그람양성균 및 혐기성 세균에 살균효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>2019년 06월 위탁 허가 완료, 2019년 12월 제품 출시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="751" HEIGHT="30">2021년 2분기 임상1상 실시 및 2022년 자사전환 완료 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>진네트정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>국내 230억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨   기타사항</P>
</TD>

<TD WIDTH="751" HEIGHT="30">
<P>그람음성균에 대해 1세대보다 강하게 작용함</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(2) 품목 : 세프포정(세프포독심프록세틸)</P>

<TABLE BORDER="1" WIDTH="880" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="743"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>세팔로스포린계 항생제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="752" HEIGHT="53">
<P>여러 가지 penicillin-결합 단백에 결합하여 세균 세포벽의 peptidoglycan 합성의 마지막 transpeptidation 단계를 억제함으로써 세균의 세포벽 합성을 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="752" HEIGHT="53">
<P>세파계 항생제 제품 출시로 항생제 라인 확대</P>
<P>3세대 세팔로스포린계 항생제로 그람양성균 및 그람음성균에 살균효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>2019년 06월 위탁 허가 완료, 2019년 12월 제품 출시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>2021년 임상1상 실시 및 2022년 자사전환 완료할 계획</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>바난정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧ 시장규모</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>국내 284억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="752" HEIGHT="30">
<P>그람음성 간균에 1,2세대보다 더 활성을 나타냄</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(3) 품목 : 위더세프캡슐(세파드록실수화물)</P>

<TABLE BORDER="1" WIDTH="882" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="746"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>세팔로스포린계 항생제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="755" HEIGHT="53">
<P>여러 가지 penicillin-결합 단백에 결합하여 세균 세포벽의 peptidoglycan 합성의 마지막 transpeptidation 단계를 억제함으로써 세균의 세포벽 합성을 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="755" HEIGHT="53">
<P>항생제 라인 확대, 세파계 항생제 자사생산 제품 확대로 경쟁력 증가</P>
<P>1세대 세팔로스포린계 항생제로 그람양성균 및 일부 호기성 그람음성 간균에 살균 효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>2019년 08월 위탁 허가 완료, 2020년 3월 제품 출시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="755" HEIGHT="30">2021년 1분기 임상1상 실시 및 2022년 자사전환 완료 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>보령듀리세프캡슐(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>국내 56억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="755" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(4) 품목 : 티브린타정</P>

<TABLE BORDER="1" WIDTH="891" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="753"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="762" HEIGHT="53">
<P>항혈소판제 - 급성관상동맥증후군, 심근경색의 병력이 있는 혈전성 심혈관 사건의 발생 위험이 높은 환자에서 혈전성 심혈관 사건 발생률 감소</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>ADP 수용체 길항제로서 혈소판 P2Y12 수용체에 의해 매개되는 혈소판 활성 및 응집을 가역적으로 저해함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="762" HEIGHT="76">
<P>항혈전제 제품 라인 확대</P>
<P>티에노피리딘 계열의 항혈전제 약물이 간 대사 및 활성제 전환과정을 거치는 것과 다르게 투약 후 빠르게 약물의 효과를 빠르게 나타냄 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>2019년 04월 위탁 허가 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>2022년 8월 21일 제품 출시 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>브릴린타정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧   시장규모</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>국내 108억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>우선판매권 만료 후 출시 예정</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(5) 품목 : 에스립틴정</P>

<TABLE BORDER="1" WIDTH="890" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="753"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>제2형 당뇨병 환자의 혈당조절 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>음식섭취에 반응하여 인체에서 합성되는 GLP-1과 GIP 호르몬을 상승시켜 혈당을 조절</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="762" HEIGHT="53">
<P>당뇨병 용제 제품라인 추가, 타 제네릭 회사보다 먼저 선점 가능</P>
<P>DPP-4 억제제 시장에서 시타글립틴제제는 리나글립틴 제제와 함께 시장의 대부분을 점유하고 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>
<TD WIDTH="762" HEIGHT="30">2020년 05월 위탁허가 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>2023년 9월 1일 특허 만료 이후 제품 출시할 예정 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>자누비아정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>국내 465억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="762" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">주) 글리비아정에서 에스립틴정으로 변경되었습니다. &cr;&cr;</P>
<P USERMARK="F-GL">(6) 품목 : 에스립틴정</P>

<TABLE BORDER="1" WIDTH="887" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="751"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제2형 당뇨병 환자의 혈당조절 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>음식섭취에 반응하여 인체에서 합성되는 GLP-1과 GIP 호르몬을 상승시켜 혈당을 조절</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>당뇨병 용제 제품라인 추가, 타 제네릭 회사보다 먼저 선점 가능</P>
<P>DPP-4 억제제 시장에서 시타글립틴제제는 리나글립틴 제제와 함께 시장의 대부분을 점유하고 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>2020년 05월 위탁허가 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>2023년 9월 1일 특허 만료 이후 제품 출시할 예정 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>자누메트정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>국내 757억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">주) 글리메트정에서 에스립틴엠정으로 변경되었습니다.&cr; </P>
<P USERMARK="F-GL">(7) 품목 : 조아나정</P>

<TABLE BORDER="1" WIDTH="886" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="751"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>진통소염제 - 골관절증(퇴행성관절질환), 류마티스성 관절염의 증상완화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>Free radical에 의한 연골파괴 억제 및 collagenase와 같은 관절 분해효소 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>생약성분의 진통소염제로 자사의 NSAIDs와 병용처방 유도가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>2010년 03월 위탁 허가 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>2030년 7월 14일 특허 만료 이후 제품 출시할 예정 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>조인스정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>국내 422억 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(8) 품목 : 아바젯정</P>

<TABLE BORDER="1" WIDTH="888" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="749"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>동맥경화용제 - 고콜레스테롤혈증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="122" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="758" HEIGHT="122">
<P><Atorvastatin></P>
<P>콜레스테롤 생합성의 율속 단계를 촉매하는 효소인 HMG-CoA reductase를 경쟁적으로 저해함</P>
<P><Ezetimibe></P>
<P>혈액으로부터의 콜레스테롤 클리어런스를 증가시키고 전체 콜레스테롤, LDL, ApoB, TG를 감소시키며 HDL를 &cr;증가시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>시장 규모 확대될 가능성 크며, 이층정으로 자사 기술력 확보 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>2020년 1월 동등성 입증완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>PMS 만료일(21년 1월 22일) 이후 식약처 심사를 거쳐 2021년 3분기 제품 출시할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>아토젯정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>국내 658억 (2019년 ubist 기준) <오리지널 단독출시중></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="130" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="758" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(9) 품목 : 듀로텔정 40/20(텔미사트탄/로수바스타틴칼슘)</P>

<TABLE BORDER="1" WIDTH="889" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="751"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①  구분</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>기타의 순환계용약 - 기타 심혈관용제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="168" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="760" HEIGHT="168">
<P><Telmisartan></P>
<P>- 비펩타이드성 AT1 angiotensin II receptor 길항제로서 angiotenisin II가 AT1수용체에 결합하는 것을 선택적으로 억제하여 고혈압효과를 나타냄 </P>
<P>- Angiotensin II가 AT1 수용체에 결합하는 것을 막음으로서 혈관수축을 저해하고 angiotensin II의 aldosterone의 작용을 억제함 </P>
<P><Rosuvastatin calcium></P>
<P>- HMG-Coa reductase를 억제하여 고지혈증을 치료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>이층정제로 개발되어있어 이층정타정기를 도입한 제조처에서만 생산이 가능함 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>2019년 10월 임상1상 진행완료 (동등성입증완료)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>PMS 만료일(20년 10월 31일) 에 맞춰 허가진행 및 출시예정임 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>듀오웰정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>국내 270억원 (2019년 ubist 기준) <오리지널 단독출시중></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="129" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(10) 품목 : 듀로텔정 80/20(텔미사트탄/로수바스타틴칼슘)</P>

<TABLE BORDER="1" WIDTH="889" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="754"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①   구분</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>기타의 순환계용약 - 기타 심혈관용제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="168" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="763" HEIGHT="168">
<P><Telmisartan></P>
<P>- 비펩타이드성 AT1 angiotensin II receptor 길항제로서 angiotenisin II가 AT1수용체에 결합하는 것을 선택적으로 억제하여 고혈압효과를 나타냄 </P>
<P>- Angiotensin II가 AT1 수용체에 결합하는 것을 막음으로서 혈관수축을 저해하고 angiotensin II의 aldosterone의 작용을 억제함 </P>
<P><Rosuvastatin calcium></P>
<P>- HMG-Coa reductase를 억제하여 고지혈증을 치료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>이층정제로 개발되어있어 이층정타정기를 도입한 제조처에서만 생산이 가능함 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>2020년 4월 임상1상 진행 하였으나 보완이 필요하여 제제 연구 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="763" HEIGHT="30">2021년 1분기 임상1상 진행 예정 및 2022년 2분기 허가 완료 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>듀오웰정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>국내 270억원 (2019년 ubist 기준) <오리지널 단독출시중></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="763" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(11) 품목 : 소로펜정(록소프로펜)</P>

<TABLE BORDER="1" WIDTH="891" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="759"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>해열,진통,소염제 - 비스테로이드성 소염진통제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="768" HEIGHT="53">
<P>비스테로이드성 소염진통제로서 진통작용과 해열작용이 있음</P>
<P>Loxoprofen 자체로서 약한 prostaglandin 합성 저해작용이 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>Cyclooxygenase-2 선택성이 높아서 위장장애와 신독성이 낮음  </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="768" HEIGHT="53">
<P>2014년 8월 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위한 임상1상(2019년 10월) 진행 하였으나 보완이 필요하여 제제연구중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="768" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2020년 10월 임상1상 진행 예정 2021년 자사전환 완료 예상됨 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>동화 록소닌정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>국내 870억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="123" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="768" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(12) 품목 : 위피드정(레바미피드)</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="765"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>소화성궤양용제 - 제산제, 항역류제, 항궤양제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="774" HEIGHT="76">
<P>위점막 보호작용과 궤양 취유능력을 가짐 </P>
<P>H.pylori에 의해 생성되는 산화성 스트레스와 cytokine 농도감소, 점액 합성증가, 염증성 세포반응 억제, h.pylori 의 위상피세포부착방지, 병용하는 항생제 효과상승 등을 통해 h.pylori 감염에 효과를 나타냄 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>다른 소화성궤양 용제와 다르게 위산으로 인한 위의 손상을 방지하기 위해 위표면을 보호해주는 약물임 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="774" HEIGHT="53">
<P>2013년 12월 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위한 임상1상(2019년 12월) &cr;진행 하였으나 보완이 필요하여 제제연구중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="774" HEIGHT="30">2021년 2분기 임상1상 진행 예정 및 2022년 4분기 자사전환 완료 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>무코스타정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>국내 960억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(13) 품목 : 피도그린정(클로피도그렐)</P>

<TABLE BORDER="1" WIDTH="897" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="762"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①    구분</P>
</TD>

<TD WIDTH="771" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="771" HEIGHT="30">
<P>동맥경화용제 - 항응고제/항혈소판제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="771" HEIGHT="53">
<P>혈소판 응집억제제- ADP-유도성 응집억제제</P>
<P>혈소판의 ADP수용체와 glycoprotein GP IIb/IIIa의 활성을 저해 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="771" HEIGHT="53">
<P>국내 동맥경화용제 시장에서 최다 처방을 기록하는 약물로서 허혈뇌졸증, &cr;심근경색 또는 말초동맥성질환이 있는 성인환자의 중상동맥경화성 증상을 개선하는데 탁월한 효능을 나타냄 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="771" HEIGHT="53">
<P>2013년 12월 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위한 임상1상(2019년 11월) &cr;진행완료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="771" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2020년 12월 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="771" HEIGHT="30">
<P>플라빅스정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="771" HEIGHT="30">
<P>국내 3,180억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="771" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(14) 품목 : 리트라젠정(리나글립틴)</P>

<TABLE BORDER="1" WIDTH="895" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="760"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="145" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="769" HEIGHT="145">
<P>리나글립틴은 dipeptidyl peptidase-4(DPP4)를 저해제로써 2형 당뇨병 환자에서 내인성 incretin 호르몬을 보호하고 incretin작용을 향상시킴 </P>
<P>포도당 의존성 인슐린분비자극펩타이드(GIP), 글루카곤유사펩타이드(GLP-1)는 혈당 항상성 유지하지 위해 &cr;섭취되는 음식에 반응하여 분비가 증가하는 incretin 호르몬임, 이 호르몬들은 DPP4에 의해 빠르게 대사되어 &cr;인슐린 자극효과를 잃음, Linagliptin은 DPP4에 의한 incretin 분배를 저해하여 GLP-1, GIP을 활성화 시켜 &cr;인슐린 분비증가시키고 글루카곤 수치를 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="769" HEIGHT="76">
<P>DPP-4 억제제는 저혈당 위험이 낮고 부작용발현빈도가 낮은 장점을 가지고 있으며, 주요부작용인 제중증가가&cr;적은 장점 보유</P>
<P>리나글립틴 제제는 DPP-4 억제제 시장에서 시타글립틴제제와 함께 시장의 대부분을 점유하고 있는 제제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>2019년 11월 20일 허가완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="769" HEIGHT="30">2025년 03월 08일 이후 출시 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>트라젠타정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>국내 620억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="769" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(15) 품목 : 리트라젠듀오정(리나글립틴/메트포르민)</P>

<TABLE BORDER="1" WIDTH="893" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="758"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="145" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="767" HEIGHT="145">
<P>리나글립틴은 dipeptidyl peptidase-4(DPP4)를 저해제로써 2형 당뇨병 환자에서 내인성 incretin 호르몬을 보호&cr;하고 incretin작용을 향상시킴 </P>
<P>포도당 의존성 인슐린분비자극펩타이드(GIP), 글루카곤유사펩타이드(GLP-1)는 혈당 항상성 유지하지 위해 &cr;섭취되는 음식에 반응하여 분비가 증가하는 incretin 호르몬임, 이 호르몬들은 DPP4에 의해 빠르게 대사되어 &cr;인슐린 자극효과를 잃음, Linagliptin은 DPP4에 의한 incretin 분배를 저해하여 GLP-1, GIP을 활성화 시켜 &cr;인슐린 분비를 증가시키고 글루카곤 수치를 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="767" HEIGHT="76">
<P>DPP-4 억제제는 저혈당 위험이 낮고 부작용발현빈도가 낮은 장점을 가지고 있으며, 주요 부작용인 제중 증가가 적은 장점을 보유</P>
<P>리나글립틴 제제는 DPP-4 억제제 시장에서 시타글립틴제제와 함께 시장의 대부분을 점유하고 있는 제제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>2019년 11월 20일 허가완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>2024년 6월 08일 특허 만료 이후 출시예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>트라젠타듀오정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>국내 620억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="767" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(16) 품목 : 가스핀정(모사프리드)</P>

<TABLE BORDER="1" WIDTH="890" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="750"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>기타의 소화기관용약 - 위장관 조절제/항팽만제/항염증제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>아세틸콜린 유리를 증가시키는 5-HT4 수용체 효능제로 위장관 운동을 자극하고 5-HT3 길항 효과도 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="759" HEIGHT="53">
<P>동일계열의 의약품등에 비해 부정맥유발이 보고되지 않았으며, 국내임상결과 소화불량증의 증상 및 삶을 질을 개선시키는 효과를 확인함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>2007년 1월 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위한 제제연구를 진행 중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>
<TD WIDTH="759" HEIGHT="30">2021년 2분기 임상1상 실시 및 2022년 3분기 자사전환 완료 예정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>가스모틴정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>국내 1,180억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="759" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(17) 품목 : 아레온정(에피나스틴)</P>

<TABLE BORDER="1" WIDTH="888" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="751"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>기타의 알레르기용약 - 항히스타민/ 항알러지제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="76" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="760" HEIGHT="76">
<P>직접적인 H1수용체 길항제이면서 비만세포로부터 히스타민의 유리를 억제 </P>
<P>H1 수용체에 선택적으로 작용하며, H2-, gamma1-, gamma2-,5-HT2수용체에 친화력이 있음</P>
<P>진정작용이 작은 항히스타민제-혈액뇌관문을 통과하지 않음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>1세대 항히스타민제의 부작용(졸음, 진정작용)을 크게 줄여서 장기복용일 필요한 만성알레르기비염 환자들에게 처방이 가능함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>2013년 7월 위탁제조품목으로 허가를 받아 출시중에 있으며, &cr;자사제조로 전환을 위해 2021년 1분기 임상1상 실시 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 1분기 임상1상 실시 및 2022년 2분기 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>알레스틴정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>국내 1,800억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(18) 품목 : 에스라졸정(에스오메프라졸)</P>

<TABLE BORDER="1" WIDTH="889" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="752"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>소화성궤양용제 - 제산제, 항역류제, 항궤양제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>Gastric parietal cell에서 H+/ K+ATPase를 선택적으로 억제하는 proton pump inhibitor로 작용함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="761" HEIGHT="53">
<P>1세대 PPI(proton pump inhibitor)제제의 약효지속시간 부족, 야간산분비억제 미비, 약물상호작용으로 나타나는 부작용 및 느린약효발현시간등을 개선한 제 2세대 PPI 제제임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="761" HEIGHT="53">
<P>2015년 1월위탁제조품목으로 허가를 받아 출시중에 있으며, &cr;자사제조로 전환을 위해 2021년1분기 임상1상 실시 예정 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="761" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 1분기 임상1상 실시 및 2022년 3분기 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>넥시움정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>국내 1,800억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="761" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(19) 품목 : 레이프라정(라베프라졸)</P>

<TABLE BORDER="1" WIDTH="887" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="751"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①     구분</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②  적응증</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>소화성궤양용제 - 제산제, 항역류제, 항궤양제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③  작용기전</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>benzimidazole 유도체로 위산분비를 억제하고, 위의 parietal cell의 산 분비표면에서 H+/ K+ATPase를 저해해 &cr;위산분비를 억제하는 proton pump inhibitor로 작용함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④  제품의 특성</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>1세대 PPI(proton pump inhibitor)제제의 약효지속시간 부족, 야간산분비억제 미비, 약물상호작용으로 나타나는 부작용 및 느린약효발현시간등을 개선한 제 2세대 PPI 제제임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤  진행경과</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>2007년 2월(10mg), 2014년 10월(20mg) 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 &cr;위한 제제연구를 진행중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥  향후계획</P>
</TD>

<TD WIDTH="760" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 2분기 임상1상 실시 및 2022년 4분기 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦  경쟁제품</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>파리에트정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧  시장규모</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>국내 1,300억원 (2019년 ubist 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="127" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨  기타사항</P>
</TD>

<TD WIDTH="760" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> &cr;(20) 품목 : 팜시스정</P>

<TABLE BORDER="1" WIDTH="892" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="757"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>항바이러스제 - 대상포진 바이러스 감염증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="766" HEIGHT="53">
<P>위장관 및 간에서 활성체인 penciclovir로 후, 세포내 효소에 의해 penciclovir triphosphate로 전환되어 dGTP와&cr;경쟁적으로 DNA에 삽입되어 헤르페스바이러스의 DNA 복제 및 합성을 선택적으로 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>생체이용률이 높고 반감기가 길어 다른 항바이러스제와는 달리 복용 순응도가 높음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="766" HEIGHT="53">
<P>2014년 위탁제조품목으로 허가를 받아 출시중에 있으며, &cr;자사제조로 전환을 위해 2020년 12월 임상1상 실시 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="766" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2020년 12월 임상1상 실시 및 2021년 4분기 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>팜비어정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>국내 608억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="126" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="766" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(21) 품목 : 위더스파모티딘정</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="763"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>소화성궤양용제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>위의 벽세포에 있는 H2 수용체에서 히스타민을 가역적이고 경쟁적으로 억제해서 위산분비를 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>안정성 이슈로 퇴출된 라니티딘 제제 대체약물로 활용 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>1988년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="772" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>동아가스터정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>국내 201억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="124" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="772" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(22) 품목 : 세로아핀정</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="765"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>정신신경용제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="774" HEIGHT="53">
<P>Dibenzothiazepine 계열에 속하는 atypical한 항정신병약물로 dopamine type 2(D2)와 serotonin type 2(5-HT2) &cr;수용체에 대한 길항작용을 통해 항정신병 작용을 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>CNS 치료제 제품 라인업 확대</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>2016년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="774" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>쎄로켈정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>국내 258억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="122" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="774" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(23) 품목 : 세파클러서방정</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="767"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>세팔로스포린계 항생제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="776" HEIGHT="53">
<P>2세대 세팔로스포린계 항생제로서 여러 가지 penicillin-결합 단백에 결합하여 세균 세포벽의 &cr;peptidohlycan 합성의 마지막 transpeptidation 단계를 억제함으로써 세균의 세포벽 합성을 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>서방정 제품 라인업 확대</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>자사 신제품으로 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>시클러MR서방정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>국내 36억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="120" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="776" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(24) 품목 : 타록시드정     </P>

<TABLE BORDER="1" WIDTH="897" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="771"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>퀴놀론계 항생제 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>세균의 DNA gyrase를 억제함으로써 DNA의 복제와 전사를 방해하고, 단백합성을 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="780" HEIGHT="53">
<P>Ciprofloxacin에 비해 Chlamydia trachomatis, Ureaplasma urealiticum, Mycoplasma pneumoniae, &cr;Mycobacterium tuberculosis에 더 강력한 향균력을 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>1992년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="780" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>타리비드정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>국내 242억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="117" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="780" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(25) 품목 : 위더콕스캡슐  </P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="773"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>해열진통소염제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="782" HEIGHT="53">
<P>COX-2는 염증과정에서 생성되는 유도형 효소로 COX-2가 활성화되면 프로스타글란딘과 염증, &cr;통증을 일으키는 매개물질이 합성됨. COX-2는 혈소판 또는 위점막에는 존재하지 않는다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="782" HEIGHT="53">
<P>항염, 진통 작용은 NSAIDs와 비슷하지만 COX-2를 선택적으로 억제함으로써 NSAIDs의 부작용인 위장관 부작용이 거의 없음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>2015년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="782" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>쎄레브렉스캡슐(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>국내 1,047억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(26) 품목 : 테르나정       </P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="773"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>항진균제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="782" HEIGHT="53">
<P>합성 allylamine 유도체로 진균에서 sterol 생합성에 가장 중요한 효소인 squalene epoxidases를 억제해서 진균의 &cr;세포막에서 ergosterol을 결핍시킴으로써 항진균작용을 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>Trichophyton, Microsporum, Epidermophyton 등 피부사상균에 낮은 농도로 억제하며 강력한 무좀치료제 중 하나임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>2004년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="782" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>라미실정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>국내 202억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="114" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="782" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(27) 품목 : 타가틴정400mg</P>

<TABLE BORDER="1" WIDTH="894" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="772"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>소화성궤양용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>위의 벽세포에 있는 H2 수용체에서 히스타민을 가역적이고 경쟁적으로 억제해서 위산분비를 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="781" HEIGHT="53">
<P>안정성 이슈로 퇴출된 라니티딘 제제 대체약물로 활용 가능</P>
<P>고용량 투여 시 200mg 함량에 대비 복용 편의성 증대</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>자사 신제품으로 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>타가메트정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>국내 148억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="113" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(28) 품목 : 아스틴정</P>

<TABLE BORDER="1" WIDTH="891" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="772"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>항히스타민제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="781" HEIGHT="53">
<P>위장관, 혈관, 호흡기계에 위치한 H1-수용체에 히스타민과 경쟁적으로 길항하여 Leukotriene의 생성 및 유리를 &cr;억제하고 이를 길항함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>2세대 항히스타민제로 1세대 항히스타민제에서 나타나는 졸음 등의 부작용과 짧은 약효지속 시간을 개선함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>2004년 위탁제조품목으로 허가를 받아 출시중에 있으며, 자사제조로 전환을 위해 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" VALIGN="MIDDLE" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="781" HEIGHT="53">
<P>자사제조로 전환을 통하여 약가 인하를 보전하면서 자사 수익증대를 가져가려 함</P>
<P>2021년 임상1상 실시 및 2022년 자사전환 완료 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>아젭틴정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>국내 159억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="110" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="781" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(29) 품목 : 포시진정</P>

<TABLE BORDER="1" WIDTH="891" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="774"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="783" HEIGHT="53">
<P>신장의 근위 세뇨관에서 당을 재흡수하는 SGLT2를 선택적으로 저해함으로써, 걸거진 glucose의 재흡수를 &cr;줄이고 glucose의 renal threshold를 낮추어 뇨중 glucose 배출을 증대시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>SGLT2 계열로 당뇨병환자에서 체중 감소 및 혈압 감소 효과</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>2020년 06월 위탁 허가 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>2024년 1월 8일 특허 만료 이후 출시할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>포시가정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>국내 324억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="783" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(30) 품목 : 위디앙정</P>

<TABLE BORDER="1" WIDTH="894" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="778"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="787" HEIGHT="53">
<P>신장에서 분포된 SGLT-2를 선택적으로 억제함으로써 실장에서 걸거진 포도당 체내 재흡수를 막아 소변으로&cr;배출시켜 혈당을 조절</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>우판권 취득 예정으로 타사보다 시장 먼저 선점 가능</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>위탁 허가 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>2025년 10월 23일 특허 만료 이후 출시할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>자디앙정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>국내 293억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(31) 품목 : 위디앙듀오정</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="779"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>당뇨병용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="145" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="788" HEIGHT="145">
<P><empagliflozin></P>
<P>신장에서 분포된 SGLT-2를 선택적으로 억제함으로써 실장에서 걸거진 포도당 체내 재흡수를 막아 소변으로 &cr;배출시켜 혈당을 조절</P>
<P><metformin></P>
<P>Biguarnide계 당뇨병 치료제로 insulin 분비에는 영향을 미치지 않는다. 주로 간에서 당신생을 억제하며 위장관에서&cr;당의 흡수를 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>SGLT2 계열로 당뇨병환자에서 체중 감소 및 혈압 감소 효과</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>위탁 허가 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>2025년 10월 23일 특허 만료 이후 출시할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>자디앙듀오정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>국내 63억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="108" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(32) 품목 : 자바록사정</P>

<TABLE BORDER="1" WIDTH="896" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="100"></COL>
<COL WIDTH="778"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>혈액응고저지제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>Prothrombinase complex에 결한한 Factor Xa와 자유 Factor Xa를 모두 억제하도록 최적화된 oxazolidinone 유도체</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="787" HEIGHT="53">
<P>차세대 항응고제(NOACs)로 warfarin에 비해 출혈 부작용의 위험이나 상호작용 가능성이 낮고 INR 측정을 위한 &cr;별도의 채혈과정이 필요 없음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>위탁 허가 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>2021년 10월 3일 특허 만료 이후 출시할 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>자렐토정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>국내 507억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="787" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(33) 품목 : 타스틴정</P>

<TABLE BORDER="1" WIDTH="895" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="779"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>①구분</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>②적응증</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>고지혈증용제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>③작용기전</P>
</TD>

<TD WIDTH="788" HEIGHT="53">
<P>콜레스테롤 생합성의 율속 단계를 촉매하는 효소인 HMG-CoA reductase를 경쟁적으로 저해하여 &cr;간 콜레스테롤 합성 및 LDL를 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>④제품의 특성</P>
</TD>

<TD WIDTH="788" HEIGHT="53">
<P>개발하고자 하는 함량은 시장에 경쟁사가 적어 경쟁력을 갖출 것으로 예상되며 자사 품목 동일 성분 2mg과의 &cr;시너지 효과를 기대 할 수 있음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑤진행경과</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>위탁 허가 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑥향후계획</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>2021년 2분기 출시 예정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑦경쟁제품</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>리바로정(오리지날) 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑧시장규모</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>국내 829억원 (2019년 ubitst 기준)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="107" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>⑨기타사항</P>
</TD>

<TD WIDTH="788" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL B">바. 보유기술의 경쟁력</P>
<P USERMARK="F-GL">당사는 고혈압 치료제인 텔미사르탄과 같이 기존 대조약에서 펠렛화하여 상용화 시킨 제품에 매트릭스 기술을 활용하여, 효율적인 프로세스를 통해 상품화 및 판매를 하고 있습니다. 매트릭스 기술의 활용성을 향상시키기 위해 다층정 타정기를 도입하여 생산 효율성을 극대화시켰고, 이는 당사의 경쟁력으로 자리잡고 있습니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">매트릭스 기술을 통해 대조약에선 유동층 과립기를 사용하여 제조된 제품을 다층정으로 개발하여 임상 1상을 진행 중에 있으며, 이어 고 함량 제제도 임상 준비를 진행하고 있습니다. 유동층 과립기를 사용한 기술의 경우, 설비 자체가 고가이며 운용에 있어서 기술적인 요소가 다수 작용합니다. 까다로운 생산공정의 적용이 필요하며 전문적인 기술을 가진 인원만이 운용 가능하여 고도의 기술이 필요한 생산기술입니다. 생산의 진행에 시간의 소요가 많고 수율 또한 일반 매트릭스 제품에 비해 떨어져 고가의 제품에만 일부 적용되는 기술입니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">최근 고혈압 의약품에 쓰이고 있는 중국산 발사르탄에서 암을 유발할 수 있는 불순물(N-니트로소디메틸아민)이 확인되어 관련 제품을 회수하고 유통을 중지시킨 사건 대하여 당사는 이미 문제의 중요성을 인식하고 있고, 기 보유중인 안정성 향상 기술을 더욱 발전시킬 계획입니다. 관련 기술로서 당사는 "에페리손염산염 서방정의 안정성 개선 방법에 대한 기술"을 지난 2019년 04월 특허 출원하여 기술에 대한 우위를 확보해 나가고 있습니다. 본 특허 등록시 향후 출시되는 에페리손염산염 제품에서 상당한 우위를 점유할 수 있을 것으로 생각되며 이는 특허 만료 시한인 2039년 4월까지 지속될 것입니다.&cr;</P>
<P USERMARK="F-GL">이와 더불어, 회사의 성장을 지속하기 위해 신규제형, 개량신약 및 신약의 개발이 필수적이라 판단하고 있습니다. 신규제형, 개량신약 및 신약의 개발은 방출 제어 및 지속화 기술(SR, ER정제), 약물특성개선 기술, 표적지향화 기술, 유전자 전달체 기술, 의약용 신소재/첨가제 개발 기술의 보유가 필수적입니다. 당사는 이런 주요기술들의 연구 개발을 위해 "신약연구실"을 신규로 설립하여 신약 및 개량신약, 신규제형 의약품 등의 연구개발 경험이 있는 연구인원들을 확충하였으며, 이들의 경험 및 노하우를 자사 의약품 개발에 활용할 계획입니다.</P>
<P></P>

<P>
<SPAN USERMARK="F-GL B">사. 연구개발 중단 현황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">아. 판매중단 현황</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="861">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>품 목</P>
</TH>

<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>적응증</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매승인일</P>
</TH>

<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매중단일</P>
</TH>

<TH WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>판매 중단 사유</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>화학</P>
<P>합성</P>
</TD>

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭</P>
</TD>
<TD WIDTH="173" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">액사티딘정75mg</TD>
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">소화성궤양용제</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2004-11-23</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020-12-24</TD>
<TD WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">NDMA등 불순물 함유 우려</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL B">11. 그 밖에 투자의사결정에 필요한 사항</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">가. 특허,실용신안 및 상표 등 지적재산권 현황</SPAN>
</P>

<TABLE WIDTH="783" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="774"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="783" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[특허권]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="780" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="334"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="343" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>명칭</P>
</TH>

<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>출원/등록번호</P>
<P>(일자)</P>
</TH>

<TH WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>특허만료일</P>
</TH>

<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특허권</P>
<P>(한국)</P>
</TD>

<TD WIDTH="343" VALIGN="MIDDLE" HEIGHT="53">
<P>에페리손 함유 필름코팅정제, 및 이의 제조방법</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">
<P>출원: 2011-03-10</P>
<P>등록: 2012-05-23</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2031-03-10</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특허권</P>
<P>(한국)</P>
</TD>

<TD WIDTH="343" VALIGN="MIDDLE" HEIGHT="53">
<P>에페리손 함유 필름코팅정제</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">
<P>출원: 2012-05-07</P>
<P>등록: 2014-12-11</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2031-03-10</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특허권</P>
<P>(한국)</P>
</TD>

<TD WIDTH="343" VALIGN="MIDDLE" HEIGHT="53">
<P>에페리손을 함유하는 새로운 약물 전달 시스템</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">
<P>출원: 2012-03-19</P>
<P>등록: 2015-10-28</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2032-03-19</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>특허권</P>
<P>(한국)</P>
</TD>

<TD WIDTH="343" VALIGN="MIDDLE" HEIGHT="53">
<P>보관 안정성이 향상된 에페리손 약제학적 조성물</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">
<P>출원: 2019-04-03</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>-</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="53">
<P>특허권등록진행중</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL B">나. 규제사항</P>

<TABLE WIDTH="1123" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1114"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>[제약업계 주요 정부 규제]</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1121" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="41"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="854"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>시기</P>
</TH>

<TH WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>규제</P>
</TH>

<TH WIDTH="863" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2002</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>약가 재평가</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="30">
<P>- 선진 7개국 약가와 비교하여 약가 재평가(2011년 폐지 결정)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>2006</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">
<P>약제비 적정화 방안</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="99">
<P>- 기등재 의약품 목록정비(약제비 적정화방안 후속조치): 건강보험 적용 의약품의 경제성 평가 후 가격 재조정</P>
<P>- 선별등재시스템(Positive list system): 비용 대비 효과가 우수한 의약품만 선별적으로 건강보험 적용</P>
<P>- 제네릭 약가 인하 폭 확대: 퍼스트 제네릭의 경우 오리지널의 68% 약가 인정</P>
<P>- 사용량 약가 연동제: 보험 적용 1년 이후 예상사용량보다 30% 이상 실판매가 증가한 경우 최초 협상가격 조정(최대 10% 인하)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2008</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>새 GMP 제도 도입</P>
<P>(선진국 수준으로 개선)</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 허가 전 품목별 평가 및 밸리데이션 도입</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2009</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>리베이트/약가 연동제</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 리베이트 적발 시 보험약가 최대 40% 인하 및 급여 정지 처분</P>
<P>- 3~4차 위반 시, 급여정지 또는 매출액 최대 60~100% 과징금 (2014년 폐지 / 2018년 재도입)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2010</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>리베이트 쌍벌제</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="30">
<P>- 리베이트 받은 자에 대해서도 형사처벌 규정 신설</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>2012</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">
<P>건강보험 등재약</P>
<P>일괄 약가인하</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="76">
<P>- 최초 제네릭 등재 시 오리지널 및 제네릭 가격을 특허만료 전 오리지널 가격의 53.55%로 일괄인하(계단식 약가구조 폐지)</P>
<P>- 단독등재, 퇴장방지의약품 등 인하대상 제외</P>
<P>- 3개사 이하 생산 의약품, 개량신약 등 약가 우대</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2014</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>사용량-약가연동제</P>
<P>강화</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 청구금액이 전년대비 10%, 절대금액 50억 이상 증가한 제품에 대한 청구액 상한기준 적용</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2014</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>리베이트 투아웃제</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 리베이트 금액, 지급횟수에 따라 최대 1년 요양급여 정지</P>
<P>- 리베이트 2회 적발 시 해당 품목의 보험목록 삭제 (2018년 9월 28일 폐지)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>2014</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">
<P>저가 구매 인센티브제를 &cr;포함하는 시장형 실거래가제</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="122">
<P>- 요양기관이 의약품을 저렴하게 구매하면 그 혜택을 요양기관과 환자가 공유하는 제도</P>
<P>- 시장형 실거래가제: 정부가 지정한 상한금액보다 요양기관이 의약품을 저렴하게 구입 시, 실거래가 조사를 통해 상한가 대비   차액분만큼 인하</P>
<P>- 저가 구매 인센티브제: 정부가 지정한 상한금액보다 요양기관이 의약품을 저렴하게 구입 시, 저가 구매를 통한 기관 절감액을 &cr;  산정하여 기관별 지급율(10~30%)에 따라 인센티브를 차등하여 지급</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>2016</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>약가 재평가(매년)</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="30">
<P>- 국내 약가를 선진 A7국가 조정평균가 이하로 인하</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2016</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>실거래가제도</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 유통 실거래가를 가중평균으로 조사하여 보험약가 인하</P>
<P>- 2년 단위 실시 → 약가조사 2년 단위로 기간 확대</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2016</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>부정청탁금지법</P>
<P>(김영란법)</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 공직자 등(국·공립 병원 의사 및 대학병원 교수 포함)이 직무 관련성과 상관없이 1회 100만원(연 300만원)이상 &cr;  금품 수수 시 형사처벌</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2018</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>경제적 이익지출보고서 &cr;작성 의무화</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 제약사 및 의료기기 업체에서 의료인에게 경제적 이익 제공 시 해당 내역을 보고서로 작성 및 5년간 보관 의무화</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="50" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>2019</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>제네릭 약가제도</P>
<P>개편방안(시행예정)</P>
</TD>

<TD WIDTH="863" VALIGN="MIDDLE" HEIGHT="53">
<P>- 자체 생물학적 동등성 시험 실시와 등록된 원료의약품 사용시에만 제네릭 약가 보장</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="1117" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1108"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="1117" VALIGN="MIDDLE" HEIGHT="30">
<P>(출처 : SK증권 제약산업 분석보고서, 위더스제약 정리)</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P USERMARK=" B">(1) 요약재무상태표</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="888">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="273" HEIGHT="30">구분</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="205" HEIGHT="30" ALIGN="CENTER">제17기</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="205" HEIGHT="30" ALIGN="CENTER">제16기</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="205" HEIGHT="30" ALIGN="CENTER">제15기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">[유동자산]</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    현금및현금성자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">15,490,449,131 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">25,146,076,792 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">5,576,504,303 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    매출채권및기타채권</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">26,625,014,125 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">21,844,493,706 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">20,987,584,875 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    단기금융상품</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">3,500,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,500,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,500,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    당기손익-공정가치 측정 금융자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">16,253,776,884 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">15,322,789,595 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">20,547,799,801 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    상각후원가 측정 금융자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">  4,190,397,167 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,704,801,839 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    재고자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">   7,921,852,481 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">      6,974,482,537 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">5,487,800,907 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    기타유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">33,203,817 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">37,324,192 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">      32,529,446 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">[비유동자산]</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    비유동기타채권</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">475,932,351 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">4,734,830,714 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">392,569,939 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    당기손익-공정가치 측정 금융자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">6,511,580,507 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">3,565,194,696 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,863,188,878 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    상각후원가 측정 금융자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">697,877,985 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,190,448,352 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,502,423,153 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    유형자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">20,070,563,839 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">19,383,454,690 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">12,319,392,564 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    투자부동산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">                                 - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">366,181,661 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,409,219,594 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    무형자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,950,498,700 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,974,740,800 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,517,761,765 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    기타비유동자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">                   - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> - </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">2,131,993 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    이연법인세자산</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,458,872,161 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,267,941,887 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,144,075,308 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">자산총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">106,180,019,148 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> 107,012,761,461 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">76,282,982,526 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">[유동부채]</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">20,348,889,410 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">24,160,928,952 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">18,167,305,971 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">[비유동부채]</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">8,954,031,703 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> 6,092,362,124 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">5,686,868,774 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">부채총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">29,302,921,113 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">30,253,291,076 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">23,854,174,745 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">[자본]</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    자본금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,758,483,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,758,483,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,550,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    자본잉여금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">15,845,608,835 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">15,845,608,835 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    자본조정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">393,343,063 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">214,543,174 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> - </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">    이익잉여금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">58,879,663,137 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">58,940,835,376 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">50,878,807,781 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">자본총계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> 76,877,098,035 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">76,759,470,385 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30"> 52,428,807,781 </TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">(2)요약 포괄손익계산서</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="888">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH VALIGN="MIDDLE" WIDTH="273" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　</TH>
<TH WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기</TH>
<TH WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제16기</TH>
<TH WIDTH="205" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제15기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">매출액</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">26,216,391,736 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">52,393,203,844 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">51,732,081,636 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">영업이익</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">1,362,391,952 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">9,735,265,079 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">10,934,656,637 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">법인세차감전순이익</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">1,902,076,015 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">10,035,983,283 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">11,022,654,712 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">당기순이익</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">1,867,397,657 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">8,038,596,924 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">8,661,484,052 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">총포괄손익</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">1,741,272,836 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">8,062,027,595 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">8,332,683,322 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="273" HEIGHT="30">기본주당순이익(단위 : 원)</TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">212 </TD>
<TD VALIGN="MIDDLE" WIDTH="205" HEIGHT="30" ALIGN="RIGHT">1,036 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="205" HEIGHT="30">1,118 </TD>
</TR>
</TBODY>
</TABLE>
<P>※ 제17기, 제16기 및 제15기 연결재무재표는 K-IFRS기준에 따른 외부감사를 받았습니다.&cr;※ 제17기, 제16기 및 제15기 연결재무제표는 K-IFRS기준에 따라 작성되었습니다.&cr;※ 제17기는 사업연도 변경으로 인하여 2020년 07월 01일 부터 2020년 12월 31일 까지 입니다.&cr;</P>
<WARNING>※ 아래 『재무제표』단위서식을 클릭하여 해당사항을 선택하면,&cr;    2.연결재무제표 ~ 5.재무제표주석 항목을 삽입할 수 있습니다.</WARNING>
</SECTION-2>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『재무제표』 삽입</COMMENT>
<LIBRARYLIST>11011#*재무제표_*.*</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dslx:1615967085">사업보고서_17_00765851_위더스제약(주)_김주형.ixd</FILENAME>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>
<P USERMARK="F-GL">"해당사항 없음"</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P>"해당사항 없음"</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="732" BORDER="0">

<COLGROUP>
<COL WIDTH="723"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30" AUPDATECONT="N">
<P>제 16 기          2020.06.30 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="732" HEIGHT="30" AUPDATECONT="N">
<P>제 15 기          2019.06.30 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="732" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="732" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="274">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="153">
<P>제 17 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="153">
<P>제 16 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="152">
<P>제 15 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>74,014,693,605</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>73,529,968,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>55,132,219,332</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>15,490,449,131</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>25,146,076,792</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>5,576,504,303</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　매출채권 및 기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>26,625,014,125</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>21,844,493,706</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>20,987,584,875</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　단기금융상품</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>3,500,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>2,500,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>2,500,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　당기손익-공정가치 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>16,253,776,884</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>15,322,789,595</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>20,547,799,801</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　상각후원가 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>4,190,397,167</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,704,801,839</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>7,921,852,481</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>6,974,482,537</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>5,487,800,907</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　기타유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>33,203,817</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>37,324,192</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>32,529,446</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>32,165,325,543</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>33,482,792,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>21,150,763,194</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　비유동기타채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>475,932,351</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>4,734,830,714</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>392,569,939</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　당기손익-공정가치 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>6,511,580,507</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>3,565,194,696</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,863,188,878</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　상각후원가 측정 금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>697,877,985</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>2,190,448,352</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>2,502,423,153</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>20,070,563,839</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>19,383,454,690</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>12,319,392,564</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>366,181,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,409,219,594</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>2,950,498,700</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,974,740,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,517,761,765</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　기타비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>2,131,993</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　이연법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,458,872,161</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,267,941,887</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,144,075,308</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>106,180,019,148</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>107,012,761,461</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>76,282,982,526</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>20,348,889,410</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>24,160,928,952</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>18,167,305,971</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　매입채무 및 기타채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>5,829,348,310</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>8,226,287,126</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>5,474,509,136</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　단기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>10,589,115,515</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>11,395,865,250</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>8,326,793,270</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　유동성장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,900,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,900,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,000,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,155,779,566</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>924,601,024</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,177,583,632</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　당기법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>128,495,374</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>933,918,423</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,394,361,934</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　반품충당부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>746,150,645</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>780,257,129</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>794,057,999</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>8,954,031,703</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>6,092,362,124</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>5,686,868,774</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>4,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,600,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,900,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　기타비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>426,533,898</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>370,353,711</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　　순확정급여부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>4,527,497,805</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>4,122,008,413</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>3,786,868,774</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>29,302,921,113</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>30,253,291,076</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>23,854,174,745</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,758,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>1,758,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>1,550,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>15,845,608,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>15,845,608,835</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　자본조정</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>393,343,063</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>214,543,174</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　이익잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>58,879,663,137</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>58,940,835,376</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>50,878,807,781</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>76,877,098,035</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>76,759,470,385</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>52,428,807,781</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="274">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>106,180,019,148</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="153">
<P>107,012,761,461</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="152">
<P>76,282,982,526</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="856" BORDER="0">

<COLGROUP>
<COL WIDTH="847"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="856" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="856" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2020.07.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="856" HEIGHT="30" AUPDATECONT="N">
<P>제 16 기 2019.07.01 부터 2020.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="856" HEIGHT="30" AUPDATECONT="N">
<P>제 15 기 2018.07.01 부터 2019.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="856" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="855" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="343"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="158"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="352">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="168">
<P>제 17 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="168">
<P>제 16 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="167">
<P>제 15 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>매출액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>26,216,391,736</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>52,393,203,844</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>51,732,081,636</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>11,066,563,492</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>19,425,996,633</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>19,742,816,241</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>15,149,828,244</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>32,967,207,211</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>31,989,265,395</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>판매비와관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>13,787,436,292</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>23,231,942,132</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>21,054,608,758</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>영업이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,362,391,952</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>9,735,265,079</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>10,934,656,637</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>기타수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>30,503,422</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>65,520,934</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>97,491,227</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>기타비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>22,180,300</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>330,701,970</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>325,065,502</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>717,349,374</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>991,290,859</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>761,859,189</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>금융비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>185,988,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>425,391,619</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>446,286,839</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>법인세비용차감전순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,902,076,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>10,035,983,283</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>11,022,654,712</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>34,678,358</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,997,386,359</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>2,361,170,660</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>당기순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,867,397,657</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>8,038,596,924</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>8,661,484,052</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>(126,124,821)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>23,430,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>(328,800,730)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>　후속적으로 당기손익으로 재분류되지 않는 항목</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>(126,124,821)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>23,430,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>(328,800,730)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>　　순확정급여부채의 재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>(126,124,821)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>23,430,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>(328,800,730)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,741,272,836</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>8,062,027,595</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>8,332,683,322</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="352">
<P>　기본?희석주당이익 (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>212</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="168">
<P>1,036</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="167">
<P>1,118</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="900" BORDER="0">

<COLGROUP>
<COL WIDTH="891"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2020.07.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 16 기 2019.07.01 부터 2020.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>제 15 기 2018.07.01 부터 2019.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="900" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="914" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="218" ROWSPAN="2">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="696" COLSPAN="5">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="140">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="139">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="139">
<P>기타자본항목</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="139">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="139">
<P>자본  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2018.07.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,550,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>42,546,124,459</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>44,096,124,459</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>당기순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>8,661,484,052</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>8,661,484,052</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>순확정급여부채의 재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(328,800,730)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(328,800,730)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>주식선택권 부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2019.06.30 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,550,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>50,878,807,781</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>52,428,807,781</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2019.07.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,550,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>50,878,807,781</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>52,428,807,781</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>당기순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>8,038,596,924</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>8,038,596,924</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>순확정급여부채의 재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>23,430,671</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>23,430,671</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>208,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>15,845,608,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>16,054,091,835</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>주식선택권 부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>214,543,174</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>214,543,174</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2020.06.30 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,758,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>15,845,608,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>214,543,174</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>58,940,835,376</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>76,759,470,385</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2020.07.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,758,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>15,845,608,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>214,543,174</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>58,940,835,376</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>76,759,470,385</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>당기순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>1,867,397,657</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>1,867,397,657</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>순확정급여부채의 재측정요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(126,124,821)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(126,124,821)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(1,802,445,075)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(1,802,445,075)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>주식선택권 부여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>178,799,889</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>178,799,889</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="218">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="140">
<P>1,758,483,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>15,845,608,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>393,343,063</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>58,879,663,137</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>76,877,098,035</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>&cr;</P>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="848" BORDER="0">

<COLGROUP>
<COL WIDTH="839"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="848" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="848" HEIGHT="30" AUPDATECONT="N">
<P>제 17 기 2020.07.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="848" HEIGHT="30" AUPDATECONT="N">
<P>제 16 기 2019.07.01 부터 2020.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="848" HEIGHT="30" AUPDATECONT="N">
<P>제 15 기 2018.07.01 부터 2019.06.30 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="848" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="849" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="310">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="180">
<P>제 17 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="180">
<P>제 16 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="179">
<P>제 15 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>404,767,664</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>7,927,294,414</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>6,765,389,971</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　당기순이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>1,867,397,657</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>8,038,596,924</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>8,661,484,052</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　조정</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>1,034,782,979</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>3,976,694,703</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>4,026,277,479</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(1,584,422,508)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(1,941,316,863)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(3,686,534,067)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　이자의 수취</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>247,770,614</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>803,302,849</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>583,400,573</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　이자의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(165,303,065)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(361,678,098)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(410,361,943)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　법인세의 납부</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(995,458,013)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(2,588,305,101)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(2,408,876,123)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(9,661,654,277)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(7,777,103,412)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(6,065,987,893)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기대여금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>51,604,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>71,500,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>289,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기대여금의 매각</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>8,185,100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　보증금의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>25,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>210,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기금융상품의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>1,000,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>3,500,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　당기손익-공정가치 측정 금융자산의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>11,672,152,325</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>29,138,440,723</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>19,485,069,755</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　유형자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>5,136,364</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기금융상품의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(2,500,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　당기손익-공정가치 측정 금융자산의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(15,115,677,550)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(25,534,311,701)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(29,847,468,633)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　상각후원가측정금융자산 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(1,999,999,840)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(2,404,899,387)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(2,505,700,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(2,632,040,076)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(4,668,672,703)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(1,961,989,015)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(979,530,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(464,619,600)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　대여금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(558,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(4,937,189,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(680,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　임차보증금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(105,300,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(240,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　투자부동산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(2,351,344)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(394,771,727)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>19,419,856,633</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(1,777,372,046)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　유상증자</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>16,054,091,835</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기차입금의 차입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>2,092,003,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>12,029,094,878</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>15,558,946,650</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　장기차입금의 차입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>2,400,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>1,600,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　단기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(2,898,752,750)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(8,960,022,898)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(17,321,318,696)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　유동성장기부채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(1,000,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　리스부채의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(152,576,917)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(273,307,182)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　임대보증금의 반환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(33,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(30,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(15,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>　배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(1,802,445,075)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>0</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>현금및현금성자산에 대한 환율변동효과</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(3,969,321)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(475,146)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(265,706)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>(9,655,627,661)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>19,569,572,489</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>(1,078,235,674)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>25,146,076,792</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>5,576,504,303</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>6,654,739,977</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="310">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>15,490,449,131</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="180">
<P>25,146,076,792</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="179">
<P>5,576,504,303</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">
<SPAN>제 17(당) 기    2020년 </SPAN>
<SPAN></SPAN>
<SPAN>07월 01일부터 2020년 12월 31일까지</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">
<SPAN>제 16(전) 기    2019년 </SPAN>
<SPAN></SPAN>
<SPAN>07월 01일부터 2020년 06월 30일까지</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" VALIGN="MIDDLE">위더스제약 주식회사</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">1. 회사의 개요&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">위더스제약 주식회사(이하 "회사")는 2004년 8월 19일자로 설립되어 서울 서초구 동산로 12길 9 위더스빌딩에 본사와 경기도 안성시 미양면 제2공단2길 103에 제조공장을 두고 있으며 의약품 등의 제조 및 도소매를 주 영업목적으로 하고 있습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">당사는 2020년 7월 1일에 코스닥시장 상장 승인을 받아, 2020년 7월 3일</SPAN>
<SPAN USERMARK="F-GL"> 당</SPAN>
<SPAN USERMARK="F-GL">사의 보통주식이 코스닥 시장에 상장되었습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;회사는 설립 이후 수차례의 증자 등을 거쳐 당기말 현재 회사의 자본금은 1,758백만원이며, 보고기간 말 현재 주요 주주 구성현황은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="234"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="243" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주 주 명</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주 식 수</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지 분 율</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" VALIGN="MIDDLE" HEIGHT="30">성대영</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">4,614,865</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">52.49%</TD>
<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">대표이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" VALIGN="MIDDLE" HEIGHT="30">우리사주조합</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">274,288</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">3.12%</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" VALIGN="MIDDLE" HEIGHT="30">기타주주</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">3,903,262</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">44.39%</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="243" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="121" ALIGN="RIGHT" HEIGHT="30">8,792,415</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">한편, 당사는 2020년 9월 25일주주총회의 결의에 의하여 당기부터 보고기간종료일을 6월말에서 12월말로 결산기를 변경함에 따라 당사의 당기 재무제표는 6개월 기간의 회계연도의 재무성과와 자본변동 및 현금흐름의 내용을 표시하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">2. 중요한 회계정책&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;다음은 재무제표 작성에 적용된 중요한 회계정책입니다. 이러한 정책은 별도의 언급이 없다면, 표시된 회계기간에 계속적으로 적용됩니다.&cr;&cr;2.1 재무제표 작성기준&cr;</SPAN>
</P>
<P USERMARK="F-GL">회사는 2017년 7월 1일 이후에 개시하는 연차보고기간부터 국제회계기준을 채택하여 제정한 한국채택국제회계기준을 적용하고 있습니다. 한국채택국제회계기준은 국제회계기준위원회("IASB")가 발표한 기준서, 해석서 중 대한민국이 채택한 내용을 의미합니다. </P>
<P USERMARK="F-GL">&cr;회사의 재무제표는 한국채택국제회계기준(이하 기업회계기준)에 따라 작성되었습니다. 한국채택국제회계기준은 국제회계기준위원회("IASB")가 발표한 기준서와 해석서 중 대한민국이 채택한 내용을 의미합니다. &cr;</P>
<P USERMARK="F-GL">한국채택국제회계기준은 재무제표 작성시 중요한 회계추정의 사용을 허용하고 있으며, 회계정책을 적용함에 있어 경영진의 판단을 요구하고 있습니다. 보다 복잡하고 높은 수준의 판단이 요구되는 부분이나 중요한 가정 및 추정이 요구되는 부분은 주석3에서 설명하고 있습니다. </P>
<P USERMARK="F-GL">&cr;2.2 회계정책과 공시의 변경</P>
<P USERMARK="F-GL">&cr;2.2.1 회사가 채택한 제ㆍ개정 기준서 &cr;</P>
<P USERMARK="F-GL">당사는 2020년 7월 1일로 개시하는 회계기간부터 다음의 제ㆍ개정 기준서를 신규로 적용하였습니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL">(1) 기업회계기준서 제1001호 '재무제표 표시', 제1008호 '회계정책, 회계추정의 변경 및 오류' 개정 - 중요성의 정의&cr;&cr;'중요성의 정의'를 명확히 하고 기준서 제1001호와 제1008호를 명확해진 정의에 따라 개정하였습니다. 중요성 판단 시 중요한 정보의 누락이나 왜곡표시뿐만 아니라 중요하지 않은 정보로 인한 영향과 회사가 공시할 정보를 결정할 때 정보이용자의 특성을 고려하도록 하였습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;(2) 기업회계기준서 제1103호 '사업결합' 개정 - 사업의 정의&cr;&cr;개정된 사업의 정의에서는, 취득한 활동과 자산의 집합을 사업으로 판단하기 위해서는 산출물의 창출에 함께 유의적으로 기여할 수 있는 능력을 가진 투입물과 실질적인과정을 반드시 포함하도록 하였고 원가 감소에 따른 경제적 효익은 제외하였습니다. 이와 함께 취득한 총자산의 대부분의 공정가치가 식별가능한 단일 자산 또는 자산집합에 집중되어 있는 경우, 취득한 활동과 자산의 집합은 사업이 아닌, 자산 또는 자산의 집합으로 결정할 수 있는 선택적 집중테스트가 추가되었습니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 기업회계기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시' 개정 - 이자율지표 개혁&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;개정 기준서에서는 이자율지표 개혁 움직임으로 인한 불확실성이 존재하는 동안 위험회피회계 적용과 관련하여 미래 전망 분석 시 예외규정을 적용토록 하고 있습니다.예외규정에서는 기존 이자율지표를 준거로 하는 예상현금흐름의 발생가능성이 매우 높은지, 위험회피대상항목과 위험회피수단 사이의 경제적 관계가 있는지, 양자간에 높은 위험회피효과가 있는지를 평가할 때, 위험회피대상항목과 위험회피수단이 준거로 하고 있는 이자율지표는 이자율지표 개혁의 영향으로 바뀌지 않는다고 가정합니다. 해당 기준서의 개정이 재무제표에 미치는 중요한 영향은 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(4) 기업회계기준서 제1116호 '리스' 개정(코로나 19 관련 임차료 면제, 할인, 유예에 대한 실무적 간편법)&cr;&cr;실무적 간편법으로 리스이용자는 코로나 19의 직접적인 결과로 발생한 임차료 할인 (Rent concession)이 리스변경에 해당하는지 평가하지 않을 수 있습니다. 이러한 선택을 한 리스이용자는 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 이 기준서가 규정하는 방식과 일관되게 회계처리 하여야 합니다. 당사는 동 개정으로 인해 재무제표에 중요한 영향은 없습니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">2.2.2 회사가 적용하지 않은 제ㆍ개정 기준서 및 해석서&cr;&cr;제정 또는 공표되었으나 시행일이 도래하지 않아 회사가 조기 적용하지 아니한 제개정 기준서 및 해석서는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL">(1) 기업회계기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시', 제 1104호 '보험계약' 및 제 1116호 '리스' 개정 - 이자율지표 개혁</P>
<P USERMARK="F-GL">&cr;이자율지표 개혁과 관련하여 상각후원가로 측정되는 금융상품의 이자율지표 대체시장부금액이 아닌 유효이자율을 조정하고, 위험회피관계에서 이자율지표 대체가 발생한 경우에도 중단 없이 위험회피회계를 계속할 수 있도록 하는 등의 예외규정을 포함하고 있습니다. 동 개정사항은 2021년 1월 1일 이후에 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;&cr;(2) 기업회계기준서 제1103호  '사업결합' 개정 - 개념체계의 인용&cr;&cr;인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;</P>
<P USERMARK="F-GL">(3) 기업회계기준서 제1016호 '유형자산' 개정 - 의도한 사용 전의 매각금액&cr;&cr;기업이 자산을 의도한 방식으로 사용하기 전에 생산된 품목의 판매에서 발생하는 수익을 생산원가와 함께 당기손익으로 인식하도록 요구하며, 유형자산의 취득원가에서차감하는 것을 금지하고 있습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인한 재무제표의 영향을 검토 중에 있습니다.&cr;</P>
<P USERMARK="F-GL">(4) 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 개정 - 손실부담계약: 계약이행원가&cr;&cr;손실부담계약을 식별할 때 계약이행원가의 범위를 계약 이행을 위한 증분원가와 계약 이행에 직접 관련되는 다른 원가의 배분이라는 점을 명확히 하였습니다. 동 개정사항은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다. &cr;</P>
<P USERMARK="F-GL">(5) 한국채택국제회계기준 연차개선 2018-2020</P>
<P USERMARK="F-GL">&cr;한국채택국제회계기준 연차개선 2018-2020은 2022년 1월 1일 이후 시작하는 회계연도부터 적용되며, 조기적용이 허용됩니다. 회사는 동 개정으로 인해 재무제표에 중요한 영향은 없을 것으로 예상하고 있습니다.&cr;&cr; -기업회계기준서 제1101호 '한국채택국제회계기준의 최초 채택' : 최초채택기업인 종속기업</P>
<P USERMARK="F-GL"> -기업회계기준서 제1109호 '금융상품' : 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P USERMARK="F-GL"> -기업회계기준서 제1116호 '리스' : 리스 인센티브</P>
<P USERMARK="F-GL"> -기업회계기준서 제1041호 '농립어업' : 공정가치 측정&cr;</P>
<P USERMARK="F-GL">(6) 기업회계기준서 제1001호 '재무제표 표시' 개정 - 부채의 유동/비유동 분류&cr;&cr;보고기간말 현재 존재하는 실질적인 권리에 따라 유동 또는 비유동으로 분류되며, 부채의 결제를 연기할 수 있는 권리의 행사가능성이나 경영진의 기대는 고려하지 않습니다. 또한, 부채의 결제에 자기지분상품의 이전도 포함되나, 복합금융상품에서 자기지분상품으로 결제하는 옵션이 지분상품의 정의를 충족하여 부채와 분리하여 인식된경우는 제외됩니다. 동 개정사항은 2023년 1월 1일 이후 시작하는 회계연도부터 적용하며, 조기적용이 허용됩니다. 회사는 동 개정으로 인한 재무제표의 영향을 검토 중에 있습니다.</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.3 외화환산</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(1) 기능통화와 표시통화</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 재무제표에 포함되는 항목들을 각각의 영업활동이 이뤄지는 주된 경제 환경에서의 통화("기능통화")를 적용하여 측정하고 있습니다. 회사의 기능통화는 대한민국 원화이며, 재무제표는 대한민국 원화로 표시돼 있습니다.</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(2) 외화거래와 보고기간말의 환산</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">외화거래는 거래일의 환율 또는 재측정되는 항목인 경우 평가일의 환율을 적용한 기능통화로 인식됩니다. 외화거래의 결제나 화폐성 외화 자산ㆍ부채의 환산에서 발생하는 외환차이는 당기손익으로 인식됩니다. </P>
<P USERMARK="F-GL">&cr;비화폐성 금융자산ㆍ부채로부터 발생하는 외환차이는 공정가치 변동손익의 일부로 보아 당기손익-공정가치 측정 지분상품으로부터 발생하는 외환차이는 당기손익으 로, 기타포괄손익-공정가치 측정 지분상품의 외환차이는 기타포괄손익에 포함하여 인식됩니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL">2.4 금융자산&cr;</SPAN>
</P>
<P USERMARK="F-GL">(1) 분류</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 다음의 측정 범주로 금융자산을 분류합니다.</P>
<P USERMARK="F-GL">  - 당기손익-공정가치 측정 금융자산</P>
<P USERMARK="F-GL">  - 기타포괄손익-공정가치 금융자산</P>
<P USERMARK="F-GL">  - 상각후원가 측정 금융자산</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">금융자산은 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에근거하여 분류합니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">공정가치로 측정하는 금융자산의 손익은 당기손익 또는 기타포괄손익으로 인식합니다. 채무상품에 대한 투자는 해당 자산을 보유하는 사업모형에 따라 그 평가손익을 당기손익 또는 기타포괄손익으로 인식합니다. 회사는 금융자산을 관리하는 사업모형을 변경하는 경우에만 채무상품을 재분류합니다. </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">단기매매항목이 아닌 지분상품에 대한 투자는 최초 인식시점에 후속적인 공정가치 변동을 기타포괄손익으로 표시할 것을 지정하는 취소불가능한 선택을 할 수 있습니다. 지정되지 않은 지분상품에 대한 투자의 공정가치 변동은 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(2) 측정</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 최초 인식시점에 금융자산을 공정가치로 측정하며, 당기손익-공정가치 측정 금융자산이 아닌 경우에 해당 금융자산의 취득과 직접 관련되는 거래원가는 공정가치에 가산합니다. 당기손익-공정가치 측정 금융자산의 거래원가는 당기손익으로 비용처리합니다. </P>
<P USERMARK="F-GL">&cr;내재파생상품을 포함하는 복합계약은 계약상 현금흐름이 원금과 이자로만 구성되어 있는지를 결정할 때 해당 복합계약 전체를 고려합니다.</P>
<P USERMARK="F-GL">&cr;① 채무상품&cr;</P>

<P>
<SPAN USERMARK="F-GL">금융자산의 후속적인 측정은 금융자산의 계약상 현금흐름 특성과 그 금융자산을 관리하는 사업모형에 근거합니다. 회사는 채무상품을 다음의 세 범주로 분류합니다.&cr; &cr; (가) 상각후원가&cr;계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 자산은 상각후원가로 측정합니다. 상각후원가로 측정하는 금융자산으로서 위험회피관계의 적용 대상이 아닌 금융자산의 손익은 해당 금융자산을 제거하거나 손상할 때 당기손익으로 인식합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익</SPAN>
<SPAN USERMARK="F-GL">은</SPAN>
<SPAN USERMARK="F-GL"> '금융수익'</SPAN>
<SPAN USERMARK="F-GL">에 </SPAN>
<SPAN USERMARK="F-GL">포함됩니다.&cr; &cr; (나) 기타포괄손익-공정가치 측정 금융자산&cr;계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 금융자산은 기타포괄손익-공정가치로 측정합니다. 손상차손(환입)과 이자수익 및 외환손익을 제외하고는, 공정가치로 측정하는 금융자산의 평가손익은 기타포괄손익으로 인식합니다. 금융자산을 제거할 때에는 인식한 기타포괄손익누계액을 자본에서 당기손익으로 재분류</SPAN>
<SPAN USERMARK="F-GL">합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은  </SPAN>
<SPAN USERMARK="F-GL">'금융수익'</SPAN>
<SPAN USERMARK="F-GL">에</SPAN>
<SPAN USERMARK="F-GL"> 포</SPAN>
<SPAN USERMARK="F-GL">함됩니다. 외환손익은 </SPAN>
<SPAN USERMARK="F-GL">'기타수익 또는 기타비용</SPAN>
<SPAN USERMARK="F-GL">'으로 표시하고 손상차손은'기타 비용'으로 표시합니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr; (다) 당기손익-공정가치측정 금융자산&cr;상각후원가 측정이</SPAN>
<SPAN USERMARK="F-GL">나 기타포괄손익-공정가치 측정 금융자산이 아닌 채무상품은 당기손익-공정가치로 측정됩니다. 위험회피관계가 적용되지 않는 당기손익-공정가치 측정 채무상품의 손익은 당기손익으로 인식하고 발생한 기간에 손익계산서에</SPAN>
<SPAN USERMARK="F-GL"> '금융수익 또는 금융비용'</SPAN>
<SPAN USERMARK="F-GL">으로 </SPAN>
<SPAN USERMARK="F-GL">표시합니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL">② 지분상품</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">회사는 모든 지분상품에 대한 투자를 후속적으로 공정가치로 측정합니다. 공정가치 변동을 기타포괄손익으로 표시할 것을 선택한 장기적 투자목적 또는 전략적 투자목적의 지분상품에 대해 기타포괄손익으로 인식한 금액은 해당 지분상품을 제거할 때에도 당기손익으로 재분류하지 않습니다. 이러한 지분상품에 대한 배당수익은 회사가 배당을 받을 권리가 확정된 때</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"> '금융수익'</SPAN>
<SPAN USERMARK="F-GL">으로 당기손익</SPAN>
<SPAN USERMARK="F-GL">으로 인식합니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">당기손익-공정</SPAN>
<SPAN USERMARK="F-GL">가치로 측정하는 금융자산의 공정가치 변동은 손익계산서에 '</SPAN>
<SPAN USERMARK="F-GL">금융수익 또는 금융비용'</SPAN>
<SPAN USERMARK="F-GL">으로 표시합니다.  기타포괄손익-공정가치로 측정하는 지분상품에대한 손상차손(환입)은</SPAN>
<SPAN USERMARK="F-GL"> 별도로 구분하여 인식하지 않습니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL">(3) 손상 </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 미래전망정보에 근거하여 상각후원가로 측정하거나 기타포괄손익-공정가치로 측정하는 채무상품에 대한 기대신용손실을 평가합니다. 손상 방식은 신용위험의 유의적인 증가 여부에 따라 결정됩니다. 단, 매출채권에 대해 회사는 채권의 최초 인식시점부터 전체기간 기대신용손실을 인식하는 간편법을 적용합니다.&cr;</P>
<P USERMARK="F-GL">(4) 인식과 제거</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">금융자산의 정형화된 매입 또는 매도는 매매일에 인식하거나 제거합니다. 금융자산은 현금흐름에 대한 계약상 권리가 소멸하거나 금융자산을 양도하고 소유에 따른 위험과 보상의 대부분을 이전한 경우에 제거됩니다.</P>

<P>
<SPAN USERMARK="F-GL">&cr;회사가 금융자산을 양도한 경우라도 채무자의 채무불이행시의 소구권 등으로 양도한금융자산의 소유에 따른 위험과 보상의 대부분을 회사가 보유하는 경우에는 이를 제거하지 않고 그 양도자산 전체를 계속하여 인식하되, 수취한 대가를 '금융부채'로 인식합니다. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(5) 금융상품의 상계&cr;</P>
<P USERMARK="F-GL">금융자산과 부채는 인식한 자산과 부채에 대해 법적으로 집행가능한 상계권리를 현재 보유하고 있고, 순액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할 의도를 가지고 있을 때 상계하여 재무상태표에 순액으로 표시합니다. 법적으로 집행가능한 상계권리는 미래사건에 좌우되지 않으며, 정상적인 사업과정의 경우와 채무불이행의 경우 및 지급불능이나 파산의 경우에도 집행가능한 것을 의미합니다.</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">2.5 재고자산</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B"> </SPAN>
<SPAN USERMARK="F-GL">&cr;재고자산은 원가와 순실현가능가치 중 작은 금액으로 표시되고, 재고자산의 원가는 선입선출법에 따라 결정됩니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"> &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.6 </SPAN>
<SPAN USERMARK="F-GL">매각예정비유동자산(또는 처분자산집단)  &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;비유동자산(또는 처분자산집단)은 장부금액이 매각거래를 통하여 주로 회수되고, 매각될 가능성이 매우 높은 경우에 매각예정으로 분류되며, 그러한 자산은 장부금액과 순공정가치 중 작은 금액으로 측정됩니다.&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.7 유형자산 &cr;</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">유형자산은 원가에서 감가상각누계액과 손상차손누계액을 차감하여 표시됩니다. 역사적 원가는 자산의 취득에 직접적으로 관련된 지출을 포함합니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">토지를 제외한 자산은 취득원가에서 잔존가치를 제외하고, 다음의 추정 경제적 내용연수에 걸쳐 정액법으로 상각됩니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="594">

<COLGROUP>
<COL WIDTH="288"></COL>
<COL WIDTH="288"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구         분</TH>
<TH WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추정내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건             물</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">20년, 40년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기  계  장  치</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">차 량 운 반 구</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">공 구 와 기 구</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비              품</TD>
<TD WIDTH="297" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5년 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">유형자산의 감가상각방법과 잔존가치 및 경제적 내용연수는 매 회계연도 말에 재검토되고 필요한 경우 추정의 변경으로 조정됩니다. &cr;</P>

<P>
<SPAN USERMARK="F-GL">2.8 무형자산</SPAN>
<SPAN USERMARK="F-GL B"> </SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">무</SPAN>
<SPAN USERMARK="F-GL">형자산은 역사적 원가로 최초 인식되고, 원가에서 상각누계액과 손상차손누계액을차감한 금액으로 표시됩니다. </SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">무형자산은 사용 가능한 시점부터 잔존가치를 영("0")으로 하여 아래의 추정내용연수동안 정액법으로 상각하고 있습니다. 다만, 회원권에 대해서는 이를 이용할 수 있을 것으로 기대되는 기간이 예측가능하지 않아 당해 무형자산의 내용연수가 비한정인 것으로 평가하고 상각하지 아니하고 있습니다.&cr;</P>

<TABLE BORDER="1" WIDTH="592" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="287"></COL>
<COL WIDTH="287"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="296" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>과     목 </P>
</TH>

<TH WIDTH="296" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">
<P>추정 내용연수 </P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소프트웨어</TD>

<TD WIDTH="296" HEIGHT="30" ALIGN="CENTER">
<P>5년</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="296" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">개   발   비</TD>
<TD WIDTH="296" HEIGHT="30" ALIGN="CENTER">5년</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;무형자산의 상각방법과 내용연수는 매 회계연도 말에 재검토하고 재검토 결과 이를 변경하는 것이 적절하다고 판단되는 경우 회계추정의 변경으로 처리하고 있습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.9 투자부동산</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;임대수익이나 투자차익을 목적으로 보유하고 있는 부동산은 투자부동산으로 분류됩니다. 투자부동산은 최초 인식시점에 원가로 측정되며, 최초 인식 후에는 원가에서 감가상각누계액과 손상차손누계액을 차감한 금액으로 표시됩니다. 투자부동산 중 토지를 제외한 투자부동산은 추정 경제적 내용연수 20년 동안 정액법으로 상각됩니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.10 비금융자산의 손상  </SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;영업권이나 내용연수가 비한정인 무형자산에 대하여는 매년, 상각대상 자산에 대하여는 자산손상을 시사하는 징후가 있을 때 손상검사를 수행하고 있습니다. 손상차손은 회수가능액(사용가치 또는 처분부대원가를 차감한 공정가치 중 높은 금액)을 초과하는 장부금액만큼 인식되고 영업권 이외의 비금융자산에 대한 손상차손은 매 보고기간말에 환입가능성이 검토됩니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.11 금융부채&cr;</SPAN>
</P>
<P USERMARK="F-GL">(1)  분류 및 측정</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사의 당기손익-공정가치 측정 금융부채는 단기매매목적의 금융상품입니다. 주로 단기간 내에 재매입할 목적으로 부담하는 금융부채는 단기매매금융부채로 분류됩니다. 또한, 위험회피회계의 수단으로 지정되지 않은 파생상품이나 금융상품으로부터 분리된 내재파생상품도 단기매매금융부채로 분류됩니다.</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">당기손익-공정가치 측정 금융부채, 금융보증계약, 금융자산의 양도가 제거조건을 충족하지 못하는 경우에 발생하는 금융부채를 제외한 모든 비파생금융부채는 상각후원가로 측정하는 금융부채로 분류되고 있으며, 재무상태표 상 </SPAN>
<SPAN USERMARK="F-GL">'</SPAN>
<SPAN USERMARK="F-GL">매입채무' 및 '차입금' </SPAN>
<SPAN USERMARK="F-GL"> 등으로 표시됩니다. </SPAN>
</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">특정일에 의무적으로 상환해야 하는 우선주는 부채로 분류됩니다. 이러한 우선주에 대한 유효이자율법에 따른 이자비용은 다른 금융부채에서 인식한 이자비용과 함께 손익계산서 상</SPAN>
<SPAN USERMARK="F-GL"> '금융비용'으</SPAN>
<SPAN USERMARK="F-GL">로 인식됩니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(2)  제거</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">금융부채는 계약상 의무가 이행, 취소 또는 만료되어 소멸되거나 기존 금융부채의 조건이 실질적으로 변경된 경우에 재무상태표에서 제거됩니다. 소멸하거나 제3자에게 양도한 금융부채의 장부금액과 지급한 대가(양도한 비현금자산이나 부담한 부채를 포함)의 차액은 당기손익으로 인식합니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">2.12 금융보증계약</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;회사가 제공한 금융보증계약은 최초 인식시 공정가치로 측정되며, 후속적으로는 다음중 큰 금액으로 측정하여 '기타금융부채'로 인식됩니다. &cr;(1) 금융상품의 손상규정에 따라 산정한 손실충당금 &cr;(2) 최초 인식금액에서 기업회계기준서 제1115호에 따라 인식한 이익누계액을 차감한 금액</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.13 충당부채 &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;충당부채는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 측정되며, 시간경과로 인한 충당부채의 증가는 이자비용으로 인식됩니다.&cr;  &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2.14 당기법인세 및 이연법인세  &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;법인세비용은 당기법인세와 이연법인세로 구성됩니다. 법인세는 기타포괄손익이나 자본에 직접 인식된 항목과 관련된 금액은 해당 항목에서 직접 인식하며, 이를 제외하고는 당기손익으로 인식됩니다. &cr;&cr;법인세비용은 보고기간말 현재 제정됐거나 실질적으로 제정된 세법을 기준으로 측정됩니다. </SPAN>
</P>
<P USERMARK="F-GL">&cr;경영진은 적용 가능한 세법 규정이 해석에 따라 달라질 수 있는 상황에 대하여 회사가 세무신고 시 적용한 세무정책에 대하여 주기적으로 평가하고 있습니다. 회사는 세무당국에 납부할 것으로 예상되는 금액에 기초하여 당기법인세비용을 인식합니다.&cr;</P>
<P USERMARK="F-GL">이연법인세는 자산과 부채의 장부금액과 세무기준액의 차이로 발생하는 일시적 차이에 대하여 장부금액을 회수하거나 결제할 때의 예상 법인세효과로 인식됩니다. 다만,사업결합 이외의 거래에서 자산ㆍ부채를 최초로 인식할 때 발생하는 이연법인세자산과 부채는 그 거래가 회계이익이나 과세소득에 영향을 미치지 않는다면 인식되지 않습니다. &cr;&cr;이연법인세자산은 차감할 일시적 차이가 사용될 수 있는 미래 과세소득의 발생가능성이 높은 경우에 인식됩니다.&cr;&cr;종속기업, 관계기업 및 공동기업 투자지분과 관련된 가산할 일시적 차이에 대해 소멸시점을 통제할 수 있는 경우, 그리고 예측가능한 미래에 일시적 차이가 소멸하지 않을 가능성이 높은 경우를 제외하고 이연법인세부채를 인식하고 있습니다. 또한 이러한 자산으로부터 발생하는 차감할 일시적 차이에 대하여 일시적 차이가 예측가능한 미래에 소멸할 가능성이 높고 일시적 차이가 사용될 수 있는 과세소득이 발생할 가능성이 높은 경우에만 이연법인세자산을 인식하고 있습니다.&cr;&cr;이연법인세자산과 부채는 법적으로 당기법인세자산과 당기법인세부채를 상계할 수 있는 권리를 회사가 보유하고 있으며, 동시에 이연법인세자산과 부채가 동일한 과세당국에 의해서 부과되는 법인세와 관련이 있으면서 순액으로 결제할 의도가 있는 경우에 상계됩니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">2.15 종업원급여</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL B"> </SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 퇴직급여 &cr; &cr;회사의 퇴직연금제도</SPAN>
<SPAN USERMARK="F-GL">는 </SPAN>
<SPAN USERMARK="F-GL">확정기여제도</SPAN>
<SPAN USERMARK="F-GL">와 </SPAN>
<SPAN USERMARK="F-GL">확정급여제도</SPAN>
<SPAN USERMARK="F-GL">로 구분됩니다. &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">확정기여제도는 회사가 고정된 금액의 기여금을 별도 기금에 지급하는 퇴직연금제도이며, 기여금은 종업원이 근무 용역을 제공했을 때 비용으로 인식됩니다.&cr;&cr;확정급여제도는 확정기여제도를 제외한 모든 퇴직연금제도입니다. 일반적으로 확정급여제도는 연령, 근속연수나 급여수준 등의 요소에 의하여 종업원이 퇴직할 때 지급받을 퇴직연금급여의 금액이 확정됩니다. 확정급여제도와 관련하여 재무상태표에 계상된 부채는 보고기간말 현재 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감한 금액입니다. 확정급여채무는 매년 독립된 보험계리인에 의해 예측단위적립방식에 따라 산정되며, 확정급여채무의 현재가치는 그 지급시점과 만기가 유사한 우량회사채의 이자율로 기대미래현금유출액을 할인하여 산정됩니다. 한편, 순확정급여부채와 관련한 재측정요소는 기타포괄손익으로 인식됩니다.&cr;&cr;제도개정, 축소 또는 정산이 발생하는 경우, 과거근무원가 또는 정산으로 인한 손익은 당기손익으로 인식됩니다. &cr; &cr;(2) 주식기준보상 &cr;&cr;종업원에게 부여한 주식결제형 주식기준보상은 부여일에 지분상품의 공정가치로 측정되며, 가득기간에 걸쳐 종업원 급여비용으로 인식됩니다. 가득될 것으로 예상되는 지분상품의 수량은 매 보고기간말에 비시장성과조건을 고려하여 재측정되며, 당초 추정치로부터의 변동액은 당기손익과 자본으로 인식됩니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">주식선택권의 행사시점에 신주를 발행할 때 직접적으로 관련되는 거래비용을 제외한순유입액은 자본금(명목가액)과 주식발행초과금으로 인식됩니다. </P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">2.16 수익인식</SPAN>
<SPAN USERMARK="F-GL">&cr; </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 수행의무의 식별&cr;&cr;회사는 의약품을 제조하여 고객에게 판매하는 사업을 주요 사업으로 영위하고 있습니다. 기업회계기준서 제1115호에 따라서 고객과의 제품판매 계약에서 제품 판매, 운송서비스 등과 같이 다양한 혜택 제공으로 구별되는 수행의무를 식별합니다. 각각의 수행의무를 한 시점에 이행하는지, 기간에 걸쳐 이행하는지에 따라 회사의 수익으로 인식하고 있습니다.&cr;&cr;(2) 거래가격의 배분&cr;&cr;회사는 하나의 계약에서 식별된 여러 수행의무에 상대적 개별 판매가격을 기초로 거래가격을 배분합니다. &cr;&cr;(3) 변동대가 &cr;&cr;회사는 받을 권리를 갖게 될 금액을 더 잘 예측할 것으로 예상하는 기댓값 방법을 사용하여 변동 대가를 추정하고, 반품기한이 경과할 때 이미 인식한 누적 수익금액 중 유의적인 부분을 되돌리지 않을 가능성이 매우 높은 금액까지만 변동대가를 거래가격에 포함하여 수익을 인식합니다. 기업이 받았거나 받을 대가 중에서 권리를 갖게 될 것으로 예상하지 않는 금액은 환불부채로 계상합니다.&cr;&cr;(4) 반품&cr;&cr;회사는 고객에게 환불할 것으로 예상되는 총액을 환불부채로 인식하고 수익을 조정하며, 고객이 반품 권리를 행사할 때 고객으로부터 제품을 회수할 권리를 가지므로 그 자산을 인식하고 해당 금액만큼 매출원가를 조정합니다. 제품을 회수할 권리는 제품의 과거장부금액에서 제품을 회수하는데 드는 원가를 차감하여 측정합니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">2.17 리스</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL">회사는 다양한 사무실, 자동차 등을 리스하고 있습니다. </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">리스에서 생기는 자산과 부채는 최초에 현재가치기준으로 측정합니다. 리스부채는 다음 리스료의 순현재가치를 포함합니다.</P>
<P USERMARK="F-GL"></P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="22"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">받을 리스 인센티브를 차감한 고정리스료(실질적인 고정리스료 포함)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="55" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="55">개시일 현재 지수나 요율을 사용하여 최초 측정한, 지수나 요율(이율)에 따라 달라지는 변동리스료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">잔존가치보증에 따라 회사(리스이용자)가 지급할 것으로 예상되는 금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="55" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="55">회사(리스이용자)가 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="55" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="55">리스기간이 회사(리스이용자)의 종료선택권 행사를 반영하는 경우에 그 리스를종료하기 위하여 부담하는 금액</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">리스의 내재이자율을 쉽게 산정할 수 있는 경우 그 이자율로 리스료를 할인합니다. 내재이자율을 쉽게 산정할 수 없는 경우에는 리스이용자가 비슷한 경제적 환경에서 비슷한 기간에 걸쳐 비슷한 담보로 사용권자산과 가치가 비슷한 자산을 획득하는 데 필요한 자금을 차입한다면 지급해야 할 이자율인 리스이용자의 증분차입이자율을 사용합니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 증분차입이자율을 다음과 같이 산정합니다.</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="22"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">회사의 신용 위험을 고려하여 차입금 이자율을 사용하여 산출 반영</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">각 리스료는 리스부채의 상환과 금융원가로 배분합니다. 금융원가는 각 기간의 리스부채 잔액에 대하여 일정한 기간 이자율이 산출되도록 계산된 금액을 리스기간에 걸쳐 당기손익으로 인식합니다. </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">사용권자산은 다음 항목들로 구성된 원가로 측정합니다.</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="22"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">리스부채의 최초 측정금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">받은 리스 인센티브를 차감한 리스개시일이나 그 전에 지급한 리스료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">리스이용자가 부담하는 리스개설직접원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="31" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="569" HEIGHT="31">복구원가의 추정치</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">사용권자산은 리스개시일부터 사용권자산의 내용연수 종료일과 리스기간 종료일 중 이른 날까지의 기간동안 감가상각합니다. 회사가 매수선택권을 행사할 것이 상당히 확실한(reasonably certain) 경우 사용권자산은 기초자산의 내용연수에 걸쳐 감가상각합니다. &cr;</P>
<P USERMARK="F-GL">단기리스와 모든 소액자산 리스와 관련된 리스료는 정액 기준에 따라 당기손익으로 인식합니다. 단기리스는 리스기간이 12개월 이하인 리스이며, 소액리스자산은 IT기기와 소액의 사무실 비품 등으로 구성되어 있습니다.</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">2.18 영업부문</SPAN>
<SPAN USERMARK="F-GL">&cr;  &cr;회사는 영업수익을 창출하는 재화나 용역의 성격 및 서비스를 제공하기 위한 자산의 특성 등을 기준으로 최고경영자의 의사결정을 위해 제공되는 수준으로 보고부문을 구분하며, 그 결과 회사 전체를 단일의 보고부문으로 식별하였습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">2.19 재무제표 승인</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">회사의 재무제표는 </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">2021년 2월 10일</SPAN>
<SPAN USERMARK="F-GL">자</SPAN>
<SPAN USERMARK="F-GL">로 이사회에서 승인되었으며, </SPAN>
<SPAN USERMARK="F-GL">2021년 3월 26일 정기주주총회에서 최종 승인 될 예정입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL B">3. 중요한 회계추정 및 가정</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">회사는 미래에 대하여 추정 및 가정을 하고 있습니다. 추정 및 가정은 지속적으로 평가되며, 과거 경험과 현재의 상황에서 합리적으로 예측가능한 미래의 사건을 고려하여 이루어집니다. 이러한 회계추정은 실제 결과와 다를 수도 있습니다. 다음 회계연도에 자산 및 부채 장부금액에 조정을 미칠 수 있는 유의적 위험에 대한 추정 및 가정은 다음과 같습니다. </SPAN>
</P>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL">(1) 수익인식 &cr;</P>

<P>
<SPAN USERMARK="F-GL">회사는 고객에게 제품 판매 후 고객이 반품할 것으로 예상되는 제품에 대하여 환불부채와 회수할 재화에 대한 권리를 인식하고 있습니다. 판매시점에 포트폴리오 수준에서 누적된 경험에 기초하여 기댓값 방법으로 반품율을 예측하고 있으며, 회사의 수익은 예측된 반품율의 변동에 영향을 받습니다. &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(2) </SPAN>
<SPAN USERMARK="F-GL">순확정급여부채 </SPAN>
<SPAN USERMARK="F-GL"> &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">순확정급여부채의 현재가치는 보험수리적방식에 의해 결정되는 다양한 요소들 특히 할인율의 변동에 영향을 받습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">(3) 법인세 &cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">회사는 보고기간말 현재까지의 영업활동의 결과로 미래에 부담할 것으로 예상되는 법인세효과를 최선의 추정과정을 거쳐 당기법인세 및 이연법인세로 인식하였습니다.하지만 실제 미래 최종 법인세부담은 인식한 관련 자산ㆍ부채와 일치하지 않을 수 있으며, 이러한 차이는 최종 세효과가 확정된 시점의 당기법인세 및 이연법인세 자산ㆍ부채에 영향을 줄 수 있습니다</SPAN>
<SPAN USERMARK="F-GL B">.</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<P USERMARK="F-GL">(4) 금융상품의 공정가치</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">활성시장에서 거래되지 않는 금융상품의 공정가치는 원칙적으로 평가기법을 사용하여 결정됩니다. 회사는 보고기간말 현재 중요한 시장상황에 기초하여 다양한 평가기법의 선택 및 가정에 대한 판단을 하고 있습니다. </P>
<P USERMARK="F-GL">&cr;(5) 금융자산의 손상&cr;&cr;기준서 제1109호의 금융자산의 손실충당금은 채무불이행위험과 기대신용률에 대한 가정에 근거하였습니다. 회사는 이러한 가정을 세우고 손상 계산을 위한 투입요소를 선택할 때 보고기간종료일의 미래 전망에 대한 추정 및 과거 경험, 현재 시장 상황에 근거하여 판단합니다.</P>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">4. 현금및현금성자산 &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기말 및 전기말 현재 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="319" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE">현금</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">1,147</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">1,512</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE">예금 등</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">15,489,302</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">25,144,565</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">15,490,449</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">25,146,077</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">5. 사용제한금융상품 &cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">당기말 현재 사용이 제한되어 있는 금융상품의 내용은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="721">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="405"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="414" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="721">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">예금의 종류</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">은 행 명</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금     액</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용제한내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER">보증금</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">당좌개설보증금</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">우리은행 등</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">4,500</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="CENTER">인출제한</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">6. 범주별 금융상품 </SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기말 및 전기말 현재 범주별 금융상품 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="693">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="377"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기말></TD>
<TD WIDTH="386" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="694">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="219" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융자산</TH>
<TH WIDTH="150" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각후원가&cr;측정 금융자산</TH>
<TH WIDTH="163" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="162" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="694" HEIGHT="30" COLSPAN="4">유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  당기손익-공정가치금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,253,777</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,253,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,490,449</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,490,449</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  매출채권 및 기타채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    매출채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,950,605</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,950,605</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    대손충당금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,542,648)</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,542,648)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    단기대여금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,135,485</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,135,485</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    미수수익</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,747</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,747</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    미수금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,825</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,825</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,500,000</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  상각후원가 측정 금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,190,397</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,190,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">49,805,860</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,253,777</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">66,059,637</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="694" HEIGHT="30" COLSPAN="4">비유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  당기손익-공정가치금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">6,511,581</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">6,511,581</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  상각후원가 측정 금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">697,878</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">697,878</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  비유동기타채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    장기대여금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    보증금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">475,932</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">475,932</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    현재가치할인차금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">1,173,810</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">6,511,581</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">7,685,391</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">50,979,670</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">22,765,358</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">73,745,028</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="310" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융부채</TH>
<TH WIDTH="310" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가&cr;측정 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">유동부채</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">  매입채무및기타채무</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">    매입채무</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">2,869,105</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">    미지급금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,856,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">    예수보증금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">19,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">    미지급비용</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,084,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">  단기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">10,589,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">  유동성장기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">18,318,464</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">비유동부채</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">  장기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">22,318,464</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="692">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="376"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기말></SPAN>
</TD>
<TD WIDTH="385" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="694">

<COLGROUP>
<COL WIDTH="210"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="219" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융자산</TH>
<TH WIDTH="150" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각후원가&cr;측정 금융자산</TH>
<TH WIDTH="163" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="162" HEIGHT="53" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="694" HEIGHT="30" COLSPAN="4">유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  당기손익-공정가치금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,322,790</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,322,790</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  현금및현금성자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,146,077</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,146,077</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  매출채권 및 기타채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    매출채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,077,503</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,077,503</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    대손충당금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,575,795)</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,575,795)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    단기대여금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,261,900</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,261,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    미수수익</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">79,346</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">79,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">    미수금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,540</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,540</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  단기금융상품</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,500,000</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE">  상각후원가 측정 금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,704,802</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,704,802</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">51,195,373</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,322,790</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">66,518,163</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="694" HEIGHT="30" COLSPAN="4">비유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  당기손익-공정가치금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">3,565,195</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">3,565,195</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  상각후원가 측정 금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,190,448</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">2,190,448</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">  비유동기타채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    장기대여금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">4,367,189</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">4,367,189</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    보증금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">369,773</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">369,773</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30">    현재가치할인차금</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(2,131)</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">(2,131)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">6,925,279</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">3,565,195</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">10,490,474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">58,120,652</TD>
<TD WIDTH="163" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT">77,008,637</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="310" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융부채</TH>
<TH WIDTH="310" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가&cr;측정 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">유동부채</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">   매입채무및기타채무</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">      매입채무</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">2,891,136</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">      미지급금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">4,188,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">      예수보증금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">19,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">      미지급비용</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,094,351</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">      임대보증금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">33,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">   단기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">11,395,865</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30">   유동성장기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">21,522,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">비유동부채</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">   장기차입금</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,600,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">1,600,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합     계</TD>
<TD WIDTH="310" HEIGHT="30" ALIGN="RIGHT">23,122,152</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 금융상품 범주별 순손익 구분</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><당기></SPAN>
</TD>
<TD WIDTH="318" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융자산</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가&cr;측정 금융자산</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="141" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">평가/처분손익(당기손익)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">433,848</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">433,848</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">이자수익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">245,610</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">245,610</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="311" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융부채</TH>
<TH WIDTH="311" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가 측정 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30">이자비용</TD>
<TD WIDTH="311" HEIGHT="30" ALIGN="RIGHT">148,097</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="318" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융자산</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가&cr;측정 금융자산</TH>
<TH WIDTH="142" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치&cr;측정 금융자산</TH>
<TH WIDTH="141" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">평가/처분손익(당기손익)</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">141,822</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">141,822</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30">이자수익</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">791,739</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="141" HEIGHT="30" ALIGN="RIGHT">791,739</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="311" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융부채</TH>
<TH WIDTH="311" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가 측정 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30">이자비용</TD>
<TD WIDTH="311" HEIGHT="30" ALIGN="RIGHT">367,662</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>

<P>
<SPAN USERMARK="F-GL B">7. 공정가치 측정 금융자산 &cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기말 및 전기말 현재 공정가치 측정 금융자산의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">채무상품 등</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">20,265,345</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지분상품 등</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,500,012</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합    계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">22,765,357</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;(2) 당기 및 전기의 공정가치 측정 금융자산의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기초금액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">22,410,989</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  취득</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">15,115,677</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">25,534,311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  처분</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">(11,623,139)</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">(29,229,802)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  공정가치평가</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">384,834</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">172,487</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기말금액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">22,765,357</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 당기말 현재 공정가치 측정 금융상품 중 지분증권의 구성내역은 다음과 같습니 다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="768">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="452"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="461" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="767">

<COLGROUP>
<COL WIDTH="248"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">종목명</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">보유주식수</TH>
<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">지분율</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">취득원가</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">공정가치</TH>
<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" VALIGN="MIDDLE" HEIGHT="30">(주)인벤티지랩</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329주</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.47%</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000,012</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000,012</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000,012</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" VALIGN="MIDDLE" HEIGHT="53">케이브릿지-디에이밸류&cr;넥스트 파마슈티컬 신기술투자조합</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">500좌</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">15.15%</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">500,000</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">500,000</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="470" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,012</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,012</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,500,012</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;(4) 공정가치 서열체계&cr;</P>
<P USERMARK="F-GL">① 금융자산과 금융부채의 공정가치를 결정하는데 사용한 가정&cr;&cr;표준화된 거래조건과 활성화된 거래시장이 존재하는 금융상품의 공정가치는 시장가격을 이용하여 결정되었고, 활성화된 거래시장에서 거래되지 않는 금융상품은 시장참가자들에 의해 일반적으로 사용되는 평가기법 또는 경영자의 판단을 사용하여 공정가치를 측정하고 있습니다.&cr;</P>
<P USERMARK="F-GL">② 공정가치 서열체계&cr;</P>
<P USERMARK="F-GL">공정가치로 측정되는 금융상품은 공정가치 서열체계에 따라 구분되며 정의된 수준들은 다음과 같습니다.&cr;</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="17"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="31">'수준 1' : 동일한 자산이나 부채에 대한 시장 공시가격</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="55" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="55">'수준 2' : 시장에서 관측가능한 투입변수를 활용한 공정가치&cr;              (단, '수준 1'에 포함된 공시가격은 제외)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="31" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="31">'수준 3' : 관측가능하지 않은 투입변수를 활용한 공정가치</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="695">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="388" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="695" HEIGHT="30" COLSPAN="5">당기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 당기손익-공정가치 측정금융자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,265,345</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,500,012</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,765,357</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="695" HEIGHT="30" COLSPAN="5">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" HEIGHT="30"> 당기손익-공정가치 측정금융자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,887,984</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,887,984</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL B">8. 재고자산</P>

<P>
<SPAN USERMARK="F-GL">&cr;(1) 당기말 및 전기말 현재</SPAN>
<SPAN USERMARK="F-GL"> 재고자산</SPAN>
<SPAN USERMARK="F-GL">의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="876">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="560"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="569" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="877">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구     분</TH>
<TH WIDTH="366" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">당기말</TH>
<TH WIDTH="365" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가전금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가충당금(*)</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가전금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가충당금(*)</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE">제품</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">4,681,723</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(66,336)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">4,615,386</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">4,405,891</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(44,176)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">4,361,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">2,207,747</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">2,207,747</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,612,608</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,612,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE">미착품</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">688</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">688</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE">재공품</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,169,553</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(71,522)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,098,031</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,021,960</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(21,800)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,000,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">8,059,711</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(137,858)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">7,921,852</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">7,040,459</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(65,976)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">6,974,483</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">(*) 당기 중 회사가 '매출원가'에 가산하여 계상한 재고자산평가손실은 72백만원입니다.&cr;</P>
<P USERMARK="F-GL">(2) 당기 중 비용으로 인식되어 '매출원가'에 포함된 재고자산의 원가는 11,067백만원(전기: 19,426백만원) 입니다. 동 비용에는 재고자산 평가손실 금액이 포함되어 있습니다.&cr;&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">9. 기타자산 및 기타부채&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">(1) 당기말 및 전기말 현재 기타유동자산의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="313" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">선급금</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">6,281</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">10,777</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE">선급비용</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">26,923</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">26,547</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">33,204</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">37,324</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">(2) 당기말 및 전기말 현재 기타부채의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">   선수금</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">56,513</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">55,751</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">   예수금</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">55,836</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">53,560</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">   부가세예수금</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">740,342</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">567,024</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">   리스부채</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">303,088</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">248,266</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">유동부채 계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">1,155,779</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">924,601</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">비유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">   리스부채</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">426,534</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">370,354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비유동부채 계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">426,534</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">370,354</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">10. 유형자산&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기말 및 전기말 현재 유형자산의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="311" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="618">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">6,237,756</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">5,915,683</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">9,657,260</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">9,350,420</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(1,586,766)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(1,429,614)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">10,653,984</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">10,091,131</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(6,693,444)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(6,094,277)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">365,399</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">414,164</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(284,334)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(385,237)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">공구와기구</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">1,097,395</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">958,401</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(681,753)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(611,646)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">228,877</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">209,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(188,342)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(181,795)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">미착기계</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">238,000</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">533,022</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">건설중인자산</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">308,000</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">사용권자산</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">1,074,082</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">860,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">감가상각누계액</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(355,550)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">(246,334)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합     계</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">20,070,563</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">19,383,455</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL">(2) 당기 및 전기 중 유형자산의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="854">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="538"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기></TD>
<TD WIDTH="547" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="854">

<COLGROUP>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구    분</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초장부금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">폐기ㆍ처분금액</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대체(*)</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">토지</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">5,915,683</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">322,073</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">6,237,756</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">건물</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">7,920,806</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">242,000</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(135,050)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">42,738</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">8,070,494</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">기계장치</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">3,996,854</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">271,826</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(609,166)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(1)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">301,027</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">3,960,540</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">차량운반구</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">28,927</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">64,885</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(12,746)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(1)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">81,065</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">공구와 기구</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">346,755</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">138,994</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(70,107)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">415,642</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">비품</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">27,569</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">19,513</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(6,547)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">40,535</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">미착기계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">533,022</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">6,005</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(301,027)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">238,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">308,000</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">308,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">사용권자산</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">613,839</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">254,262</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(149,570)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">718,531</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">19,383,455</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,305,485</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(983,186)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(2)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">364,811</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">20,070,563</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN>(*) 당기 중 토지 및 건물 364,812천원이 투자부동산으로부터 대체되었습니다.&cr;</SPAN>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="866">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="550"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="559" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="867">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구    분</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초장부금액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득금액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">폐기ㆍ처분금액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대체(*)</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">토지</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">5,001,443</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">914,240</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">5,915,683</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">건물</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">4,553,113</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">3,395,483</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(159,646)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">131,856</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">7,920,806</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">기계장치</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,385,830</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,441,604</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(830,580)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">3,996,854</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">차량운반구</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">45,335</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(16,408)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">28,927</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">공구와 기구</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">296,691</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">163,769</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(113,705)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">346,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">비품</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">36,980</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">2,660</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(12,071)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">27,569</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">미착기계</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">533,022</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">533,022</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30">사용권자산</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">889,500</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(264,552)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(11,109)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">613,839</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">12,319,392</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">7,426,038</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(1,396,962)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(11,109)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">1,046,096</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT">19,383,455</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">(*) 전기 중 토지 및 건물 1,034,778천원이 투자부동산으로부터 대체되었습니다.&cr;(*) 전기 중 차입원가 11,318천원을 자본화 하였습니다.&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL">(3) 당기말 현재 차입금 관련하여 금융기관에 담보로 제공한 자산의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="728">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="412"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="421" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="728">

<COLGROUP>
<COL WIDTH="188"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="197" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권최고액</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보권자</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30" VALIGN="MIDDLE">토지ㆍ건물</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,800,000</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,088,439</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">국민은행</TD>
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">차입금 담보</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="197" HEIGHT="30" VALIGN="MIDDLE">토지ㆍ건물ㆍ투자부동산</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,800,000</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,291,565</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="132" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">차입금 담보</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(4) 당기 및 전기에 사용권자산과 관련하여 손익으로 인식된 금액은 다음과 같습니 다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30"></TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="311" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30" VALIGN="MIDDLE">사용권자산 감가상각비</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">149,571</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">264,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30" VALIGN="MIDDLE">리스부채 이자비용</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,242</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,047</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30" VALIGN="MIDDLE">단기리스 관련 비용</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">232</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,255</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30" VALIGN="MIDDLE">소액자산리스 관련 비용</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,485</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,624</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(5) 당기말 및 전기말 현재 보유 토지(투자부동산 포함) 공시지가는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" HEIGHT="30"></TD>
<TD WIDTH="308" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보유토지</TH>
<TH COLSPAN="2" WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="252" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공시지가</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공시지가</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">공장부지</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,277,782</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,390,437</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,277,782</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,390,437</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">직원숙소</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,039</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">41,039</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">본사사옥</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,753,096</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,907,590</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,753,096</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,907,590</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">신약연구실</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,840</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,382</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">165,840</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,382</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합    계 </TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,237,756</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,450,409</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,237,756</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,450,409</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">11. 투자부동산&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기 및 전기 중 투자부동산의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="836">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="520"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><당기></SPAN>
</TD>
<TD WIDTH="529" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구    분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초장부금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각비</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기타증(감)액</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">토지</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">322,074</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(322,074)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">건물</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">44,108</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(1,370)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(42,738)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">합    계 </TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">366,182</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(1,370)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(364,812)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">(*) 당기 중 토지 및 건물 364,812천원이 유형자산으로 대체되었습니다.</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="837">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="521"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="530" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타증(감)액(*)</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">토지</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,236,313</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(914,239)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">322,074</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">건물</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">172,907</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">2,351</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(10,611)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(120,539)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">44,108</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">합    계 </TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,409,220</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">2,351</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(10,611)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(1,034,778)</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">366,182</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11">(*) 전기 중 토지 및 건물 1,034,778천원이 유형자산으로 대체되었습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL11">&cr;</SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL11"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(2) 당기 및 전기 중 투자부동산과 관련하여 인식한 임대수익은 각각 </SPAN>
<SPAN USERMARK="F-GL">7,000천원 및 43,232천원입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">12. 무형자산&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기 및 전기 중 무형자산의 변동내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="836">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="520"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><당기></SPAN>
</TD>
<TD WIDTH="529" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구    분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초장부금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각비</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기타증(감)액</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">회원권</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,530,445</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">1,530,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">12,396</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">3,300</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(3,772)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">11,924</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">개발비</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">431,900</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">976,230</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">1,408,130</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">합    계 </TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,974,741</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">979,530</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(3,772)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">2,950,499</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="837">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="521"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="530" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="837">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득금액</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타증(감)액</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">회원권</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,497,725</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">32,720</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">1,530,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">소프트웨어</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">20,037</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(7,641)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">12,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">개발비</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">431,900</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">431,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">합    계 </TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">1,517,762</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">464,620</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">(7,641)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">1,974,741</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">&cr;(2) 당기말 현재 개발비의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1081">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="765"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="774" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1082">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="83" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XDCDCDC">분     류</TD>
<TD ROWSPAN="2" WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XDCDCDC">단    계</TD>
<TD ROWSPAN="2" WIDTH="204" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XDCDCDC">개발자산명</TD>
<TD COLSPAN="6" WIDTH="382" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XDCDCDC">자산화한 연구개발비 금액(누계)</TD>
<TD COLSPAN="3" WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XDCDCDC">개발비</TD>
<TD ROWSPAN="2" WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83" USERMARK=" BC0XDCDCDC">잔여&cr;상각기간</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="74" HEIGHT="53" USERMARK=" BC0XDCDCDC">생동</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="53" USERMARK=" BC0XDCDCDC">1상</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="53" USERMARK=" BC0XDCDCDC">2상</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="53" HEIGHT="53" USERMARK=" BC0XDCDCDC">3상</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="74" HEIGHT="53" USERMARK=" BC0XDCDCDC">판매승인</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="75" HEIGHT="53" USERMARK=" BC0XDCDCDC">계</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="70" HEIGHT="53" USERMARK=" BC0XDCDCDC">손상차손&cr;누계액</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="84" HEIGHT="53" USERMARK=" BC0XDCDCDC">상각누계액</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="80" HEIGHT="53" USERMARK=" BC0XDCDCDC">장부가액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="83" HEIGHT="180">개발비</TD>
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="100" HEIGHT="180">개발중</TD>
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">듀로텔정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">202,300</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">202,300</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">202,300</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">아바젯정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">334,430</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">334,430</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">334,430</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">아트로바스타틴정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">430,080</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">430,080</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">430,080</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">소로펜정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">166,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">166,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">166,500</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">팜시스정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">130,900</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">130,900</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">130,900</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="204" HEIGHT="30">아레온정(Epinastine)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">143,920</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="53" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="74" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">143,920</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">143,920</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="8" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="694" HEIGHT="30">합    계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="75" HEIGHT="30">1,408,130</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="70" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="80" HEIGHT="30">1,408,130</TD>
<TD VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;회사는 외부 연구용역기관에게 지급한 제네릭 관련 생동시험 용역 금액 중 식약처 승인받은 품목을 개발비로 계상하고 있</SPAN>
<SPAN USERMARK="F-GL">으며, </SPAN>
<SPAN USERMARK="F-GL">판매승인</SPAN>
<SPAN USERMARK="F-GL"> 시점부터 5년 동안 상각할 예정입니다. &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL">(3) 무형자산상각비는 모두 판매비와관리비에 포함되어 있습니다. 또한, 당기 및 전기 중 회사가 비용으로 인식한 경상연구개발비는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="215"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30">판매비와 관리비</TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">856,348</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">1,512,387</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">합    계 </TD>
<TD WIDTH="225" HEIGHT="30" ALIGN="RIGHT">856,348</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT">1,512,387</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">13. 리스부채&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">(1) 당기말 및 전기말 현재 리스부채 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="631" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH COLSPAN="2" WIDTH="277" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="276" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비유동</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">리스부채</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">303,088</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">426,534</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,266</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">303,088</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">426,534</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">248,266</TD>
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">370,354</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 당기 및 전기 중 손익계산서에 인식한 내역은 다음과 같습니다. </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="630" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">리스부채에 대한 이자비용</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,242</TD>
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,047</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,242</TD>
<TD WIDTH="219" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,047</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(3) 당기 및 전기 중 현금흐름표에 인식한 내역은 다음과 같습니다. </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="628" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="208"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="218" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="217" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">리스부채의 상환</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,577</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">273,307</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합  계</TD>
<TD WIDTH="218" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">152,577</TD>
<TD WIDTH="217" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">273,307</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">14. 차입금&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기말 및 전기말 현재 단기차입금의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="715">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="399"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="408" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차 입 처</TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내     역</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율(당기말)</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">국민은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">시설자금 외</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.55% ~ 1.64%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,500,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,118,232</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">운영자금 외</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.75% ~ 1.99%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,589,116</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,577,633</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">운전자금</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.66%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">KEB하나은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">운전자금 외</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.55% ~ 2.00%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,200,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합     계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,589,116</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,395,865</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">(2) 당기말 및 전기말 현재 장기차입금의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="714">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="398"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="407" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차 입 처</TH>
<TH WIDTH="138" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내     역</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율(당기말)</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">농협은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">운전자금</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.06%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">산업은행</TD>
<TD WIDTH="138" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">시설자금</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.50%</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,000,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합         계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,900,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">유동성대체</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,900,000)</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,900,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="413" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차 감 잔 액</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,000,000</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 회사의 장단기차입금과 관련하여 토지 및 건물이 담보로 제공되어 있으며 대표이사가 지급보증을 제공하고 있습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">15. 반품충당부채&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기 및 전기 중 충당부채의 변동내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="632">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="325" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="634">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">기초장부금액</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">780,257</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">794,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">   증가액</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">   감소액</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">(34,106)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">(13,801)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30">기말장부금액</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">746,151</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">780,257</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">16. </SPAN>
<SPAN USERMARK="F-GL B">순</SPAN>
<SPAN USERMARK="F-GL B">확정급여부채&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;회사는 종업원들을 위하여 퇴직급여제도로 확정급여형제도와 확정기여형제도를 운영하고 있습니다. 확정급여형제도하에서, 종업원들은 60</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">세(정년)에 도달하게 되면 인사규정에 정한 퇴직급여를 받을 수 있는 자격을 갖추게 됩니다.&cr;&cr;가장 최근의 확정급여채무와 사외적립자산의 보험수리적 평가는 (주)국민은행에 의하여 수행되었습니다. 확정급여채무의 현재가치와 관련된 당기근무원가 및 과거근무원가는 예측단위적립방식을 사용하여 측정되었습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기말과 전기말 현재 보험수리적 평가를 위하여 사용된 주요 추정은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE">할인율(*)</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">2.36%</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">2.21%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE">미래임금상승률</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">3.04%</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">3.04%</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="626" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="587"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" HEIGHT="31" VALIGN="MIDDLE">(*)</TD>

<TD WIDTH="596" HEIGHT="31">
<SPAN>할인율은 우량회사채수익률(</SPAN>
<SPAN></SPAN>
<SPAN>AA+</SPAN>
<SPAN>)을 적용하였습니다.</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL">(2) 당기말과 전기말 현재 확정급여부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="307"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="316" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="246"></COL>
<COL WIDTH="177"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="255" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="186" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="185" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" HEIGHT="30">확정급여채무 현재가치 기말잔액</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">5,433,060</TD>
<TD WIDTH="185" HEIGHT="30" ALIGN="RIGHT">4,941,055</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" HEIGHT="30">사외적립자산 공정가치 기말잔액</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">(905,562)</TD>
<TD WIDTH="185" HEIGHT="30" ALIGN="RIGHT">(819,046)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="255" HEIGHT="30">확정급여부채 기말잔액</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">4,527,498</TD>
<TD WIDTH="185" HEIGHT="30" ALIGN="RIGHT">4,122,009</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(3) 당기 및 전기 중 확정급여채무 현재가치의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="252"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="174"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="261" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">확정급여채무 현재가치 기초잔액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">4,941,055</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">4,453,958</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">급여지급액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">(122,275)</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">(342,292)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">당기근무원가</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">410,997</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">777,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">이자원가</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">46,438</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">86,275</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">재측정요소</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">156,845</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">(34,661)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">확정급여채무 현재가치 기말잔액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">5,433,060</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">4,941,055</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL9">&cr;</SPAN>
<SPAN USERMARK="F-GL">(4) 당기 및 전기 중 사외적립자산 공정가치의 변동내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL10"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="628">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="312"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="321" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="252"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="174"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="261" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">사외적립자산 공정가치 기초잔액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">819,046</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">667,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">기여금</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">82,730</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">142,186</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">급여지급액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">이자수익</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">8,640</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">14,392</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">재측정요소</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">(4,854)</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">(4,621)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">사외적립자산 공정가치 기말잔액</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">905,562</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">819,046</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL9"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(5) 당기말과 전기말 현재 사외적립자산은 정기예금 등의 항목으로 구성되어 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>
<P USERMARK="F-GL">(6) 당기 및 전기 중 퇴직급여제도와 관련하여 당기손익에 인식된 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">확정급여제도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">   당기근무원가</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">410,998</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">777,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">   순이자원가</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">37,799</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">71,883</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">소    계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">448,797</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">849,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">확정기여제도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE">   당기 비용인식 기여금</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">57,366</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소    계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">57,366</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합    계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">506,163</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">849,658</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(7) 당기 및 전기 중 퇴직급여제도와 관련하여 당기손익으로 인식된 금액의 계정별 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="252"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="261" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">매출원가</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">135,269</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">283,184</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">370,894</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">566,474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">506,163</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">849,658</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(8) 민감도 분석&cr;&cr;당기말 현재 유의적인 다음의 보험수리적 가정이 발생가능한 합리적인 범위 내에서 변동한다면 확정급여채무에 미치게 될 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="252"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="261" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구     분</TH>
<TH WIDTH="365" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">확정급여채무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 증가</TH>
<TH WIDTH="182" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 감소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30" VALIGN="MIDDLE">할인율</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">5,087,670</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">5,830,962</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="261" HEIGHT="30" VALIGN="MIDDLE">미래임금상승률</TD>
<TD WIDTH="183" HEIGHT="30" ALIGN="RIGHT">5,824,321</TD>
<TD WIDTH="182" HEIGHT="30" ALIGN="RIGHT">5,086,500</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;민감도 분석은 제도에서 발생할 것으로 기대되는 모든 현금흐름의 분산을 고려하지는 않았으나, 사용된 가정에 대한 민감도의 근사치를 제공하고 있습니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL">(9) </SPAN>
<SPAN USERMARK="F-GL">당기말 및 전기말 현재 확정급여채무의 가중평균만기는 각각 7.79년 및 7.99년 입니다.&cr;&cr;</SPAN>
</P>
<PGBRK></PGBRK>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL B">17. 법인세</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL">(1) 당기 및 전기 법인세비용의 구성요소는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="319" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="311"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="320" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30">법인세부담액</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">190,035</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">2,127,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30">일시적차이의 발생과 소멸로 인한 이연법인세</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">(190,931)</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">(123,867)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30">자본에 직접 반영된 법인세비용(*)</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">35,574</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">(6,609)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30">법인세비용</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">34,678</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="RIGHT">1,997,386</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(*) 당기 및 전기 중 자본에 직접 반영된 법인세비용의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="626">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="310"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="319" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="345"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="354" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="354" HEIGHT="30">확정급여부채의 재측정요소</TD>
<TD WIDTH="137" HEIGHT="30" ALIGN="RIGHT">35,574</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">(6,609)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">(2) 당기 및 전기 법인세비용과 회계이익의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="322"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="331" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">법인세비용차감전순이익</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">1,902,076</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">10,035,983</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">적용세율(11%, 22%)에 따른 법인세비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">418,457</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">2,207,916</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">조정사항</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">   세무상 공제되지 않는 비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">200,599</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">374,493</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">   세액공제</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(573,378)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(563,023)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">   적용세율차이</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(11,000)</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">(22,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">법인세비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">34,678</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">1,997,386</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL">(3) 당기 및 전기 중 이연법인세자산(부채)의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="679">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기></TD>
<TD WIDTH="372" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="100"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구     분</TH>
<TH WIDTH="110" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">기초잔액</TH>
<TH WIDTH="220" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">증(감)액</TH>
<TH WIDTH="109" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">기말잔액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익 반영</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본에 가감</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">대손충당금</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">297,661</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(7,016)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">290,645</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">미수수익</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(17,456)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">132</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(17,324)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">반품충당부채</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">171,657</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(7,504)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">164,153</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">확정급여채무</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,087,032</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">73,735</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">34,506</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">1,195,273</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">사외적립자산</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(180,190)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(20,101)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,068</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(199,223)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">토지</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(362,604)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(362,604)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">건설자금이자</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">11,106</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(175)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">10,931</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">단기금융상품평가손실</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">43,045</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">8,336</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">51,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">단기금융상품평가이익</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(90,732)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(59,071)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(149,803)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">대손금</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">미지급급여</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">79,215</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,927)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">76,288</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">회원권</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,310</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">감가상각비</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(15,642)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">2,498</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(13,144)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">재고자산평가손실</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">14,515</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,299</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">15,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">사용권자산</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(135,045)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(23,032)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">(158,077)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">리스부채</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">136,096</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">24,421</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">160,517</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">임차보증금</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,000</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">1,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">매출(변동대가)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">178,974</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(43,150)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">135,824</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30">세액공제 등으로 인한 이연법인세</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">206,911</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">206,911</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,267,942</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">155,356</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">35,574</TD>
<TD WIDTH="109" HEIGHT="30" ALIGN="RIGHT">1,458,872</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="679">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="372" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="238" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="111" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="221" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증(감)액</TH>
<TH WIDTH="110" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익 반영</TH>
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자본에 가감</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">대손충당금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">297,980</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(319)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">297,661</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">미수수익</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(5,661)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(11,795)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(17,456)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">반품충당부채</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">174,693</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(3,036)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">171,657</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">확정급여채무</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">979,871</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">114,787</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(7,626)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,087,032</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">사외적립자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(146,760)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(34,447)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,017</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(180,190)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">토지</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(362,604)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(362,604)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">건설자금이자</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">11,457</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(351)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">11,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="53">당기손익-공정가치 측정 금융자산평가손실</TD>
<TD WIDTH="111" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">75,394</TD>
<TD WIDTH="111" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(32,349)</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">43,045</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="53">당기손익-공정가치 측정 금융자산평가이익</TD>
<TD WIDTH="111" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(106,903)</TD>
<TD WIDTH="111" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">16,171</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="110" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(90,732)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">대손금</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">미지급급여</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">74,051</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">5,164</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">79,215</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">회원권</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">6,310</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">6,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">감가상각비</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(38,991)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">23,349</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(15,642)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">재고자산평가손실</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">5,611</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">8,904</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">14,515</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">사용권자산</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">(135,045)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(135,045)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">리스부채</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">136,096</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">136,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30">매출(변동대가)</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">135,627</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">43,347</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">178,974</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">1,144,075</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT">130,476</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">(6,609)</TD>
<TD WIDTH="110" HEIGHT="30" ALIGN="RIGHT">1,267,942</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">18. 자본</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) 자본금&cr;&cr;당기말 및 전기말 현재 회사의 자본금의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="317" HEIGHT="30" ALIGN="RIGHT">(단위: 주,원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="625" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">당기말</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30">
<P>발행할 주식의 총수</P>
</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30">
<P>발행주식수</P>
</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,792,415</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,792,415</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30">
<P>1주당금액</P>
</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="200" HEIGHT="30">
<P>자본금</P>
</TD>
<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,758,483,000</TD>
<TD WIDTH="212" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,758,483,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(2) 자본잉여금&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">당기말 및 전기말 현재 자본잉여금의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">당기말</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">주식발행초과금</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">15,845,609</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">15,845,609</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 기타자본구성요소&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">당기말 및 전기말 현재 기타자본구성요소의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">당기말</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">주식매입선택권</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">393,343</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">214,543</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(4) 이익잉여금&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기말 및 전기말 현재 이익잉여금의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">당기말</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" BC0XD7D7D7">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">법정적립금(이익준비금)(*)</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">845,244</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">665,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">미처분이익잉여금</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">58,034,419</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">58,275,835</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합     계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">58,879,663</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">58,940,835</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="28"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="37" HEIGHT="103">(*)</TD>
<TD WIDTH="588" HEIGHT="103">상법상 회사는 자본금의 50%에 달할 때까지 매결산기에 금전에 의한 이익배당액의 10% 이상을 이익준비금으로 적립하도록 규정되어 있고, 동 이익준비금은 현금으로 배당할 수없으며 주주총회의 결의에 의하여 이월결손금의 보전과 자본전입에만 사용될 수 있습니다. </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(5) 이익잉여금처분계산서</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">당기 및 전기 중 이익잉여금의 처분내역은 다음과 같습니다.  </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">이익잉여금처분계산서</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="36"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="60">제 17(당) 기</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">
<SPAN>2020년 </SPAN>
<SPAN>0</SPAN>
<SPAN>7월 </SPAN>
<SPAN>0</SPAN>
<SPAN>1일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="45" HEIGHT="30">부터</TD>
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="60">제 16(전) 기</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30">
<SPAN>2019년 </SPAN>
<SPAN></SPAN>
<SPAN>07월 </SPAN>
<SPAN>0</SPAN>
<SPAN>1일</SPAN>
</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="148" HEIGHT="30">2020년 12월 31일</TD>
<TD VALIGN="MIDDLE" WIDTH="45" HEIGHT="30">까지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="143" HEIGHT="30">2020년 06월 30일</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="30">처분예정일</TD>
<TD VALIGN="MIDDLE" WIDTH="148" HEIGHT="30" ALIGN="RIGHT">2021년 03월 26일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="45" HEIGHT="30"></TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30">처분확정일</TD>

<TD VALIGN="MIDDLE" WIDTH="143" HEIGHT="30" ALIGN="RIGHT">
<SPAN>2020년 </SPAN>
<SPAN></SPAN>
<SPAN>09월 </SPAN>
<SPAN>25일</SPAN>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="719" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="410"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">위더스제약 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="419" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="720" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="262" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과     목</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="230" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">Ⅰ. 미처분이익잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">58,034,419</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">58,275,835</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">   전기이월미처분이익잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">56,293,145</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">50,213,808</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">   확정급여부채의 재측정요소</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">(126,124)</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">23,430</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">   당기순이익</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">1,867,398</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">8,038,597</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">Ⅱ. 이익잉여금처분액</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">456,033</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">1,982,690</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">   이익준비금</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">33,997</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">180,245</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">   현금배당</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">422,036</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">1,802,445</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30">Ⅲ. 차기이월미처분이익잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="115" HEIGHT="30">57,578,386</TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" WIDTH="114" HEIGHT="30">56,293,145</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL">(6) 배당금&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">① 당기 및 전기 배당금의 세부내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="636">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="320"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>

<TD WIDTH="329" HEIGHT="30" ALIGN="RIGHT">
<SPAN> (</SPAN>
<SPAN>단위: 원</SPAN>
<SPAN>)</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="636">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">배당받을 주식수</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">8,792,415주</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">8,792,415주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">주당 액면금액</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">200</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">액면배당률</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">24.00%</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">102.50%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">배당금액</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">422,035,920</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">1,802,445,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">주당 배당금액</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">48</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">205</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">② 당기 및 전기 배당성향의 계산내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="630">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="314"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="323" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">배 당 금</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">422,036</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,802,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">당기순이익</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,867,398</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">8,038,597</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">배당성향</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">22.60%</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">22.42%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>

<P>
<SPAN USERMARK="F-GL B">19. 수익</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">당기 및 전기 중 회사의 수익과 관련하여 포괄손익계산서상 인식한 금액은 다음과 같습니다. </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="629">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="313"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="322" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="630">

<COLGROUP>
<COL WIDTH="322"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="331" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">고객과의 계약에서 생기는 수익 (재화의 판매)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">26,209,392</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">52,349,972</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30">기타 원천으로부터의 수익 (임대수익)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">7,000</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">43,232</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">26,216,392</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">52,393,204</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">20. 판매비와관리비&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기 및 전기 판매비와관리비의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="631">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="315"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="324" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="631">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">급여</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">6,114,016</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">9,200,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">370,894</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">566,474</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">복리후생비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,597,547</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">2,952,671</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">여비교통비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">630,867</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,447,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">영업활동비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">901,440</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,513,055</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">접대비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">803,908</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,583,635</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">세금과공과</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">128,579</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">236,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">감가상각비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">193,031</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">325,488</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">지급임차료</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">5,493</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">14,757</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">경상연구개발비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">856,348</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">1,512,387</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">운반비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">98,904</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">167,996</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">회의비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">191,882</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">313,867</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">지급수수료</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">262,629</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">538,562</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">광고선전비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">374,373</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">802,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">대손상각비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">23,777</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">263,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">판매수수료</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">601,513</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">542,385</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">무형자산상각비</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">3,772</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">7,641</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">카드수수료</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">337,065</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">620,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" VALIGN="MIDDLE">기타</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">291,398</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">623,274</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">13,787,436</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="RIGHT">23,231,942</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">21. 비용의 성격별 분류&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기 및 전기 비용의 성격별 분류 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="632">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="325" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="187"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">재고자산의 변동</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">(423,425)</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">(1,514,699)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">원재료 사용액</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">2,845,019</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">6,907,428</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">종업원급여</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">7,968,815</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">12,587,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">감가상각비 및 무형자산상각비</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">988,327</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,415,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">지급수수료</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">358,641</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">728,390</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">광고선전비</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">374,373</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">802,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">외주가공비</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">4,448,844</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">6,666,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30" VALIGN="MIDDLE">기   타</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">8,293,405</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">15,065,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30" ALIGN="CENTER">합     계</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">24,853,999</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">42,657,939</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">22. 기타수익 및 기타비용&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기 및 전기 기타수익 및 기타비용의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="637">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="330" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="637">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="637" HEIGHT="30" COLSPAN="3">기타수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   외환차익</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">9,855</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">1,973</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   외화환산이익</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">10</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">2,012</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   유형자산처분이익</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">5,134</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   기타</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">15,504</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">61,536</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">기타수익 계</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">30,503</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">65,521</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="637" HEIGHT="30" COLSPAN="3">기타비용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   외환차손</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">541</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">15,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   외화환산손실</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">3,969</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">475</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   기부금</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">14,000</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">311,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30">   기타</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">3,670</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">3,507</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">기타비용 계</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">22,180</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">330,702</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">23. 금융수익 및 금융원가&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;당기 및 전기 금융손익의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="306"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="315" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="312"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="321" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구          분</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" COLSPAN="3">금융수익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   이자수익</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">245,610</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">791,739</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   당기손익-공정가치 측정 금융자산평가이익</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">422,726</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">198,083</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   당기손익-공정가치 측정 금융자산처분이익</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">49,013</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">1,469</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융수익 계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">717,349</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">991,291</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="3">금융원가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   이자비용</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">148,096</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">367,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   당기손익-공정가치 측정 금융자산평가손실</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">37,892</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">25,596</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30">   당기손익-공정가치 측정 금융자산처분손실</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">32,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융원가 계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">185,988</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">425,392</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">24. 주당손익&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 당기 및 전기 기본주당이익의 계산내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="631">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="315"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="324" HEIGHT="30" ALIGN="RIGHT"> (단위: 원, 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="187"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기 (*)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">당기순이익</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,867,397,657</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">8,038,596,924</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">가중평균유통보통주식수</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">8,792,415주</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">7,755,696주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30">기본주당이익</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">212</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT">1,036</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="631">

<COLGROUP>
<COL WIDTH="34"></COL>
<COL WIDTH="579"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="43" HEIGHT="53" ALIGN="RIGHT">(*) </TD>

<TD WIDTH="588" HEIGHT="53">
<SPAN>전기 중 액면분할로 인하여 기초주식수가 310,000주에서 7,750,000주로 증가하였으며, 전기 가중평균유통보통주식수 계산시 액면분할 후 주식수를 소급 적용하였습니다.</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(2) 희석주당이익 &cr;&cr;희석주당이익은 모든 희석성 잠재적보통주가 보통주로 전환된다고 가정하여 조정한 가중평균 유통보통주식수를 적용하여 산정하고 있으며, 당기 및 전기는 희석화 효과가 없어 산출하지 않았습니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">25. 주식보상비용</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;(1) 회사는 </SPAN>
<SPAN USERMARK="F-GL">임직원에게 주식매입선택권을 부여하였으며, 주요약정사항은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부여일</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2019-11-28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부여주식의 총수</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">232,500주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부여방법</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보통주 신주발행 교부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">행사가격</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">13,548원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가득조건</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부여일로부터 2년 이상 재임 또는 재직</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">행사가능기간</TD>
<TD WIDTH="318" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2021.11.28. ~ 2026.11.27.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 당기 중 주식선택권의 변동내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 주)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기초</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">230,206</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부여</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">취소</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,294)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기말</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">227,912</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 동 주식선택권의 공정가치는 이항모형에 따라 산정되었으며, 모형에 적용된 변수는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="320" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">적용변수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식가격</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">14,286</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">행사가격</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,548</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기대변동성</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20.68%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">무위험이자율</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1.61%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">적용할인율</TD>
<TD WIDTH="320" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6.31%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(4) 당기 중 동 주식선택권과 관련하여 인식된 주식보상비용은 178,800천원입니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">26. 특수관계자</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">(1) 당기말 현재 회사와 거래가 있는 특수관계자는 다음과 같습니다. </SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="397"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="218" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="406" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">특수관계자의 명칭</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="218" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">기타 특수관계자</TD>
<TD WIDTH="406" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">의료법인 석경의료재단</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">(2) 당기 및 전기 중 특수관계자와의 주요 거래내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="205"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="214" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자 명</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입 등</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매입 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">의료법인 석경의료재단</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">3,750</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">7,612</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(3) 당기말 및 전기말  현재 특수관계자와의 주요 채권, 채무내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="704">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="388"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="397" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="703">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계자 명</TH>
<TH COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH COLSPAN="2" WIDTH="268" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타 채무</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여금</TH>
<TH WIDTH="134" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">기타 채무</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ALIGN="CENTER">의료법인 석경의료재단</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">2,311</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">2,365</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="165" HEIGHT="30" ALIGN="CENTER">종 업 원</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">6,135,485</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="135" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">5,629,089</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="134" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(4) 당기 및 전기 중 특수관계자와의 자금거래 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기></TD>
<TD WIDTH="313" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="220"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계자 명</TH>
<TH COLSPAN="2" WIDTH="457" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="228" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="165" HEIGHT="30">종 업 원</TD>
<TD WIDTH="229" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">558,000</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">51,605</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="313" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="156"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="219"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">특수관계자 명</TH>
<TH COLSPAN="2" WIDTH="456" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자금대여 거래</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="228" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">대여</TH>
<TH WIDTH="228" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="165" HEIGHT="30">종 업 원</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,937,189</TD>
<TD WIDTH="228" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,500</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(5) 당기말 현재 회사는 대표이사로부터 차입금 등에 대하여 지급보증을 제공받고 있습니다.&cr;&cr;(6) 당기 및 전기 중 주요 경영진에 대한 보상내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="313" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구      분</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">급      여</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">432,121</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">829,053</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">퇴직급여</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35,918</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,242</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합      계</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">468,039</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">898,295</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;주요 경영진은 회사의 활동계획ㆍ운영ㆍ통제에 대한 중요한 권한과 책임을 가지고 있는 등기이사입니다.</P>
<P USERMARK="F-GL">&cr;</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">27. 영업부문 정보&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) 회사는 기업회계기준서 제1108호 "영업부문"에 따른 보고부문은 의약품 등의 제조 및 도소매 단일부문으로 기업 전체 수준에서의 부문별 정보는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="313" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제품매출</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,209,392</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,349,972</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타매출</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,000</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,232</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합      계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,216,392</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,393,204</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 지역에 대한 정보&cr;&cr;회사의 수익은 전부 국내에서 창출되고 있습니다.&cr;&cr;(3) 주요 고객에 대한 정보&cr;&cr;회사의 제품의 판매 등으로 인한 수익 중 10% 이상을 차지하는 단일 고객은 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">28. 현금흐름표&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(1) 당기 및 전기 중 영업으로부터 창출된 현금의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="668">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="352"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="361" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="669">

<COLGROUP>
<COL WIDTH="331"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="340" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">당기순이익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,867,398</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,038,597</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">손익항목의 조정 :</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    감가상각비</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">984,555</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,407,574</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    무형자산상각비</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,772</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,641</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    퇴직급여</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">448,796</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">849,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    이자비용</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">148,097</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">367,662</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    당기손익-공정가치 측정 금융자산 평가손실</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">37,892</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,596</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    당기손익-공정가치 측정 금융자산 처분손실</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">32,134</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    재고자산평가손실</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">71,882</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">40,469</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    대손상각비</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,777</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">263,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    외화환산손실</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,969</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">475</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    법인세비용</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">34,678</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,997,386</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    이자수익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(245,610)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(791,539)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    당기손익-공정가치 측정 금융자산 평가이익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(422,726)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(198,083)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    당기손익-공정가치 측정 금융자산 처분이익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(49,013)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,469)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    유형자산 처분이익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(5,134)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    외화환산이익</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,012)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    기타</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(143)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,118)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소      계</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,034,782</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,976,695</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">자산부채의 변동 :</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    매출채권</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">69,974</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(648,463)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    미수금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,285)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">79,508</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    선급금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,496</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(6,438)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    선급비용</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,265</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,775</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    재고자산</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,019,252)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,527,151)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    매입채무</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(22,030)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">260,778</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    미지급금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(751,316)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">589,561</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    선수금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">762</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(10,113)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    예수금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,276</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,884</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    예수보증금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(15,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    부가세예수금</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">173,318</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(474,252)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    미지급비용</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">196,481</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">298,874</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    퇴직금의 지급</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(122,275)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(342,293)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    사외적립자산의 납입</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(82,730)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(142,186)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30">    반품충당부채</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(34,106)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13,801)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소   계</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,584,422)</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,941,317)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,317,758</TD>
<TD WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,073,975</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF"></SPAN>
<SPAN USERMARK="F-GL 0X0000FF"> &cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(2) 당기 및 전기 중 현금흐름표에 포함되지 않는 주요 비현금 투자활동거래와 비현금 재무활동거래는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="667">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="351"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="667">

<COLGROUP>
<COL WIDTH="282"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구  분</TH>
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기</TH>
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">대여금의 유동성분류</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,355,185</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">상각후원가측정 금융자산의 유동성 분류</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,488,708</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,704,802</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">투자부동산의 유형자산으로의 대체</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">364,812</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,034,778</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">유형자산 취득 관련 미지급금의 증감</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,580,816)</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,867,865</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">장기차입금 유동성 대체</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="291" VALIGN="MIDDLE" HEIGHT="30">리스자산.부채 설정</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">254,261</TD>
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">911,237</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL 0X0000FF">&cr;</SPAN>
<SPAN USERMARK="F-GL">(3) 재무활동에서 생기는 부채의 조정내용&cr;&cr;재무활동에서 생기는 부채의 조정내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="678">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기></TD>
<TD WIDTH="371" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   초</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증가</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기감소</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,395,865</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,092,003</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,898,752)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,589,116</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">유동성장기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">임대보증금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(33,000)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">618,619</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">263,580</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(152,577)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">729,622</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,547,484</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,755,583</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,084,329)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,218,738</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="676">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="360"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기></SPAN>
</TD>
<TD WIDTH="369" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   초</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증가</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기감소</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기   말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,326,793</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,029,095</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(8,960,023)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,395,865</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">유동성장기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,000,000)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,900,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,900,000)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,600,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">임대보증금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">63,000</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(30,000)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">리스부채</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">444,975</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">467,839</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(294,194)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">618,619</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합   계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,734,768</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,996,934</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(12,184,217)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,547,484</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">29. 우발부채 및 약정사항</SPAN>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) 당기말 현재 금융기관과 체결한 한도거래 약정의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="694">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="378"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="387" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="694">

<COLGROUP>
<COL WIDTH="223"></COL>
<COL WIDTH="222"></COL>
<COL WIDTH="222"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="232" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="231" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="231" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">단기한도대출 외</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">산업은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">12,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운전자금대출</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">KEB하나은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">3,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운전자금대출</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">NH농협은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">1,900,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운전자금대출 외</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">KB국민은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">1,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">회전자금대출</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">1,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="232" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운전자금대출</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">우리은행</TD>
<TD WIDTH="231" HEIGHT="30" ALIGN="RIGHT">500,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 당기말 현재 회사가 타인을 위하여 제공한 지급보증은 없습니다.&cr;&cr;(3) 당기말 현재 회사가 특수관계자를 제외한 타인으로부터 제공받은 지급보증의 내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="714">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="398"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="407" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="715">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증처</TH>
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증내용</TH>
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증(담보)금액</TH>
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증받은자</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">서울보증보험</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">이행보증</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">10,000</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">거래처</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">서울보증보험</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">공탁보증</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">47,440</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">법원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">서을보증보험</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="CENTER">인허가보증</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">11,000</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER">경기도 안성시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="358" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합계</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">68,440</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">30. 재무위험관리&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;(1) 재무위험관리요소&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">회사는 여러 활동으로 인하여 이자율위험, 신용위험 및 유동성위험과 같은 다양한 금융위험에 노출되어 있습니다. 회사의 전반적인 위험관리정책은 금융시장의 예측불가능성에 초점을 맞추고 있으며 재무성과에 잠재적으로 불리할수 있는 효과를 최소화하는데 중점을 두고 있습니다. 위험관리는 이사회에서 승인한 정책에 따라 회사의 관리팀에 의해 이루어지고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;(2) 이자율위험관리&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">이자율 위험은 미래 시장이자율 변동에 따라 예금 또는 차입금 등에서 발생하는 이자수</SPAN>
<SPAN USERMARK="F-GL">익 및 이자비용이 변동될 위험을 뜻하며, 주로 장단기 차입금에서 발생하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL">당기말 현재 다른 변수가 일정하고 차입금에 대한 이자율이 1% 상승 또는 하락할 경우, </SPAN>
<SPAN USERMARK="F-GL">당기 세전이익은 82,446천원 만큼 감소 또는 증가하였을 것입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">(3) 신용위험관리&cr;&cr;신용위험은 거래상대방이 금융상품, 계약 등과 관련하여 의무를 이행하지 않아 재무손실이 발생할 위험입니다. 회사는 영업활동(주로 매출채권)과 투자활동에서 신용위험에 노출되어 있습니다. &cr;</SPAN>
</P>
<P USERMARK="F-GL">회사는 신용거래를 원하는 모든 거래상대방에 대하여 재무상태, 과거 채무불이행 경험 등의 기타 여러 요소를 고려하여 신용평가를 수행함으로써 신용도가 건전한 거래상대방과의 거래만을 수행하고 있으며, 일부 기존 거래처의 신용도가 낮아질 경우에는 개별적인 신용한도 관리정책을 시행하여 집중관리하고 있습니다. 또한, 주기적으로 모든 거래상대방에 대한 신용도를 검토하는 등의 지속적인 관리업무를 수행하여 채권 관련 대손위험에 대한 회사의 노출정도가 중요하지 않은 수준으로 유지될 수 있도록 함으로써 신용위험을 최소화하고 있습니다. </P>
<P USERMARK="F-GL">&cr;또한, 회사는 현금및현금성자산 및 금융기관예치금 등과 관련하여 신용위험에 노출되어 있으며, 신용위험에 대한 최대 노출정도는 해당 금융상품 장부금액과 동일한 금액이 될 것입니다. 한편, 회사는 신용등급이 우수하여 안정성이 보장되는 금융기관과의 거래를 수행함으로써, 현금및현금성자산 및 금융기관예치금 등과 관련된 신용위험에 대한 실질적인 노출정도는 제한적입니다.</P>

<P>
<SPAN USERMARK="F-GL">&cr;당기말 및 전기말 현재 회사의 신용위험에 대한 최대 노출정도는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="641">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="325"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="334" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="642">

<COLGROUP>
<COL WIDTH="257"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="266" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="188" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="188" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" HEIGHT="30" VALIGN="MIDDLE">현금및현금성자산(현금시재 제외)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,489,302</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">25,144,565</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" HEIGHT="30" VALIGN="MIDDLE">매출채권및기타채권(유동 및 비유동)</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,100,946</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">26,579,324</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" HEIGHT="30" VALIGN="MIDDLE">금융자산</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31,153,633</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">25,283,234</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="266" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합    계</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,743,881</TD>
<TD WIDTH="188" HEIGHT="30" ALIGN="RIGHT">77,007,123</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">당기말 과 전기말 매출채권 및 유동자산으로 분류된 기타채권의 연령별 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="679">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="31" USERMARK="F-12"><당기말></TD>
<TD WIDTH="372" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정상채권</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">7~12개월</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합    계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">매출채권(*)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,229,978</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,956,832</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,763,795</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,950,605</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">기타채권</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  단기대여금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,135,485</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,135,485</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  미수수익</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,747</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">78,747</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  미수금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,825</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,825</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,447,035</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,956,832</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,763,795</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,167,662</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="676" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="28"></COL>
<COL WIDTH="630"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="37" HEIGHT="55" ALIGN="RIGHT">(*) </TD>

<TD WIDTH="639" HEIGHT="55">
<SPAN>연체되었으나 손상되지 않은 채권은 최근 부도기록이 없는 여러 독립된 거래처들과 관련되어 있으며, </SPAN>
<SPAN>당기말 현</SPAN>
<SPAN>재 421,603</SPAN>
<SPAN>천원의 대손충당금을 설정하</SPAN>
<SPAN>고 있습니다.</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL"> </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="678">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="362"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="307" HEIGHT="31">
<SPAN USERMARK="F-12"><전기말></SPAN>
</TD>
<TD WIDTH="371" HEIGHT="31" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="677">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="123"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정상채권</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">7~12개월</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">12개월 초과</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합    계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">매출채권</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,453,655</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,093,984</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,529,863</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,077,502</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">기타채권</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  단기대여금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,261,900</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,261,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  미수수익</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">79,346</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">79,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE">  미수금</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,540</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,540</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합   계</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,796,441</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,093,984</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,529,863</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,420,288</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="679">

<COLGROUP>
<COL WIDTH="28"></COL>
<COL WIDTH="633"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="37" HEIGHT="55" ALIGN="RIGHT">(*) </TD>

<TD WIDTH="642" HEIGHT="55">
<SPAN>연체되었으나 손상되지 않은 채권은 최근 부도기록이 없는 여러 독립된 거래처들과 관련되어 있으며, </SPAN>
<SPAN>전기말 현재 327,011천원의 대손충당금을 설정하고 있습니다.</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">당기말과 전기말 현재 손상된 채권의 내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="665">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="349"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="358" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="669">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">매출채권(*)</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,291,533</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,202,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합      계</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,291,533</TD>
<TD WIDTH="223" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,202,585</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="668">

<COLGROUP>
<COL WIDTH="28"></COL>
<COL WIDTH="622"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="37" HEIGHT="55">(*)</TD>
<TD WIDTH="631" HEIGHT="55">당기말과 전기말 현재 각각 1,121,044천원 및 1,164,305천원의 대손충당금을 설정하고 있습니다.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL">당기와 전기 중 매출채권 대손충당금 변동내역은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="671">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="355"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="364" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="673">

<COLGROUP>
<COL WIDTH="216"></COL>
<COL WIDTH="215"></COL>
<COL WIDTH="215"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="225" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="224" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기초</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,575,795</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,393,776</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대손</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">23,777</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">263,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">제각</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(56,924)</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(81,302)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기말</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,542,648</TD>
<TD WIDTH="224" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,575,795</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;(4) 유동성위험관리&cr;&cr;유동성위험은 충분한 자금을 조달하지 못하여 경영성과 또는 현금흐름에 영향을 받게 되는 것을 의미합니다. 회사는 조달하는 자금의 만기를 분산시켜 유동성 위험을 감소시키고 있습니다.&cr;</P>

<P>
<SPAN USERMARK="F-GL">당기말 현재 금융부채의 연도별 상환계획은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="777">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="461"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="470" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="778">

<COLGROUP>
<COL WIDTH="174"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="139"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 미만</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년에서 3년 이하</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합     계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">매입채무및기타채무</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">5,829,348</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">5,829,348</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30" VALIGN="MIDDLE">차입금(유동 및 비유동)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">12,489,116</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">4,000,000</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">16,489,116</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;상기 현금흐름은 현재가치 할인을 하지 않은 금액이며, 이자비용의 현금흐름을 포함한 금액입니다.&cr;</P>
<P USERMARK="F-GL">(5) 자본위험관리&cr;&cr;회사의 자본관리 목적은 계속기업으로서 주주 및 이해당사자들에게 이익을 지속적으로 제공할 수 있는 능력을 보호하고 자본비용을 절감하기 위해 최적 자본구조를 유지하기 위함입니다.</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">당사는 자본관리지표로 부채비율을 이용하고 있으며 이 비율은 총부채에서 현금및현금성자산을 차감한 순부채를 총자본으로나누어 산출하고 있으며 당기말 및 전기말 현재 부채비율은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="686">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="370"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="379" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="687">

<COLGROUP>
<COL WIDTH="220"></COL>
<COL WIDTH="220"></COL>
<COL WIDTH="220"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="229" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" VALIGN="MIDDLE">총부채(A)</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,302,921</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">30,253,291</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" VALIGN="MIDDLE">차감: 현금및현금성자산(B)</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,490,449</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">25,146,077</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" VALIGN="MIDDLE">순부채(C = A - B)</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,812,472</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">5,107,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" VALIGN="MIDDLE">자본총계(D)</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">76,877,098</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">76,759,470</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="229" HEIGHT="30" VALIGN="MIDDLE">부채비율(C / D)</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17.97%</TD>
<TD WIDTH="229" HEIGHT="30" ALIGN="RIGHT">6.65%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<P USERMARK="F-GL B">31. 사업연도변경</P>
<P USERMARK="F-GL">&cr;당사는 2020년 9월 25일자 정기주주총회에서 사업연도를 변경하였습니다. 변경 후 최초적용 사업연도는 2020년 7월 1일부터 2020년 12월 31일까지이며, 이후 사업연도는 매년 1월 1일에 개시하여 12월 31일에 종료합니다.</P>
<P USERMARK="F-GL">&cr;</P>
</SECTION-2>
</LIBRARY>
</INSERTION>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 재무제표 재작성 등 유의사항&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) (연결)재무제표를 재작성한 경우 재작성 사유&cr;"해당사항 없음"&cr;&cr;(2) 합병, 분할, 자산양수도, 영업양수도&cr;"해당사항 없음"&cr;&cr;(3) 자산유동화와 관련한 자산매각의 회계처리 및 우발채무 등에 관한 사항&cr;"해당사항 없음"&cr;&cr;(4) 기타 재무제표 이용에 유의하여야 할 사항&cr;"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 대손충당금 현황  &cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">(1) 계정과목별 대손충당금 설정내용        </SPAN>
</P>

<TABLE WIDTH="608" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="608" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="73"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>구 분</P>
</TH>

<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>계정과목</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>채권금액</P>
</TH>

<TH WIDTH="140" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>대손충당금 </P>
</TH>

<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>대손충당금</P>
<P>설정률</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>제17기</P>
</TD>
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        21,950,605 </TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,542,648) </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.03%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 미수금</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                2,824 </TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">                 - </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">        21,953,429 </TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,542,648) </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.03%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>제16기</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 매출채권</P>
</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       22,077,503</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,575,795)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.14%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 미수금</P>
</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">               1,540</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">0.00%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">       22,079,043</TD>
<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,575,795)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7.14%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>제15기</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 매출채권</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>21,510,341</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(1,393,776)</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6.48%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 미수금</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P> 262,293</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P> (180,405)</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>    68.78%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>21,772,634</P>
</TD>

<TD WIDTH="140" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(1,574,181)</P>
</TD>

<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7.23%</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="608" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="608" VALIGN="MIDDLE" HEIGHT="53">주) 제15기 회계연도부터 미수금 계정과목으로 분류하였던 카드사의 판매대금 미회수분 을 매출채권 계정과목으로 재분류하였습니다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> &cr;(2)  대손충당금 변동현황</P>

<TABLE WIDTH="611" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="602"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="611" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30"> (단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="266"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="275" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기</TH>

<TH WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>1. 기초 대손충당금 잔액합계</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">      1,575,795 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,393,776 </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P> 1,323,721</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>2. 순대손처리액(①-②±③)</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(56,924) </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(81,302) </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(137,638)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ① 대손처리액(상각채권액)</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(56,924) </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(81,302)</TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(137,638)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ② 상각채권회수액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>  ③ 기타증감액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">- </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>3. 대손상각비 계상(환입)액</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">23,777 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">263,321 </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P> 207,693</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="275" VALIGN="MIDDLE" HEIGHT="30">
<P>4. 기말 대손충당금 잔액합계</P>
</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,542,648 </TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,575,795 </TD>

<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,393,776</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;(3) 매출채권 관련 대손충당금 설정방침&cr;1) 당사는 매 결산 시 채권의 회수가 불확실한 부분에 대하여 과거 3개년 채권의 연령 분석 및 경험률에 근거하여 대손충당금을 설정하고 있습니다.&cr;     &cr;2) 채무자의 부도, 폐업 등으로 손상발생의 증거가 명백해지는 경우 개별평가를 통하여 충당금을 설정하고 있습니다. 또한 개인회생 등 채권 회수 예상이 가능한 손상채권의 경우 예상 변제금액을 고려하여 손상차손을 인식하며 담보가 있는 손상채권은 담보 종류와 금액을 고려하여 손상차손을 인식하고 있습니다.</P>
<P USERMARK="F-GL">&cr;(4) 당분기말 현재 경과기간별 매출채권 잔액 현황</P>

<TABLE WIDTH="608" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="608" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="32"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>6월 이하</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>6월 초과</P>
<P>1년 이하</P>
</TH>

<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>1년 초과</P>
<P>3년 이하</P>
</TH>

<TH WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>3년 초과</P>
</TH>

<TH WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="41" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90">
<P>금액</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>일반</P>
</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,229,978</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,956,832 </TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  544,993 </TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,218,802 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  21,950,605 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>특수관계자</P>
</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">- </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>계</P>
</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,229,978</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,956,832 </TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  544,993 </TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  1,218,802 </TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">  21,950,605 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>구성비율</P>
</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83.05%</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8.91%</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.48%</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.55%</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">100.00%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다.  재고자산 현황&cr;</SPAN>
<SPAN USERMARK="F-GL">(1) 재고자산의 사업부문별 보유현황</SPAN>
</P>

<TABLE WIDTH="704" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="695"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="704" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(단위 : 천원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="704" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>사업부문 </P>
</TH>

<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>계정과목</P>
</TH>
<TH WIDTH="114" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제17기</TH>

<TH WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">

<P>
<SPAN>  </SPAN>
<SPAN>제16기</SPAN>
</P>
</TH>

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기</P>
</TH>

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="7" WIDTH="190" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="210">
<P> 의약품 제조</P>
</TD>

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,681,723 </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,405,891</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3,171,547</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>제품평가충당금</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(66,336) </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(44,176)</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(18,556)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>원재료</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,207,747 </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,612,608 </TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,600,155</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재공품</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,169,553 </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,021,960 </TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>741,605</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>재공품평가충당금</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(71,522) </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(21,800)</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>(6,950)</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">미착품</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">687</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>소    계</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,921,852 </TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,974,483 </TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5,487,801</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="328" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>총자산대비 재고자산 구성비율(%)</P>
<P>[재고자산합계÷기말자산총계×100]</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">7.46%</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">6.52%</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>7.2％</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="328" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>재고자산회전율(회수)</P>
<P>[연환산 매출원가÷{(기초재고+기말재고)÷2}]</P>
</TD>
<TD WIDTH="114" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.0회</TD>
<TD WIDTH="100" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3.1회</TD>

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">
<P>3.4회</P>
</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;(2) 재고자산의 실사내용</P>

<TABLE BORDER="1" WIDTH="612" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="308"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>일자</P>
</TH>

<TH WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내용</P>
</TH>

<TH WIDTH="317" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>실사방법</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">
<P>2019.06.29</P>
</TD>

<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30">
<P>제15기 기말 재고자산 실사</P>
</TD>

<TD WIDTH="317" ALIGN="CENTER" HEIGHT="30">
<P>삼일회계법인의 입회하에 재고조사 실시</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">2020.07.01</TD>
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30">제16기 기말 재고자산 실사</TD>
<TD WIDTH="317" ALIGN="CENTER" HEIGHT="30">대현회계법인의 입회하에 재고조사 실시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" ALIGN="CENTER" HEIGHT="30">2020.12.30</TD>
<TD WIDTH="201" ALIGN="CENTER" HEIGHT="30">제17기 기말 재고자산 실사</TD>
<TD WIDTH="317" ALIGN="CENTER" HEIGHT="30">대현회계법인의 입회하에 재고조사 실시</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;(3) 재고자산의 담보제공&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 수주계약 현황&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">마. 금융자산 공정가치 평가내역&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">(1) </SPAN>
<SPAN USERMARK="F-GL B">금융자산&cr;</SPAN>
</P>
<P USERMARK="F-GL">1) 분류</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 다음의 측정 범주로 금융자산을 분류합니다.</P>
<P USERMARK="F-GL">- 당기손익-공정가치 측정 금융자산</P>
<P USERMARK="F-GL">- 기타포괄손익-공정가치 금융자산</P>
<P USERMARK="F-GL">- 상각후원가 측정 금융자산</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">금융자산은 금융자산의 관리를 위한 사업모형과 금융자산의 계약상 현금흐름 특성에근거하여 분류합니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">공정가치로 측정하는 금융자산의 손익은 당기손익 또는 기타포괄손익으로 인식합니다. 채무상품에 대한 투자는 해당 자산을 보유하는 사업모형에 따라 그 평가손익을 당기손익 또는 기타포괄손익으로 인식합니다. 회사는 금융자산을 관리하는 사업모형을 변경하는 경우에만 채무상품을 재분류합니다. </P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">단기매매항목이 아닌 지분상품에 대한 투자는 최초 인식시점에 후속적인 공정가치 변동을 기타포괄손익으로 표시할 것을 지정하는 취소불가능한 선택을 할 수 있습니다. 지정되지 않은 지분상품에 대한 투자의 공정가치 변동은 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">2) 측정</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 최초 인식시점에 금융자산을 공정가치로 측정하며, 당기손익-공정가치 측정 금융자산이 아닌 경우에 해당 금융자산의 취득과 직접 관련되는 거래원가는 공정가치에 가산합니다. 당기손익-공정가치 측정 금융자산의 거래원가는 당기손익으로 비용처리합니다. </P>
<P USERMARK="F-GL">&cr;내재파생상품을 포함하는 복합계약은 계약상 현금흐름이 원금과 이자로만 구성되어 있는지를 결정할 때 해당 복합계약 전체를 고려합니다.</P>
<P USERMARK="F-GL">&cr;① 채무상품&cr;</P>

<P>
<SPAN USERMARK="F-GL">금융자산의 후속적인 측정은 금융자산의 계약상 현금흐름 특성과 그 금융자산을 관리하는 사업모형에 근거합니다. 회사는 채무상품을 다음의 세 범주로 분류합니다.&cr; &cr; (가) 상각후원가&cr; 계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 자산은 상각후원가로 측정합니다. 상각후원가로 측정하는 금융자산으로서 위험회피관계의 적용 대상이 아닌 금융자산의 손익은 해당 금융자산을 제거하거나 손상할 때 당기손익으로 인식합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익</SPAN>
<SPAN USERMARK="F-GL">은</SPAN>
<SPAN USERMARK="F-GL"> '금융수익'</SPAN>
<SPAN USERMARK="F-GL">에 </SPAN>
<SPAN USERMARK="F-GL">포함됩니다.&cr; &cr; (나) 기타포괄손익-공정가치 측정 금융자산&cr; 계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고, 계약상 현금흐름이 원리금만으로 구성되어 있는 금융자산은 기타포괄손익-공정가치로 측정합니다. 손상차손(환입)과 이자수익 및 외환손익을 제외하고는, 공정가치로 측정하는 금융자산의 평가손익은 기타포괄손익으로 인식합니다. 금융자산을 제거할 때에는 인식한 기타포괄손익누계액을 자본에서 당기손익으로 재분류</SPAN>
<SPAN USERMARK="F-GL">합니다. 유효이자율법에 따라 인식하는 금융자산의 이자수익은  </SPAN>
<SPAN USERMARK="F-GL">'금융수익'</SPAN>
<SPAN USERMARK="F-GL">에</SPAN>
<SPAN USERMARK="F-GL"> 포</SPAN>
<SPAN USERMARK="F-GL">함됩니다. 외환손익은 </SPAN>
<SPAN USERMARK="F-GL">'기타수익 또는 기타비용</SPAN>
<SPAN USERMARK="F-GL">'으로 표시하고 손상차손은 '기타 비용'으로 표시합니다.&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr; (다) 당기손익-공정가치측정 금융자산&cr; 상각후원가 측정이</SPAN>
<SPAN USERMARK="F-GL">나 기타포괄손익-공정가치 측정 금융자산이 아닌 채무상품은 당기손익-공정가치로 측정됩니다. 위험회피관계가 적용되지 않는 당기손익-공정가치 측정 채무상품의 손익은 당기손익으로 인식하고 발생한 기간에 손익계산서에</SPAN>
<SPAN USERMARK="F-GL"> '금융수익 또는 금융비용'</SPAN>
<SPAN USERMARK="F-GL">으로 </SPAN>
<SPAN USERMARK="F-GL">표시합니다.&cr;</SPAN>
</P>
<P USERMARK="F-GL">② 지분상품</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">회사는 모든 지분상품에 대한 투자를 후속적으로 공정가치로 측정합니다. 공정가치 변동을 기타포괄손익으로 표시할 것을 선택한 장기적 투자목적 또는 전략적 투자목적의 지분상품에 대해 기타포괄손익으로 인식한 금액은 해당 지분상품을 제거할 때에도 당기손익으로 재분류하지 않습니다. 이러한 지분상품에 대한 배당수익은 회사가 배당을 받을 권리가 확정된 때</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"> '금융수익'</SPAN>
<SPAN USERMARK="F-GL">으로 당기손익</SPAN>
<SPAN USERMARK="F-GL">으로 인식합니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">당기손익-공정</SPAN>
<SPAN USERMARK="F-GL">가치로 측정하는 금융자산의 공정가치 변동은 손익계산서에 '</SPAN>
<SPAN USERMARK="F-GL">금융수익 또는 금융비용'</SPAN>
<SPAN USERMARK="F-GL">으로 표시합니다.  기타포괄손익-공정가치로 측정하는 지분상품에 대한 손상차손(환입)은</SPAN>
<SPAN USERMARK="F-GL"> 별도로 구분하여 인식하지 않습니다.&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL">3) 손상 </SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사는 미래전망정보에 근거하여 상각후원가로 측정하거나 기타포괄손익-공정가치로 측정하는 채무상품에 대한 기대신용손실을 평가합니다. 손상 방식은 신용위험의 유의적인 증가 여부에 따라 결정됩니다. 단, 매출채권에 대해 회사는 채권의 최초 인식시점부터 전체기간 기대신용손실을 인식하는 간편법을 적용합니다.&cr;</P>
<P USERMARK="F-GL">4) 인식과 제거</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">금융자산의 정형화된 매입 또는 매도는 매매일에 인식하거나 제거합니다. 금융자산은 현금흐름에 대한 계약상 권리가 소멸하거나 금융자산을 양도하고 소유에 따른 위험과 보상의 대부분을 이전한 경우에 제거됩니다.</P>

<P>
<SPAN USERMARK="F-GL">&cr;회사가 금융자산을 양도한 경우라도 채무자의 채무불이행시의 소구권 등으로 양도한금융자산의 소유에 따른 위험과 보상의 대부분을 회사가 보유하는 경우에는 이를 제거하지 않고 그 양도자산 전체를 계속하여 인식하되, 수취한 대가를 '금융부채'로 인식합니다. </SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
</P>
<P USERMARK="F-GL">&cr;5) 금융상품의 상계&cr;</P>
<P USERMARK="F-GL">금융자산과 부채는 인식한 자산과 부채에 대해 법적으로 집행가능한 상계권리를 현재 보유하고 있고, 순액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할 의도를 가지고 있을 때 상계하여 재무상태표에 순액으로 표시합니다. 법적으로 집행가능한 상계권리는 미래사건에 좌우되지 않으며, 정상적인 사업과정의 경우와 채무불이행의 경우 및 지급불능이나 파산의 경우에도 집행가능한 것을 의미합니다.</P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">(2) </SPAN>
<SPAN USERMARK="F-GL B">금융부채&cr;</SPAN>
</P>
<P USERMARK="F-GL">1)  분류 및 측정</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">회사의 당기손익-공정가치 측정 금융부채는 단기매매목적의 금융상품입니다. 주로 단기간 내에 재매입할 목적으로 부담하는 금융부채는 단기매매금융부채로 분류됩니다. 또한, 위험회피회계의 수단으로 지정되지 않은 파생상품이나 금융상품으로부터 분리된 내재파생상품도 단기매매금융부채로 분류됩니다.</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">당기손익-공정가치 측정 금융부채, 금융보증계약, 금융자산의 양도가 제거조건을 충족하지 못하는 경우에 발생하는 금융부채를 제외한 모든 비파생금융부채는 상각후원가로 측정하는 금융부채로 분류되고 있으며, 재무상태표 상 </SPAN>
<SPAN USERMARK="F-GL">'</SPAN>
<SPAN USERMARK="F-GL">매입채무' 및 '차입금' </SPAN>
<SPAN USERMARK="F-GL"> 등으로 표시됩니다. </SPAN>
</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">특정일에 의무적으로 상환해야 하는 우선주는 부채로 분류됩니다. 이러한 우선주에 대한 유효이자율법에 따른 이자비용은 다른 금융부채에서 인식한 이자비용과 함께 손익계산서 상</SPAN>
<SPAN USERMARK="F-GL"> '금융비용'으</SPAN>
<SPAN USERMARK="F-GL">로 인식됩니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">2)  제거</P>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL">금융부채는 계약상 의무가 이행, 취소 또는 만료되어 소멸되거나 기존 금융부채의 조건이 실질적으로 변경된 경우에 재무상태표에서 제거됩니다. 소멸하거나 제3자에게 양도한 금융부채의 장부금액과 지급한 대가(양도한 비현금자산이나 부담한 부채를 포함)의 차액은 당기손익으로 인식합니다.&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">(3) 공정가치&cr;</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">1) 당기말 및 전기말 현재 공정가치 측정 금융자산의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 17(당) 기 기말</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 16(전) 기 기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">채무상품 등</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT"> 20,265,345</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">지분상품 등</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT"> 2,500,012</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;2) 당기 및 전기의 공정가치 측정 금융자산의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="309"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="318" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구      분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 17(당) 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 16(전) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기초금액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">22,410,989</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  회계정책의 변경</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">                - </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  취득</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">15,115,677 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">25,534,311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  처분</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">(11,623,139 )</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">(29,229,802)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">  공정가치평가</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">         384,834 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">172,487</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">기말금액</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">22,765,357 </TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">18,887,985</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;3) 공정가치 서열체계&cr;</P>
<P USERMARK="F-GL">① 금융자산과 금융부채의 공정가치를 결정하는데 사용한 가정&cr;&cr;표준화된 거래조건과 활성화된 거래시장이 존재하는 금융상품의 공정가치는 시장가격을 이용하여 결정되었고, 활성화된 거래시장에서 거래되지 않는 금융상품은 시장참가자들에 의해 일반적으로 사용되는 평가기법 또는 경영자의 판단을 사용하여 공정가치를 측정하고 있습니다.&cr;</P>
<P USERMARK="F-GL">② 공정가치 서열체계&cr;</P>
<P USERMARK="F-GL">공정가치로 측정되는 금융상품은 공정가치 서열체계에 따라 구분되며 정의된 수준들은 다음과 같습니다.&cr;</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="17"></COL>
<COL WIDTH="565"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="53" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="53">측정일에 동일한 자산이나 부채에 대해 접근할 수 있는 활성시장의 (조정하지 않은) 공시가격 (수준 1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="53" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="53">수준 1의 공시가격 외에 자산이나 부채에 대해 직접적으로나 간접적으로 관측할 수 있는 투입변수 (수준 2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="30" ALIGN="RIGHT">- </TD>
<TD WIDTH="574" HEIGHT="30">자산이나 부채에 대한 관측할 수 없는 투입변수 (수준 3)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="695">

<COLGROUP>
<COL WIDTH="298"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="307" HEIGHT="30"></TD>
<TD WIDTH="388" HEIGHT="30" ALIGN="RIGHT"> (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="181"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 1</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 2</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준 3</TH>
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합  계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="695" HEIGHT="30" COLSPAN="5">제 17(당) 기 기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="53"> 당기손익-공정가치 측정&cr; 금융자산</TD>
<TD WIDTH="127" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">20,265,345</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,500,012</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">22,765,357</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="695" HEIGHT="30" COLSPAN="5">제 16(전) 기 기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="190" HEIGHT="53"> 당기손익-공정가치 측정&cr; 금융자산</TD>
<TD WIDTH="127" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">18,887,985</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">18,887,984</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B">바. 채무증권 발행 실적&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE2" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『진행률적용 수주계약 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*진행률적용수주계약현황*.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK=" B">(1) 채무증권 발행실적</P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="747" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="445"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="454" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="1">(단위 : 원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="748" BORDER="1">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="67"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="69" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="80" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급&cr;(평가기관)</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="68" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환&cr;여부</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_CMPY">-</TE>
<TU WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_KNN" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_STC" AUNITVALUE="-">-</TU>
<TU WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_DAT" AUNITVALUE="-">-</TU>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MON">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATE">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="BSS_PIS_LAS" AUNITVALUE="-">-</TU>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_REC">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">-</TE>
<TE WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK=" B">(2) 사채관리계약 주요내용 및 충족여부</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆ 『사채관리계약 주요내용 및 충족여부 등』 삽입</COMMENT>
<LIBRARYLIST>11011#*사채관리계약주요내용.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK=" B">(3) 기업어음증권 미상환 잔액</P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">(4) 전자단기사채 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과&cr;30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과&cr;90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과&cr;180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과&cr;1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">(5) 회사채 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B">(6)신종자본증권 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과&cr;20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">(7) 조건부자본증권 미상환 잔액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과&cr;2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과&cr;3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과&cr;4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과&cr;5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과&cr;10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과&cr;20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과&cr;30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN USERMARK=" B">사. 기업인수목적회사의 재무규제 및 비용 등&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>&cr;
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>
<P USERMARK="F-GL B">1. 예측정보에 대한 주의사항</P>
<P USERMARK="F-GL">당사가 동 사업보고서에서 기재한 예측은 당해 공시서류 작성시점의 재무성과에 대한 당사의 의견을 반영한 것입니다. 동 예측정보는 미래의 경영환경과 관련된 여러 가정에 근거하고 있으며 이러한 가정들은 결과적으로 부정확한 것으로 판명될 수 도 있습니다. 이러한 중요한 차이를 초래 할 수 있는 요인에는 회사 경영성과 등 내부 환경에 관련된 요인과 외부환경에 관한 요인 및 기타요인이 포함되어 있습니다. 회사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 동 보고서에 기재된 예측 정보는 동 보고서 작성시점을 기준으로 작성한 것이며, 회사가 이러한 위험요인이나 예측 정보를 수정할 예정이 없음을 유의하시기 바랍니다.</P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL B">2. 개요</P>
<P USERMARK="F-GL">당사는 제네릭 의약품의 연구 개발로 고지혈증치료제인 '아토렌정' 혈압강하제인 '미르토정'과 '브이디핀정', 중추신경용제인 '위더페질정', 항생제인 '위더스세파클러캡슐' 등 전문의약품을 출시하고 있으며 전문의약품 판매가 매출의 대부분을 차지하고 있습니다. </P>
<P USERMARK="F-GL">또한, 회사는 전문의약품 생산에 필수적인 생물학적 동등성 임상 시험과 생산 시설의 R&D 투자를 더욱 확대하여 전문의약품의 전문성을 강화하고 있습니다. </P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL B">3. 영업실적 및 재무상태</P>
<P USERMARK="F-GL">(1) 영업실적 </P>
<P USERMARK="F-GL">당사의 제17(당)기 매출액은 26,216백만원으로서 전기 대비 약 49.96%(26,177백만원) 감소하였으나, 사업연도 변경으로 인하여 6개월 간의 성과만 반영된 결과입니다. 코로나 19사태로 전 세계적인 실물경제 침체 상황이지만 당사의 강점인 노인성 질환 약품군의 지속적인 매출과 안정적인 CMO 사업부문으로 매출에 큰 영향은 없었습니다.</P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL">한편, 제17(당)기 영업이익은1,362백만원으로 전기 대비 약86.19%(8,373백만원) 감소하였고, 당기순이익은1,867백만원으로 전기 대비 약76.56%(6,172백만원) 감소하였으나, 이는 사업연도 변경으로 인하여6개월의 성과만이 반영되고 사세확장 및 시설 투자 증가에 따른 영향입니다.</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">  </P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="600" HEIGHT="30">(단위:백만원, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD COLSPAN="2" WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제 17 기</P>
</TD>

<TD COLSPAN="2" WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제 16 기</P>
</TD>

<TD ROWSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">
<P>전기 대비 증감률</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>금액</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구성비</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>금액</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구성비 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매출액</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>26,216</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>100.0</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>52,393</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>100.0</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-49.96%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매출총이익</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,150</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>57.8</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>32,967</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>62.9</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-54.04%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>영업이익</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,362</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5.2</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>9,735</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18.6</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-86.01%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>법인세차감전순이익</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,902</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7.3</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,039</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>19.2</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-81.05%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당기순이익</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,867</P>
</TD>

<TD WIDTH="68" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7.1</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,039</P>
</TD>

<TD WIDTH="74" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15.3</P>
</TD>

<TD WIDTH="141" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-76.78%</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL">(2) 재무상태</P>
<P USERMARK="F-GL">제 17(당)기 (2020년 12월말) 당사의 자산총계는 833백만원이 감소한 106,180백만원으로 전기 대비 다소 감소하였습니다. 부채총계는 950백만원 감소하였으며 자본총계는 117백만원 증가하였습니다.</P>
<P USERMARK="F-GL"> </P>
<P USERMARK="F-GL">(단위 : 백만원,%) </P>

<TABLE BORDER="1" WIDTH="560" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구 분</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제17기</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제16기</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증감액</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증감율</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[유동자산]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>74,015</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>73,529</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>486</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0.66%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ당좌자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>66,093</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>66,555</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-462</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-0.69%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ재고자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,922</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,974</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>948</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>13.59%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[비유동자산]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>32,165</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>33,483</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-1,318</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-3.94%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ투자자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7,685</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,490</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-2,805</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-26.74%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ유형자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>20,071</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>19,383</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>688</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>3.55%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ무형자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,950</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,975</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>975</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>49.37%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>ㆍ기타비유동자산</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,459</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,634</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-175</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-10.71%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>자산총계</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>106,180</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>107,013</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-833</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-0.78%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[유동부채]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>20,349</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>24,161</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-3,812</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-15.78%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[비유동부채] </P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8,954</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>6,092</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,862</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>46.98%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>부채총계</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>29,303</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>30,253</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-952</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-3.15%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본금]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,758</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,758</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본잉여금]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,846</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,846</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[자본조정] </P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>393</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>215</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>178</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>82.79%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>[이익잉여금]</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>58,879</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>58,941</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-62</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-0.11%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="146" VALIGN="MIDDLE" HEIGHT="30">
<P>자본총계</P>
</TD>

<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>76,877</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>76,760</P>
</TD>

<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>117</P>
</TD>

<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>0.15%</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL B">4. 유동성에 관한 분석</P>
<P USERMARK="F-GL B">  </P>
<P USERMARK="F-GL">(단위 : 백만원,%) </P>

<TABLE BORDER="1" WIDTH="561" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제17기</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제16기</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증감액</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>증감율</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>현금및현금성자산</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15,490</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>25,146</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-9,656</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-38.40%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>단기투자자산</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>23,944</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>19,528</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>4,416</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>22,61%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>단기차입금</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>10,589</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>11,396</P>
</TD>

<TD WIDTH="116" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-807</P>
</TD>

<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>-7.08%</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">당사의 단기차입금은 회사의 일반 운영 자금과 관련된 일반자금 대출입니다. 회사 자금의 유동성에는 문제가 없으며 단기차입금은 단기적으로 운영하여 상환할 예정입니다.</P>
<P USERMARK="F-GL">    ※ 주요재무비율</P>

<TABLE BORDER="1" WIDTH="556" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>산식</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제17기</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>제16기</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>총자본이익율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당기순이익/총자본×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1.75%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>8.77%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>자기자본이익율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당기순이익/자기자본×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2.43%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>12.44%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매출액영업이익율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>영업이익/매출액×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>5.20%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>18.58%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매출액순이익율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>당기순이익/매출액×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>7.12%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15.34%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>유 동 비 율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>유동자산/유동부채×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>363.72%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>304.33%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>부 채 비 율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>부채총계/자기자본×100 </P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>38.12%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>39.41%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>차입금의존도</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>차입금/총자산×100</P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>15.53%</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>13.92%</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이자보상비율</P>
</TD>

<TD WIDTH="213" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>영업이익/이자비용×100 </P>
</TD>

<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>920배</P>
</TD>

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>2,647.88배</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">주1) 총자본 및 자기자본이익율 산출시 자본금액은 기초와 기말잔액의 평균치입니다.</P>
<P USERMARK="F-GL">주 2) 사업연도 변경으로 인하여 17기 사업연도는 2020.07.01부터 2020.12.31까지로 &cr;6개월입니다.</P>
<P USERMARK="F-GL">    </P>
<P USERMARK="F-GL B">5. 부외 부채에 관한 사항</P>
<P USERMARK="F-GL">"해당사항 없음"</P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL">  </P>
<P USERMARK="F-GL B">6. 그 밖의 투자결정에 필요한 사항</P>
<P USERMARK="F-GL">"해당사항 없음"</P>
<P USERMARK="F-GL"> </P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 감사인의 감사의견 등</TITLE>
<P></P>
<WARNING>※ 회계감사인의 감사(검토)의견, 회계감사인과의 감사/비감사 용역 체결현황이 있을 경우&cr;    아래 『회계감사인의 감사의견』단위서식을 클릭하여 삽입하신 후 입력하세요.</WARNING>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『회계감사인의 감사의견』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인의감사의견.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">25_회계감사인의감사의견</FILENAME>
<P USERMARK="F-GL B">1. 회계감사인의 명칭 및 감사(검토)의견</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="140"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="112" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">대현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">대현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="149" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">해당사항 없음</TE>
<TE ALIGN="CENTER" WIDTH="112" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">2. 감사용역 체결현황</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="598" BORDER="1">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="121" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">대현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE"> 연간 재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">63</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">672</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">63</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">672</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR2" VALIGN="MIDDLE">대현회계법인</TE>
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="SIGK_CNT2" VALIGN="MIDDLE"> 연간 재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">90</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">967</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">90</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">967</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="121" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">삼일회계법인</TE>
<TE ALIGN="CENTER" WIDTH="153" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE"> 연간 재무제표 감사</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">140</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">964</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">140</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">964</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">3. 회계감사인과의 비감사용역 계약체결 현황</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제17기(당기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제16기(전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제15기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL"></P>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『내부감사기구가 회계감사인과 논의한 결과』 삽입</COMMENT>
<LIBRARYLIST>11011#*회계감사인과논의한결과.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">46_회계감사인과논의한결과</FILENAME>
<P USERMARK="F-GL B">4. 내부감사기구가 회계감사인과 논의 결과</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="992" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="209"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="502"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="218" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="511" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="99" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="DIS_DATE" AUNITVALUE="20201120" VALIGN="MIDDLE">2020년 11월 20일</TU>
<TE WIDTH="218" HEIGHT="99" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 감사, 회계팀장&cr;감사인: 담당이사, 담당회계사</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE WIDTH="511" HEIGHT="99" ACODE="DIS_CONT" VALIGN="MIDDLE">- 재무제표 감사와 관련된 감사인의 책임&cr;- 감사인의 독립성&cr;- 계획된 감사범위, 시기의 개요&cr;- 중요한 왜곡표시위험에 대한 지배기구의 견해</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="76" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="DIS_DATE" AUNITVALUE="20210219" VALIGN="MIDDLE">2021년 02월 19일</TU>
<TE WIDTH="218" HEIGHT="76" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 감사, 회계팀장&cr;감사인: 담당이사, 담당회계사</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="DIS_WAY" VALIGN="MIDDLE">대면회의</TE>
<TE WIDTH="511" HEIGHT="76" ACODE="DIS_CONT" VALIGN="MIDDLE">-감사 중에 식별된 유의적 내부통제 미비점&cr;- 회사의 회계정책과 회계추정 및 재무제표 공시 등에 개한 감사인의 견해&cr;- 핵심 감사사항 감사결과와 경영진과 논의한 사항</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>&cr;</P>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">5. 내부회계관리제도&cr;</SPAN>감사인은 2020년 12월 31일 현재의 내부회게관리제도의 운영실태평가보고서를 검토하였으며, 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였다는 의견을 표명하였습니다.
</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『조정협의회내용 및 재무제표 불일치정보』 삽입</COMMENT>
<LIBRARYLIST>11011#*조정협의회내용및재무제표불일치정보.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL B">가. 이사회 구성 개요&cr;</SPAN>
<SPAN USERMARK="F-GL B">(1) 이사회 구성 현황&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL">당사의 이사회는 이사로 구성되고 법령 또는 정관에 정하여진 사항, 주주총회로부터 위임받은 사항, 회사경영의 기본방침 및 업무집행에 관한 주요사항을 의결하며 이사 및 경영진의 직무의 집행을 감독하고 있습니다.&cr;&cr;증권신고서 작성기준일 현재 당사의 이사회는 총 4명의 이사(사내이사3명, 사외이사 1명)으로 구성되어 있으며, 이사회 내 별도의 위원회는 구성되어 있지 않습니다. 각 이사의 약력 및 담당업무 등은 'VIII. 임원 및 직원 등에 관한 사항'을 참조하시기 바랍니다.</SPAN>
</P>
<P USERMARK="F-GL">&cr;</P>
<P USERMARK="F-GL B">(2) 사외이사 현황</P>

<TABLE BORDER="1" WIDTH="680" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="369"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>성명</P>
</TH>

<TH WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>주요경력</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>최대주주와의 &cr;이해관계</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>결격요건&cr;여부</P>
</TH>

<TH WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>이용주</P>
</TD>

<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="214">
<P>1985.03~1992.02 한남대 법학 학사</P>
<P>2002 서울대학교 공과대학 IT벤처산업과정 이수</P>
<P>2005 서울대학교 공과대학 최고산업전략과정 이수</P>
<P>2006 KAIST 테크노경영대학원 전자정부고위과정 수료</P>
<P>1992.03~1993.02 한국콘도㈜</P>
<P>1993.02~1994.12 씨앤씨정보통신㈜</P>
<P>1995.02~1998.10씨엔씨엔터프라이즈㈜</P>
<P>1998.11~2000.12 사업 준비 기간</P>
<P>2001.06~2015.12 ㈜ 씨솔 대표이사</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">
<P>해당사항</P>
<P> 없음</P>
</TD>

<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" COLSPAN="2" HEIGHT="214">
<P>해당사항</P>
<P>없음</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL B">나. 주요의결사항&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="690">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="364"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">회차</TD>
<TD ROWSPAN="3" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">개최일자</TD>
<TD ROWSPAN="3" WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">의안내용</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">사외이사 등의 성명</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">이용주&cr;(출석률: 90%)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">찬 반 여 부</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">1</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.10</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">단기 차입의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.12</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제16기 재무제표 승인의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.26</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제16기 정기주주총회 소집을 위한 결의의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.26</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내부회계관리제도 운영실태보고</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.04</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">타법인 출자증권 취득결정의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.10</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">내부회계관리제도 평가보고</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.14</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">단기 차입 연장의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.13</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">타법인 주식 및 출자증권 취득 결정의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">9</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.02</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">단기 차입의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">불참</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="3" HEIGHT="90">10</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="3" HEIGHT="90">2020.12.14</TD>
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경영위원회 개설 및 운영의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입 연장의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">산업은행 차입 연장의 건</TD>
<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-GL B">다. 이사회 내의 위원회 구성</SPAN>
<SPAN USERMARK="F-GL">&cr;"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">라. 이사의 독립성</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">(1) 이사의 선임&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">당사의 이사회는 이사회 규정에 따라 법령 또는 정관에 정하여진 사항, 주주총회로부터 위임받은 사항, 회사 경영의 기본방침 및 업무집행에 관한 중요사항을 의결합니다. 이사회는 이사전원으로 구성하고, 이사회 의장은 정관에 의해서 결정되며, 증권신고서 작성기준일 현재 당사는 대표이사가 의장을 맡습니다.&cr;&cr;당사는 회사 경영의 중요한 의사 결정과 업무 집행을 이사회의 심의 및 결정을 통하여 수행하며, 대주주 등의 독단적인 경영과 이로 인한 소액주주의 이익 침해가 발생하지 않도록 이사회운영규정을 제정하여 성실히 준수하고 있습니다.&cr;&cr;현행이사회의 구성 및 최대주주와의 관계 등은 다음과 같습니다.&cr;</SPAN>
</P>

<TABLE BORDER="1" WIDTH="563" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="60"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>성명</P>
</TH>

<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>활동분야&cr;(담당업무)</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>추천인</P>
</TH>

<TH WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>회사와의 거래</P>
</TH>

<TH WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>최대주주와의&cr;  관계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>성대영</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>대표이사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이사회</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>본인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>권광영</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>관리총괄</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이사회</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>안종태</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>마케팅촐괄</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이사회</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="69" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이용주</P>
</TD>

<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>사외이사</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>이사회</P>
</TD>

<TD WIDTH="109" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>

<TD WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>타인</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-GL B">(2) 사외이사 후보 추천위원회</SPAN>
<SPAN USERMARK=" B">&cr;</SPAN>당사는 자산총액 2조원 미만으로 사외이사 후보 추천위원회 설치 의무가 없으므로, 해당사항이 없습니다.&cr;&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">사외이사 및 그 변동현황</SPAN>
</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">1</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『사외이사 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_사외이사_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">40_02_사외이사_교육_미실시내역</FILENAME>
<P USERMARK="F-GL">사외이사 교육 미실시 내역</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" HEIGHT="76" ACODE="ODRT_EDU_NOT_DTL">이사회 개최시 해당 안건의 내용을 충분히 검토할 수 있도록 관련 자료와 정보를 제공하고 있으며, 별도의 교육은 진행하지 않고있습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P USERMARK="F-GL B">
<SPAN>가. 감사위원회 설치여부 및 구성방법 등&cr;</SPAN>
<SPAN USERMARK=" !B">당사는 증현재 감사위원회를 별도로 설치하고 있지 않습니다. 하지만 정관 및 감사직무규정에 의거 감사의 권한, 책임, 운영 방안 등을 규정하고 있습니다. 현재 상근감사1인을 두고 있으며 감사에 관한 주요 사항은 다음과 같습니다.&cr;</SPAN>
</P>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="490"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구분</P>
</TH>

<TH WIDTH="499" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="352">
<P>정관</P>
</TD>

<TD WIDTH="499" HEIGHT="352">
<P>제 47 조 (감사의 직무 등) </P>
<P>① 감사는 회사의 회계와 업무를 감사한다.</P>
<P>② 감사는 회의의 목적사항과 소집의 이유를 기재한 서면을 이사회에 제출하여 임시주주총회의 소집을 청구할 수 있다. </P>
<P>③ 감사는 그 직무를 수행하기 위하여 필요한 때에는 자회사에 대하여 영업의 보고를 요구할 수 있다. 이 경우 자회사가 지체없이 보고를 하지 아니할 때 또는 그 보고의 내용을 활인할 필요가 있는 때에는 자회사의 업무와 재산상태를 조사할 수 있다. </P>
<P>④ 감사에 대해서는 제36조 제3항(이사의 의무)의 규정을 준용한다.</P>
<P>⑤ 감사는 회사의 비용으로 전문가의 도움을 구할 수 있다.</P>
<P>⑥ 감사는 필요하면 회의의 목적사항과 소집이유를 적은 서면을 이사(소집권자가 있는 경우에는 소집권자)에게 제출하여 이사회 소집을 청구할 수 있다.</P>
<P>⑦ 제6항의 청구를 하였는데도 이사가 지체 없이 이사회를 소집하지 아니하면 그 청구한 감사가 이사회를 소집할 수 있다. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="1157">
<P>감사직무규정</P>
</TD>

<TD WIDTH="499" HEIGHT="1157">
<P>제6조(감사의 직무)</P>
<P>① 감사는 이사의 직무의 집행을 감사한다.</P>
<P>② 감사는 다음 각 호의 직무를 수행한다.</P>
<P>  1) 감사계획의 수립, 집행, 결과평가, 보고 및 사후조치</P>
<P>  2) 회사 내 내부통제제도의 적정성을 유지하기 위한 개선점 모색</P>
<P>  3) 내부회계관리제도의 설계 및 운영 실태에 대한 평가 및 보고</P>
<P>  4) 외부감사인의 선임 및 감사업무 수행에 관한 사항</P>
<P>  5) 외부감사인의 감사활동에 대한 평가</P>
<P>  6) 감사결과 지적사항에 대한 조치내용 확인</P>
<P>  7) 관계법령 또는 정관에서 정한 사항의 처리</P>
<P>  8) 회계부정에 대한 내부신고.고지가 있을 경우 그에 대한 사실과 조치&cr;    내용 확인 및 신고.고지자의 신분 등에 관한 비밀유지와 신고·고지자&cr;    의 불이익한 대우 여부 확인</P>
<P>  9) 감사가 필요하다고 인정하는 사항에 대한 감사 </P>
<P>&cr;제7조(감사의 권한)</P>
<P>① 감사는 다음 각 호의 권한을 행사할 수 있다.</P>
<P>  1) 이사 등에 대한 영업의 보고 요구 및 회사의 업무.재산상태 조사</P>
<P>  2) 자회사에 대한 영업보고 요구 및 업무와 재산상태에 관한 조사</P>
<P>  3) 임시주주총회의 소집 청구</P>
<P>  4) 이사회에 출석 및 의견 진술</P>
<P>  5) 이사회의 소집청구 및 소집</P>
<P>  6) 회사의 비용으로 전문가의 조력을 받을 권한 </P>
<P>  7) 감사의 해임에 관한 의견진술</P>
<P>  8) 이사의 보고 수령</P>
<P>  9) 이사의 위법행위에 대한 유지청구</P>
<P>  10) 주주총회 결의 취소의 소 등 각종 소의 제기</P>
<P>  11) 이사.회사간 소송에서의 회사 대표</P>
<P>  12) 외부감사인으로부터 이사의 직무수행에 관한 부정행위 또는 법령&cr;    이나 정관에 위반되는 중요한 사실의 보고 수령</P>
<P>  13) 외부감사인으로부터 회사가 회계처리 등에 관한 회계처리기준을&cr;    위반한 사실의 보고 수령</P>
<P>  14) 재무제표(연결재무제표 포함)의 이사회 승인에 대한 동의</P>
<P>② 감사는 다음 각 호의 사항을 요구할 수 있으며, 그 요구를 받은 자는 &cr;   특별한 사유가 없는 한 이에 응하여야 한다.</P>
<P>  1) 회사내 모든 정보에 대한 사항</P>
<P>  2) 관계자의 출석 및 답변</P>
<P>  3) 창고, 금고, 장부 및 관계서류, 증빙, 물품 등에 관한 사항</P>
<P>  4) 그 밖에 감사업무수행에 필요한 사항의 요구</P>
<P>③ 감사는 각 부서의 장에게 임직원의 부정행위가 있거나 중대한 과실이&cr;   있을 때에는 지체 없이 보고할 것을 요구할 수 있다. 이 경우 감사는 &cr;   지체 없이 특별감사에 착수하여야 한다.</P>
<P>&cr;제8조(감사의 의무)</P>
<P>① 감사는 회사의 수임인으로서 회사에 대하여 선량한 관리자의 주의의무를 가지고 그 직무를 수행하여야 한다.</P>
<P>② 감사는 재임중뿐만아니라 퇴임 이후에도 직무상 알게된 회사의 영업상 비밀을 누설하여서는 아니 된다.</P>
<P>③ 감사는 이사가 법령 또는 정관에 위반한 행위를 하거나 그 행위를 할 염려가 있다고 인정한 때에는 이사회에 이를 보고하여야 한다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-GL B">나. 감사의 인적사항</SPAN>
</P>

<TABLE BORDER="1" WIDTH="636" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="373"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>성명</P>
</TH>

<TH WIDTH="382" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>주요경력</P>
</TH>

<TH WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>결격요건 여부</P>
</TH>

<TH WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>이승철</P>
</TD>

<TD WIDTH="382" HEIGHT="237">
<P>1987.07-1997.01  삼성생명 증권사업부</P>
<P>1997.02-1998.09  삼성생명 해외투자부</P>
<P>1998.09-2000.06  삼성생명 재무심사팀</P>
<P>2000.07-2004.08  삼성생명 투자사업부</P>
<P>2005.02-2009.06  삼성생명 재무심사팀</P>
<P>2009.07-2013.12  삼성생명 특별계정사업부</P>
<P>2013.12-2014.12  삼성생명 경영자문/상무이사</P>
<P>2014.12-2018.06  산림조합중앙회 상호금융 부문 총괄</P>
<P>2016.08-2016.11  SJ산림조합 상조주식회사 대표이사</P>
<P>2018.12 -  현재   위더스제약㈜ 상임감사</P>
</TD>

<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>없음</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="237">
<P>상근감사</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">다. 감사의 독립성&cr;</SPAN>
<SPAN USERMARK="F-GL">감사는 주주총회의 결의로 선임하며, 경영층이 채택한 내부통제 정책 및 제도의 적정성과 효과성에 대하여 독립적이고 객관적인 평가를 수행하고 있습니다.&cr;&cr;감사의 감사업무 수행은 회계감사를 위해 재무제표 등 회계관련 서류 및 회계법인의 감사절차와 감사결과를 검토하고, 신뢰할 수 있는 회계정보의 작성 및 공시를 위하여 설치한 내부회계 관리제도의 운영실태를 내부회계관리자로부터 보고받고 이를 검토합니다.&cr;&cr;또한 수시감사 및 정기감사를 통해 재무제표 등과 기업 제반 현황에 대한 감사를 실시합니다&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B"> 라. 감사의 주요 활동내용&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="611">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="364"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>개최일자</P>
</TD>

<TD WIDTH="373" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>의 안 내 용</P>
</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>가결</P>
<P>여부</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">
<P>비 고</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.10</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">단기 차입의 건</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.12</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">제16기 재무제표 승인의 건</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.26</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">제16기 정기주주총회 소집을 위한 결의의 건</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.08.26</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">내부회계관리제도 운영실태보고</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.04</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">타법인 출자증권 취득결정의 건</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.10</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">내부회계관리제도 평가보고</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.09.14</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">단기 차입 연장의 건</TD>

<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>가결</P>
</TD>

<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.10.13</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">타법인 주식 및 출자증권 취득 결정의 건</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020.11.02</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">단기 차입의 건</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" ROWSPAN="3" HEIGHT="90">2020.12.14</TD>
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">경영위원회 개설 및 운영의 건</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">차입 연장의 건</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="373" VALIGN="MIDDLE" HEIGHT="30">산업은행 차입 연장의 건</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="70" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK=" B"></SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회 위원의 인적사항 및 사외이사 여부』 삽입</COMMENT>
<LIBRARYLIST>11011#*감사위원현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 교육실시 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_교육_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">41_04_감사_교육_미실시내역</FILENAME>

<P>
<SPAN USERMARK="F-GL B">마. 감사 교육 실시계획 및 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="ADT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">감사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" HEIGHT="99" ACODE="ADT_EDU_NOT_DTL">당사의 감사는 풍부한 경험을 보유하여 감사업무를 수행하는데 전문성이 충분하다고 판단되며, 경영전반에 관한 감사업무 수행이 가능하도록 관련 자료와 정보를 제공하고 있어 별도의 교육은 진행하지 않고 있습니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『감사위원회(감사) 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_감사*_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">42_03_감사위원회(감사)_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL B">바. 감사 지원조직 현황&cr;</SPAN>
<SPAN USERMARK="F-GL">당사는 감사의 직무수행을 보조하기 위한 별도의 지원조직을 갖추고 있지 않으나 필요할 경우 경영지원본부에서 감사의 직무수행 관련 업무를 보조하고 있습니다.</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="E1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『준법지원인 등 지원조직 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*_준법지원인등_지원조직_*.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">43_02_준법지원인등_지원조직_해당사항없음</FILENAME>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>지원조직이 없는 경우에는 그 사실을 기재한다.</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL B">사. 준법지원인 등&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">당사는 준법지원인 및 준법지원인 지원조직이 없습니다.</SPAN>
</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주의 의결권 행사에 관한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 집중투표제의 채택여부&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL B">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL B">나. 서면투표제 또는 전자투표제의 채택여부&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 소수주주권의 행사여부&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 경영권 경쟁&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"</SPAN>
<SPAN USERMARK="F-GL B">&cr;</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>
<P USERMARK="F-GL16">최대주주 및 특수관계인의 주식소유 현황</P>
<P USERMARK="F-GL B">가. 최대주주 및 특수관계인의 주식소유 현황</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="709" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="389"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="398" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="710" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="384" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="107" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="208" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="114" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">성대영</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">최대주주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">4,614,865</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">52.48</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">4,614,865</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">52.48</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">권광영</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">35,000</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.39</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">35,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.39</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">안종태</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,750</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.02</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,750</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.02</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이광영</TE>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">비등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">7,000</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">7,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="156" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">우선주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="114" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">4,658,615</TE>
<TE ALIGN="RIGHT" WIDTH="94" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">52.98</TE>
<TE ALIGN="RIGHT" WIDTH="113" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">4,658,615</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">52.98</TE>
<TE ALIGN="CENTER" WIDTH="107" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P>&cr;</P>

<P USERMARK="F-GL16">
<SPAN>최대주주의 주요경력 및 개요&cr;</SPAN>
<SPAN USERMARK="F-12"></SPAN>
<SPAN USERMARK="F-12 B">나. 최대주주 주요경력</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="347"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="80" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직책</P>
</TH>

<TH WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요경력</P>
</TH>

<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>비고</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="80" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">
<P>성대영</P>
</TD>

<TD WIDTH="95" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대표이사</P>
</TD>

<TD WIDTH="356" HEIGHT="191">
<P>2011.02 중앙대학교 대학원 경제학 박사&cr;1988.09~1991.12 ㈜한샘제약</P>
<P>1992.01~1997.10 극동제약 (現비씨월드제약)</P>
<P>1997.11~1999.06 (주)열린약품&cr;1999.06~2005.04 한빛약품㈜&cr;2005.01~현재 위더스 제약㈜&cr;2009.01~2020.04 의료법인 석경의료재단 이사장</P>
<P>2012.03~2018.02 남서울대학교 국제유통학과 교수</P>
</TD>
<TD WIDTH="94" HEIGHT="191" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-16">
<SPAN USERMARK="F-12 B">&cr;</SPAN>
<SPAN USERMARK="F-GL12 B">다. 최대주주의 변동을 초래할 수 있는 특정 거래 유무&cr;</SPAN>
<SPAN USERMARK="F-GL12">"해당사항이 없음"&cr;</SPAN>
<SPAN USERMARK="F-12 B">&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주가 법인 또는 투자조합 등 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P USERMARK="F-16"></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆복수click가능◆『최대주주의 최대주주(최대출자자)가 법인 또는 단체인 경우』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주의최대출자자가단체인경우.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『최대주주 변동내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*최대주주변동내역.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK=" B"></SPAN>
</P>
<P USERMARK="F-GL B">라. 5% 이상 주주와 우리사주조합 등의 주식 소유현황</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="745" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="434"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="443" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="745" BORDER="1">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="343"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="107" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="352" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="107" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="352" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">성대영</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">4,614,865</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">52.49</TE>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최대주주</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="352" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">-</TE>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">-</TE>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="459" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">274,288</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">3.11</TE>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>&cr;
<SPAN></SPAN>
<SPAN></SPAN>
<SPAN USERMARK="F-GL B">마. 그 외 소액주주 </SPAN>
<SPAN USERMARK="F-GL B">현황</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『소액주주현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*소액주주현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">10_소액주주현황</FILENAME>

<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N"></TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="739" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="433"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="442" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="738" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="61"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="291" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="290" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="79" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주주수</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체&cr;주주수</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액&cr;주식수</TH>
<TH WIDTH="109" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행&cr;주식수</TH>
<TH WIDTH="72" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율&cr;(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNT">16,766</TE>
<TE WIDTH="110" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_CNTT">16,772</TE>
<TE WIDTH="70" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_JJ_RT">99.96</TE>
<TE WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNT">3,747,474</TE>
<TE WIDTH="109" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_CNTT">8,792,415</TE>
<TE WIDTH="72" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH4_BB_RT">42.62</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>&cr;&cr;</P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>
<P USERMARK="F-GL B">가. 임원의 현황</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1485" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="1136"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1145" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1483" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="412"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="145"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근&cr;여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당&cr;업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="421" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="167" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의&cr;관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="94" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="154" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기&cr;만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권&cr;없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="250" ACODE="SH5_NM_T" VALIGN="MIDDLE">성대영</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="250" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="250" AUNIT="SH5_BIH" AUNITVALUE="195911" VALIGN="MIDDLE">1959년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="250" ACODE="SH5_LEV" VALIGN="MIDDLE">대표이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="250" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="250" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="250" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영총괄</TE>

<TE WIDTH="421" HEIGHT="250" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">2009.02~2011.02 중앙대 경제학 박사</P>
<P USERMARK="F-GL">2012.03~2018.02 남서울대학교  국제유통학과 교수&cr;1988.09~1991.12 ㈜한샘제약</P>
<P USERMARK="F-GL">1992.01~1997.10 극동제약 (現비씨월드제약)</P>
<P USERMARK="F-GL">1997.11~1999.06 ㈜열린약품&cr;1999.06~2005.04 한빛약품㈜&cr;2009.01~2020.04 의료법인 석경의료재단 이사장</P>
<P USERMARK="F-GL">2005.01~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="250" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">4,658,615</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="250" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="250" ACODE="SH5_RLTN" VALIGN="MIDDLE">본인</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="250" ACODE="SH5_PER" VALIGN="MIDDLE">16년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="250" AUNIT="SH5_FIH" AUNITVALUE="20220819" VALIGN="MIDDLE">2022년 08월 19일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="178" ACODE="SH5_NM_T" VALIGN="MIDDLE">권광영</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="178" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="178" AUNIT="SH5_BIH" AUNITVALUE="196102" VALIGN="MIDDLE">1961년 02월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="178" ACODE="SH5_LEV" VALIGN="MIDDLE">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="178" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="178" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="178" ACODE="SH5_OBJ" VALIGN="MIDDLE">관리총괄</TE>

<TE WIDTH="421" HEIGHT="178" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1980.03~1987.02 서울대 조경학 학사</P>
<P USERMARK="F-GL">2006.03~2008.02 성균관대 경영전문대학원 석사</P>
<P USERMARK="F-GL">1987.07~2007.12 삼성인력개발원</P>
<P USERMARK="F-GL">2008.01~2015.06 흥국생명</P>
<P USERMARK="F-GL">2017.03~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="178" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">35,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="178" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="178" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="178" ACODE="SH5_PER" VALIGN="MIDDLE">3년 9개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="178" AUNIT="SH5_FIH" AUNITVALUE="20230331" VALIGN="MIDDLE">2023년 03월 31일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="235" ACODE="SH5_NM_T" VALIGN="MIDDLE">안종태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="235" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="235" AUNIT="SH5_BIH" AUNITVALUE="195810" VALIGN="MIDDLE">1958년 10월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="235" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="235" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="235" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="235" ACODE="SH5_OBJ" VALIGN="MIDDLE">마케팅총괄</TE>

<TE WIDTH="421" HEIGHT="235" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1977.03~1984.02 전북대 경영학 학사&cr;1983.11~2000.06 경향신문</P>
<P USERMARK="F-GL">2000.07~2002.02 경향 닷컴</P>
<P USERMARK="F-GL">2002.02~2007.12 알리안츠생명</P>
<P USERMARK="F-GL">2008.06~2009.01 전&김 웰스펌</P>
<P USERMARK="F-GL">2009.02~2010.04 석경의료재단</P>
<P USERMARK="F-GL">2010.07~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="235" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">1,750</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="235" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="235" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="235" ACODE="SH5_PER" VALIGN="MIDDLE">10년 5개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="235" AUNIT="SH5_FIH" AUNITVALUE="20220819" VALIGN="MIDDLE">2022년 08월 19일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="204" ACODE="SH5_NM_T" VALIGN="MIDDLE">이승철</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="204" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="204" AUNIT="SH5_BIH" AUNITVALUE="195803" VALIGN="MIDDLE">1958년 03월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="204" ACODE="SH5_LEV" VALIGN="MIDDLE">감사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="204" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="204" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="204" ACODE="SH5_OBJ" VALIGN="MIDDLE">감사</TE>

<TE WIDTH="421" HEIGHT="204" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1981.03~1985.02 성균관대 경영학학사</P>
<P USERMARK="F-GL">1985.03~1987.02 성균관대학원 경영학 석사</P>
<P USERMARK="F-GL">2016.03~2016.08 서울대 국제대학원 GLP(국제리더십)</P>
<P USERMARK="F-GL">1987.07~2014.12 삼성생명</P>
<P USERMARK="F-GL">2014.12~2018.06 산림조합중앙회</P>
<P USERMARK="F-GL">2018.12~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="204" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="204" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="204" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="204" ACODE="SH5_PER" VALIGN="MIDDLE">2년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="204" AUNIT="SH5_FIH" AUNITVALUE="20211202" VALIGN="MIDDLE">2021년 12월 02일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="294" ACODE="SH5_NM_T" VALIGN="MIDDLE">이용주</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="294" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="294" AUNIT="SH5_BIH" AUNITVALUE="196509" VALIGN="MIDDLE">1965년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="294" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="294" AUNIT="SH5_REG_DRCT" AUNITVALUE="1" VALIGN="MIDDLE">등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="294" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="294" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사</TE>

<TE WIDTH="421" HEIGHT="294" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1985.03~1992.02 한남대 법학 학사</P>
<P USERMARK="F-GL">2002 서울대학교 공과대학 IT벤처산업과정 이수</P>
<P USERMARK="F-GL">2005 서울대학교 공과대학 최고산업전략과정 이수</P>
<P USERMARK="F-GL">2006 KAIST 테크노경영대학원 전자정부고위과정 수료</P>
<P USERMARK="F-GL">1992.03~1993.02 한국콘도㈜</P>
<P USERMARK="F-GL">1993.02~1994.12 씨앤씨정보통신㈜</P>
<P USERMARK="F-GL">1995.02~1998.10씨엔씨엔터프라이즈㈜</P>
<P USERMARK="F-GL">1998.11~2000.12 사업 준비 기간</P>
<P USERMARK="F-GL">2001.06~2015.12 ㈜ 씨솔 대표이사</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="294" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="294" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="294" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="294" ACODE="SH5_PER" VALIGN="MIDDLE">1년 1개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="294" AUNIT="SH5_FIH" AUNITVALUE="20221127" VALIGN="MIDDLE">2022년 11월 27일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="285" ACODE="SH5_NM_T" VALIGN="MIDDLE">장병곤</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="285" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="285" AUNIT="SH5_BIH" AUNITVALUE="196209" VALIGN="MIDDLE">1962년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="285" ACODE="SH5_LEV" VALIGN="MIDDLE">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="285" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="285" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="285" ACODE="SH5_OBJ" VALIGN="MIDDLE">개발</TE>

<TE WIDTH="421" HEIGHT="285" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1981.03~1985.02 중앙대 약학 학사</P>
<P USERMARK="F-GL">1985.03~1987.02 중앙대학원약제학 석사</P>
<P USERMARK="F-GL">1998.03~2001.07 중앙대학원 약제학 박사</P>
<P USERMARK="F-GL">1987.02~1996.06 한일약품공업㈜</P>
<P USERMARK="F-GL">1996.07~2000.12 대원제약㈜</P>
<P USERMARK="F-GL">2001.01~2002.08 삼성제약㈜</P>
<P USERMARK="F-GL">2002.09~2003.09 한국디디에스제약</P>
<P USERMARK="F-GL">2004.03~2006.09 한불제약㈜ 부사장</P>
<P USERMARK="F-GL">2006.10~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="285" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="285" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="285" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="285" ACODE="SH5_PER" VALIGN="MIDDLE">14년 2개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="285" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="200" ACODE="SH5_NM_T" VALIGN="MIDDLE">이광영</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="200" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="200" AUNIT="SH5_BIH" AUNITVALUE="195903" VALIGN="MIDDLE">1959년 03월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="200" ACODE="SH5_LEV" VALIGN="MIDDLE">전무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="200" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="200" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="200" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="200" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1978.03~1987.02 인하대 문과대 학사&cr;1987.02~1992.12 ㈜한샘제약</P>
<P USERMARK="F-GL">1993.01~2000.12 삼천당제약</P>
<P USERMARK="F-GL">2001.01~2002.11 태준제약</P>
<P USERMARK="F-GL">2003.01~2004.08 ㈜반도제약</P>
<P USERMARK="F-GL">2005.01~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="200" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">7,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="200" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="200" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="200" ACODE="SH5_PER" VALIGN="MIDDLE">16년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="200" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="140" ACODE="SH5_NM_T" VALIGN="MIDDLE">허경환</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="140" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="140" AUNIT="SH5_BIH" AUNITVALUE="196204" VALIGN="MIDDLE">1962년 04월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="140" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="140" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="140" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="140" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="140" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1980.03~1987.02 계명대 영문학과 학사&cr;1987.03~2004.01 현대약품</P>
<P USERMARK="F-GL">2004.02~2004.11 한국이텍스 주식회사</P>
<P USERMARK="F-GL">2005.01~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="140" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="140" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="140" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="140" ACODE="SH5_PER" VALIGN="MIDDLE">16년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="140" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="164" ACODE="SH5_NM_T" VALIGN="MIDDLE">이동림</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="164" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="164" AUNIT="SH5_BIH" AUNITVALUE="196312" VALIGN="MIDDLE">1963년 12월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="164" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="164" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="164" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="164" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="164" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1982.03~1990.02 경기대 회계학과 학사&cr;1989.11~1994.04 상아제약</P>
<P USERMARK="F-GL">1994.09~2004.07 보령제약</P>
<P USERMARK="F-GL">2007.09~2011.11 하나제약</P>
<P USERMARK="F-GL">2012.03~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="164" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="164" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="164" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="164" ACODE="SH5_PER" VALIGN="MIDDLE">8년 9개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="164" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="143" ACODE="SH5_NM_T" VALIGN="MIDDLE">강경로</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="143" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="143" AUNIT="SH5_BIH" AUNITVALUE="196303" VALIGN="MIDDLE">1963년 03월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="143" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="143" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="143" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="143" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="143" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1982.03~1988.02 경희대 원자력공학 학사&cr;1988.02~2002.08 제일약품</P>
<P USERMARK="F-GL">2002.08~2004.08 한국마이팜제약</P>
<P USERMARK="F-GL">2005.01~현재위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="143" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="143" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="143" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="143" ACODE="SH5_PER" VALIGN="MIDDLE">16년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="143" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">김기용</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="196412" VALIGN="MIDDLE">1964년 12월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1984.03~1991.02 경기대 경영학과 학사&cr;1990.10~2002.12 제일약품</P>
<P USERMARK="F-GL">2004.04~2004.08 마이팜제약</P>
<P USERMARK="F-GL">2005.01~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">16년</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="149" ACODE="SH5_NM_T" VALIGN="MIDDLE">이시형</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="149" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="149" AUNIT="SH5_BIH" AUNITVALUE="196408" VALIGN="MIDDLE">1964년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="149" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="149" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="149" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="149" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="149" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1983.03~1992.02 건국대 사범대학 학사&cr;1992.05~2000.12 한미약품</P>
<P USERMARK="F-GL">2001.01~2004.11 씨트리제약</P>
<P USERMARK="F-GL">2006.02~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="149" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="149" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="149" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="149" ACODE="SH5_PER" VALIGN="MIDDLE">14년 10개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="149" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="179" ACODE="SH5_NM_T" VALIGN="MIDDLE">이금호</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="179" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="179" AUNIT="SH5_BIH" AUNITVALUE="196607" VALIGN="MIDDLE">1966년 07월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="179" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="179" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="179" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="179" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업</TE>

<TE WIDTH="421" HEIGHT="179" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1986.03~1990.02 동우대 치과기공학 졸업&cr;1992.06~2001.09 경동제약</P>
<P USERMARK="F-GL">2002.07~2006.12 삼천당제약㈜</P>
<P USERMARK="F-GL">2007.01~2008.03 이연제약</P>
<P USERMARK="F-GL">2008.05~현재위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="179" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="179" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="179" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="179" ACODE="SH5_PER" VALIGN="MIDDLE">12년 7개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="179" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="236" ACODE="SH5_NM_T" VALIGN="MIDDLE">한강의</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="236" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="236" AUNIT="SH5_BIH" AUNITVALUE="194302" VALIGN="MIDDLE">1943년 02월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="236" ACODE="SH5_LEV" VALIGN="MIDDLE">소장</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="236" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="236" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="236" ACODE="SH5_OBJ" VALIGN="MIDDLE">연구개발</TE>

<TE WIDTH="421" HEIGHT="236" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1961.03~1968.02 서울대약학 학사</P>
<P USERMARK="F-GL">1969.03~1971.02 서울대 보건대학원 석사</P>
<P USERMARK="F-GL">1972.07~1976.07 ㈜유이씨</P>
<P USERMARK="F-GL">1977.10~1985.04 정우양행</P>
<P USERMARK="F-GL">1985.05~1995.05 가람제약(주)</P>
<P USERMARK="F-GL">2004.08~2007.03 한불제약 공장장</P>
<P USERMARK="F-GL">2007.04~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="236" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="236" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="236" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="236" ACODE="SH5_PER" VALIGN="MIDDLE">13년 8개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="236" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="197" ACODE="SH5_NM_T" VALIGN="MIDDLE">이현종</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="197" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="197" AUNIT="SH5_BIH" AUNITVALUE="196307" VALIGN="MIDDLE">1963년 07월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="197" ACODE="SH5_LEV" VALIGN="MIDDLE">상무이사</TE>
<TU ALIGN="CENTER" WIDTH="93" HEIGHT="197" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기임원</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="197" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="93" HEIGHT="197" ACODE="SH5_OBJ" VALIGN="MIDDLE">생산총괄</TE>

<TE WIDTH="421" HEIGHT="197" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL">1982.03~1986.02 경희대 약학 학사</P>
<P USERMARK="F-GL">1986.03~1988.02 경희대 약학대학원 석사</P>
<P USERMARK="F-GL">1989.06~1994.05 보령제약</P>
<P USERMARK="F-GL">1994.06~1995.06 한독약품</P>
<P USERMARK="F-GL">2006.07~2008.07 인성약품</P>
<P USERMARK="F-GL">2008.08~현재 위더스제약㈜</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="197" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="197" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="197" ACODE="SH5_RLTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="94" HEIGHT="197" ACODE="SH5_PER" VALIGN="MIDDLE">12년 4개월</TE>
<TU ALIGN="CENTER" WIDTH="154" HEIGHT="197" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『등기임원후보자 및 해임대상자』 삽입</COMMENT>
<LIBRARYLIST>11011#*등기임원후보자및해임대상자.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK="F-GL">직원 등 현황</P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="929" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="562"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="571" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="925" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="33"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="30"></COL>
<COL WIDTH="30"></COL>
<COL WIDTH="30"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="740" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외&cr;근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="42" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="343" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="75" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균&cr;근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여&cr;총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균&cr;급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="39" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="39" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="39" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이&cr;없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제&cr;근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="60" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간&cr;근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">6.1년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">156,416 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   26,069 </TE>
<TE ALIGN="CENTER" WIDTH="39" HEIGHT="270" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="9">-</TE>
<TE ALIGN="CENTER" WIDTH="39" HEIGHT="270" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="9">-</TE>
<TE ALIGN="CENTER" WIDTH="39" HEIGHT="270" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="9">-</TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">연구직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.8년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">91,820 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   22,955 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">생산직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">45</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">45</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.8년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">868,956 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   17,733 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">생산직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">30</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">30</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">5.7년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE"> 475,231 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   14,400 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">사무직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">24</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">24</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">6.3년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">1,185,964 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   47,438 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">사무직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">17</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">17</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">5.7년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">340,036 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   17,896 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">영업직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">87</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">87</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">6.0년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">4,383,701 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   49,255 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">영업직</TE>
<TU ALIGN="CENTER" WIDTH="42" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">3</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">5.9년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">64,188 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">   21,396 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="121" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">215</TE>
<TE ALIGN="RIGHT" WIDTH="67" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="68" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="79" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="60" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">215</TE>
<TE ALIGN="RIGHT" WIDTH="75" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">5.7년</TE>
<TE ALIGN="RIGHT" WIDTH="101" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">7,566,316 </TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">33,185 </TE>
<TE ALIGN="CENTER" WIDTH="68" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<INSERTION ABASISNUMBER="E0" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>* 직원 현황 표는 미등기임원을 포함하여 작성한다</COMMENT>
<LIBRARYLIST></LIBRARYLIST>
</INSERTION>
<P></P>
<P USERMARK="F-GL">미등기임원 보수 현황</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="786" BORDER="1">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="156"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="210"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="165" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="164" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="219" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="119" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT">10</TE>
<TE WIDTH="165" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT"> 826,617 </TE>
<TE WIDTH="164" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR"> 82,661</TE>
<TE WIDTH="219" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">1. 주주총회 승인금액</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="PRT_PAY_SUB">등기이사&cr;(사외이사 포함)</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="PRT_PAY_NUM">4</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="PRT_PAY_KMY">3,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">1,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK="F-GL">2. 보수지급금액</P>
<P USERMARK="F-GL">2-1. 이사ㆍ감사 전체</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">5</TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">  432,121</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">  86,424 </TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK="F-GL">2-2. 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당&cr;평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사&cr;(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_NUM">3</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">400,162 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">133,387 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사&cr;(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_NUM">1</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM"> 31,959 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC"> 31,959</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL B">1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK="F-GL B">2. 산정기준 및 방법</P>

<P>
<SPAN USERMARK="F-GL16 B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL B">1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P USERMARK="F-GL B">2. 산정기준 및 방법</P>

<P>
<SPAN USERMARK="F-GL16 B"></SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『주식매수선택권의 부여 및 행사현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*주식매수선택권의부여및행사현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">14_주식매수선택권의부여및행사현황</FILENAME>
<P USERMARK="F-GL"><주식매수선택권의 부여 및 행사현황></P>
<P><표1></P>

<TABLE-GROUP ACLASS="SUB_SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="232"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주식매수선택권의 공정가치 총액</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">등기이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_NUM">2</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="RRT_PAY_SUMT"> 25,320,312</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사외이사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="ORT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">감사위원회 위원 또는 감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="GRT_PAY_SUMT">-</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_NUM">2</TE>
<TE WIDTH="241" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUMT"> 25,320,312</TE>
<TE WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P><표2></P>

<TABLE-GROUP ACLASS="SOPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1118" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="724"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="153" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="733" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1114" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여&cr;받은자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여일</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">부여방법</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의&cr;종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최초&cr;부여&cr;수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기변동수량</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="103" HEIGHT="46" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총변동수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기말&cr;미행사수량</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사&cr;가격</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">행사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">권광영</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">3,899</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">3,899</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">안종태</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="1">등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,129</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,129</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">이광영</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,815</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,815</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">장병곤</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,129</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,129</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">이현종</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,129</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,129</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">이동림</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,358</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,358</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">한강의</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">3,441</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">3,441</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">허경환</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,453</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,453</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">이시형</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">2,467</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">2,467</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">이금호</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">2,252</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">2,252</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">강경로</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">5,981</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">5,981</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">김기용</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="2">미등기임원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">4,871</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">4,871</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="30" ACODE="SH5_NM">박경동 외</TE>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="SH5_RLT" AUNITVALUE="3">직원</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="SH5_GV_DT" AUNITVALUE="20191128">2019년 11월 28일</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="SH5_MTH">신주교부</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACODE="SH5_STK_KNDD">기명식보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="SH5_START_CNT">183,576</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="53" HEIGHT="30" ACODE="SH5_MEXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_MCNL_CNT">2,294</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SH5_EXE_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="55" HEIGHT="30" ACODE="SH5_CNL_CNT">4,588</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="SH5_NEXE_CNT">178,988</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="177" HEIGHT="30" ACODE="SH5_PER">2021.11.28~2026.11.27</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="SH5_PRC">13,548</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『타법인출자 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*타법인출자현황.dsl</LIBRARYLIST>
</INSERTION>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">1. 계열회사의 현황</SPAN>
<SPAN USERMARK="F-GL16 B">&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">2. 타법인 출자현황</SPAN>
</P>

<TABLE WIDTH="1288" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="834"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="BOTTOM" HEIGHT="30">(기준일 : </TD>
<TD WIDTH="152" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2020년 12월 31일</TD>
<TD WIDTH="213" VALIGN="BOTTOM" HEIGHT="30">)</TD>
<TD WIDTH="843" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 백만원, 주, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1288" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="52"></COL>
<COL WIDTH="55"></COL>
<COL WIDTH="68"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">법인명</TD>
<TD ROWSPAN="3" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득일자</TD>
<TD ROWSPAN="3" WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">출자&cr;목적</TD>
<TD ROWSPAN="3" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="113" USERMARK=" BC0XD7D7D7">최초취득금액</TD>
<TD COLSPAN="3" WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기초잔액</TD>
<TD COLSPAN="3" WIDTH="232" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">증가(감소)</TD>
<TD COLSPAN="3" WIDTH="195" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">기말잔액</TD>
<TD COLSPAN="2" WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" USERMARK=" BC0XD7D7D7">최근사업연도&cr;재무현황</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">취득(처분)</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">평가&cr;손익</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">수량</TD>
<TD ROWSPAN="2" WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">지분율</TD>
<TD ROWSPAN="2" WIDTH="61" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">장부&cr;가액</TD>
<TD ROWSPAN="2" WIDTH="64" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">총자산</TD>
<TD ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" USERMARK=" BC0XD7D7D7">당기&cr;순손익</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">수량</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">금액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">(주)인벤티지랩&cr;(비상장)</TD>
<TD WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">2020년 9월 8일</TD>
<TD WIDTH="91" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">기술성투자</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">3,796</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="479" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">158,329</TD>
<TD WIDTH="67" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2.47</TD>
<TD WIDTH="61" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,000</TD>
<TD WIDTH="64" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,867</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,796</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 이해관계자와의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-16 0XFF1200 B">1. 대주주 등에 대한 신용공여 등</SPAN>
<SPAN USERMARK=" 0XC02700">&cr;</SPAN>
<SPAN USERMARK="F-GL 0XC02700"></SPAN>
<SPAN USERMARK="F-GL B">가. 가지급금 및 대여금(증권 대여 포함) 내역</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">나. 담보제공 내역&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 채무보증 내역&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 차입금 내역&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">마. 부동산 임대차 거래&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">바. 배서 내역&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">사. 그 밖의 보증의 성격을 가지는 이행약속 등 거래상의 신용위험을 수반하는 직ㆍ간접적거래&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>&cr;&cr;
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK=" 0XFF1200 B"></SPAN>
<SPAN USERMARK=" 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">2. 대주주와의 자산양수도 등&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>&cr;&cr;
<SPAN USERMARK=" 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">3. 대주주와의 영업거래&cr;</SPAN>
<SPAN USERMARK=" 0XFF1200"></SPAN>
</P>

<TABLE WIDTH="889" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="580"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" VALIGN="BOTTOM" HEIGHT="30"></TD>
<TD WIDTH="589" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">(단위 : 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="888" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="45"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH ROWSPAN="2" WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="83">
<P>성 명&cr;(법인명)</P>
</TH>

<TH ROWSPAN="2" WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="83">
<P>관계</P>
</TH>

<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="83">
<P>구 분</P>
</TH>

<TH COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH COLSPAN="2" WIDTH="201" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>

<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>

<TH WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>금액</P>
</TH>

<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>내용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="135" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>(의)석경의료재단</P>
</TD>

<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P> 특수관계인</P>
</TD>

<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>매입거래</P>
</TD>

<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>3,410</P>
</TD>

<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>보건 대행 수수료</P>
</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7,612</TD>
<TD WIDTH="133" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보건 대행 수수료</TD>
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3,750</TD>
<TD WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">보건 대행 수수료</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="889" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="880"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="889" VALIGN="MIDDLE" HEIGHT="53">
<P>주1) (의)석경의료재단과의 매입거래는 보건대행수수료 거래 입니다. 이는 공장 보건 대행 수수료로 산업안전보건법상 당사의 공장에 대하여 의무적으로 보건 관리자가 필요하여 용역 의뢰한 것입니다.</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>&cr;
<SPAN USERMARK="F-16 0XFF1200 B">4. 대주주 이외의 이해관계자와의 거래&cr;</SPAN>&cr;
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL B">가. 신용공여</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="657">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="63" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="93" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>관계</P>
</TH>

<TH WIDTH="167" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제15기&cr;('18.07.01~'19.06.30)</P>
</TH>

<TH WIDTH="167" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제16기&cr;('19.07.01~'20.06.30)</P>
</TH>

<TH WIDTH="167" HEIGHT="76" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>제17기&cr;('20.07.01~'20.12.31)</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증가</P>
</TH>

<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감소</P>
</TH>

<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증가</P>
</TH>

<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감소</P>
</TH>

<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증가</P>
</TH>

<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>감소</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>안종태</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>등기임원</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>350</P>
</TD>

<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>강경로</P>
</TD>

<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>미등기임원</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>

<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>10</P>
</TD>

<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P>-</P>
</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 자산양수도 등&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">다. 영업거래&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">라. 대여금 내역&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">&cr;</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">1. 공시내용의 진행ㆍ변경상황 및 주주총회 현황&cr;</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B"></SPAN>
<SPAN USERMARK="F-GL B">가. 공시사항의 진행 및 변경 상황&cr;</SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;&cr;&cr;</SPAN>
<SPAN USERMARK="F-GL B">나. 주주총회 의사록 요약</SPAN>
<SPAN USERMARK="F-GL"></SPAN>
</P>

<TABLE BORDER="1" WIDTH="910" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="517"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="61"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">주총일자</TH>
<TH WIDTH="526" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">안 건</TH>
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">결 의 내 용</TH>
<TH WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제16기 정기주주총회&cr;(2020.09.25)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 제16기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 이사보수한도 승인의 건&cr;제 4호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제16기 임시주주총회&cr;(2020.05.06)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 제 15기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제16기 임시주주총회&cr;(2019.11.28)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사외이사 이용주&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 주식매수선택권 부여의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제15기 정기주주총회&cr;(2019.09.30)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 제 15기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 정관 일부 변경의 건&cr;제 3호 의안 : 이사보수한도 승인의 건&cr;제 4호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제15기 임시주주총회&cr;(2019.08.19)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="76">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 성대영&cr;제 1-2호 의안 : 사내이사 안종태</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제15기 임시주주총회&cr;(2018.12.03)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 감사 선임의 건&cr;제 1-1호 의안 : 감사 이승철</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">제14기 정기주주총회&cr;(2018.09.28)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="168">제 1호 의안 : 제 14기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 감사 선임의 건&cr;제 2-1호 의안 : 감사 이광영&cr;제 3호 의안 : 정관 일부 변경의 건&cr;제 4호 의안 : 이사보수한도 승인의 건&cr;제 5호 의안 : 감사보수한도 승인의 건&cr;제 6호 의안 : 임원 퇴직금 규정 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="168">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제14기 임시주주총회&cr;(2018.07.02)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 권광영</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">제13기 정기주주총회&cr;(2017.09.29)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="76">제 1호 의안 : 제 13기 재무제표 (이익잉여금처분계산서(안) 포함) 승인의 건&cr;제 2호 의안 : 이사보수한도 승인의 건&cr;제 3호 의안 : 감사보수한도 승인의 건</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">제13기 임시주주총회&cr;(2017.07.03)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="53">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사외이사 민경철</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">제13기 임시주주총회&cr;(2016.08.19)</TD>
<TD WIDTH="526" VALIGN="MIDDLE" HEIGHT="99">제 1호 의안 : 이사 선임의 건&cr;제 1-1호 의안 : 사내이사 성대영&cr;제 1-2호 의안 : 사내이사 김호천&cr;제 1-3호 의안 : 사내이사 안종태</TD>
<TD WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="70" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK="F-16 0XFF1200 B">2. 우발채무 등&cr;</SPAN>
<SPAN USERMARK=" B">가. 중요한 소송사건&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">나. 견질 또는 담보용 어음, 수표현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">다. 채무보증 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">라. 채무인수약정 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">마. 그 밖의 우발채무 등&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">바. 자본으로 인정되는 채무증권의 발행&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B"></SPAN>
<SPAN USERMARK="F-16 0XFF1200 B">3. 제재현황 등 그밖의 사항&cr;</SPAN>
<SPAN USERMARK=" B">가. 제재현황&cr;</SPAN>(1) 세무조사 등&cr;당사는 최근 5사업연도 이내 1건의 세무조사를 받은 바 있으며 납부 고지세액 전액을 납부 하였습니다. &cr;&cr;
</P>
<P USERMARK="F-GL">(가) 2017년 법인세 일반통합조사</P>

<TABLE BORDER="1" WIDTH="559" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="425"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>구분</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BC0XD7D7D7">
<P>내용 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사기관</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>도봉세무서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사기간</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>2017.03.09. ~ 2017.05.17</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사대상기간</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>2013.07.01. ~ 2014.06.30 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>조사사유</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="30">
<P>법인세 일반통합조사(교차세무조사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>조사내용</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="53">
<P>접대성 경비의 계정분류 오류 정정</P>
<P>법정 증빙 부적격분 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">
<P>납부세액</P>
</TD>

<TD WIDTH="434" VALIGN="MIDDLE" HEIGHT="53">
<P>합계 791,524,520원</P>
<P>법인세 719,567,750원, 지방세 71,956,770</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">&cr;
<SPAN USERMARK=" B">나. 작성기준일 이후 발생한 주요사항&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">다. 중소기업 기준검토표</SPAN>
</P>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="909">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="835" ALIGN="CENTER" HSPACE="0">위더스제약(주)_중소기업검토기준표1.jpg</IMG>
<IMG-CAPTION ATOC="N">위더스제약(주)_중소기업검토기준표1</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="30">
<P>중소기업검토기준표1</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE WIDTH="600" BORDER="0" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="909">
<P></P>

<IMAGE>
<IMG WIDTH="591" HEIGHT="835" ALIGN="CENTER" HSPACE="0">위더스제약(주)_중소기업검토기준표2.jpg</IMG>
<IMG-CAPTION ATOC="N">위더스제약(주)_중소기업검토기준표2</IMG-CAPTION>
</IMAGE>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="600" VALIGN="MIDDLE" HEIGHT="30">
<P>중소기업검토기준표2</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">&cr;</P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『신용보강 제공 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*신용보강제공현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『장래매출채권 유동화 현황 및 채무비중』 삽입</COMMENT>
<LIBRARYLIST>11011#*장래매출채권유동화현황및채무비중.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『단기매매차익 미환수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*단기매매차익미환수현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="N">
<COMMENT>◆click◆『공모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*공모자금의사용내역.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">18_공모자금의사용내역</FILENAME>

<P>
<SPAN USERMARK=" B">라. 직접금융 자금의 사용&cr;</SPAN>(1) 공모자금의 사용 내역
</P>

<TABLE-GROUP ACLASS="FUND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="924" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="624" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="923" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="181"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="140" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="268" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증권신고서 등의&cr; 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="256" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용&cr; 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="190" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="193" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="PO_TYPE" VALIGN="MIDDLE">일반공모</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="MO_SEQ" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="140" HEIGHT="53" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20200629">2020년 06월 29일</TU>
<TE ALIGN="CENTER" WIDTH="190" HEIGHT="53" ACODE="PLA_USE" VALIGN="MIDDLE">시설자금&cr;연구개발자금 및 운전자금</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="53" ACODE="PLA_AMT" VALIGN="MIDDLE">14,000</TE>
<TE ALIGN="CENTER" WIDTH="193" HEIGHT="53" ACODE="BRK_CON" VALIGN="MIDDLE">시설자금&cr;연구개발자금 및 운전자금</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="BRK_AMT" VALIGN="MIDDLE">14,000</TE>
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="53" ACODE="PS_AMT_PL" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>&cr;(2) 사모자금의 사용 내역&cr;"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">마. 외국지주회사의 자회사 현황&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">바. 법적위험 변동사항&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">사. 금융회사의 예금자 보호 등에 관한 사항&cr;</SPAN>
<SPAN>"해당사항 없음"&cr;</SPAN>
<SPAN USERMARK=" B"></SPAN>&cr;
<SPAN USERMARK=" B">아. 기업인수목적사의 요건 충족 여부&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">자</SPAN>
<SPAN USERMARK=" B">. 기업인</SPAN>
<SPAN USERMARK=" B">수목적회사의 금융투자업의 역할 및 의부&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">차. 합병등의 사후정보&cr;</SPAN>"해당사항 없음"&cr;&cr;
<SPAN USERMARK=" B">카. 녹색경영&cr;</SPAN>"해당사항 없음"&cr;
</P>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">타. 정부의 인증 및 그 취소에 관한 사항&cr;</SPAN>"해당사항 없음"&cr;
</P>

<P>
<SPAN USERMARK=" B">파. 조건부자본증권의 전환, 채무재조정 사유등의 변동현황&cr;</SPAN>"해당사항 없음" 
</P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『사모자금의 사용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*사모자금의사용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="N">
<COMMENT>◆click◆『미사용자금의 운용내역』 삽입</COMMENT>
<LIBRARYLIST>11011#*미사용자금의운용내역.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="LE0" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『합병등 전후의 재무사항 비교표』 삽입</COMMENT>
<LIBRARYLIST>11011#*합병등전후의재무사항비교표.dsl</LIBRARYLIST>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="1" ADUPLICATION="Y">
<COMMENT>◆click◆『보호예수 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*보호예수현황.dsl</LIBRARYLIST>

<LIBRARY>
<FILENAME ATYPE="dsl">35_보호예수현황</FILENAME>
<P USERMARK="F-GL B">하. 보호예수 현황</P>

<TABLE-GROUP ACLASS="PROT_STA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="878" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="569"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="164" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20201231">2020년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="56" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="578" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="879" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예수일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">반환예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보호예수사유</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총발행주식수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="53" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="53" ACODE="PROT_CNT" VALIGN="MIDDLE">4,614,865</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PROT_DAT" AUNITVALUE="20200703" VALIGN="MIDDLE">2020년 07월 03일</TU>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PROT_DATE" AUNITVALUE="20230102" VALIGN="MIDDLE">2023년 01월 02일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="PROT_PRD" VALIGN="MIDDLE">2년 6개월</TE>
<TE ALIGN="CENTER" WIDTH="198" HEIGHT="53" ACODE="PROT_RSN" VALIGN="MIDDLE">코스닥 시장 상장으로 인한&cr;최대주주보호예수</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="53" ACODE="PROT_TONT" VALIGN="MIDDLE">8,792,415</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="53" ACODE="PROT_KND" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="93" HEIGHT="53" ACODE="PROT_CNT" VALIGN="MIDDLE">272,911</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PROT_DAT" AUNITVALUE="20200703" VALIGN="MIDDLE">2020년 07월 03일</TU>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="PROT_DATE" AUNITVALUE="20210702" VALIGN="MIDDLE">2021년 07월 02일</TU>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="53" ACODE="PROT_PRD" VALIGN="MIDDLE">1년</TE>
<TE ALIGN="CENTER" WIDTH="198" HEIGHT="53" ACODE="PROT_RSN" VALIGN="MIDDLE">코스닥 시장 상장으로 인한&cr;우리사주보호예수</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="53" ACODE="PROT_TONT" VALIGN="MIDDLE">8,792,415</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>
</INSERTION>
<P></P>

<INSERTION ABASISNUMBER="SE1" AFREQUENCY="0" ADUPLICATION="Y">
<COMMENT>◆click◆『특례상장기업 관리종목 지정유예 현황』 삽입</COMMENT>
<LIBRARYLIST>11011#*특례상장기업관리종목지정유예현황.dsl</LIBRARYLIST>
</INSERTION>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>

<P>
<SPAN USERMARK="F-GL B"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>

<P>
<SPAN USERMARK="F-GL"></SPAN>
<SPAN USERMARK="F-GL">"해당사항 없음"&cr;</SPAN>
</P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>